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Abstract 
The transfer of genetic material from one cell generation to the next requires precise genome 
duplication. Aberrant DNA replication can lead to genomic instability and contribute to 
diseases arising from an unregulated cell cycle, such as cancer. Replicative DNA 
polymerases require a single-stranded (ssDNA) template from which to produce newly 
synthesized DNA. In eukaryotes, ssDNA is generated by the heterohexameric 
minichromosome maintenance 2 through 7 (Mcm2-7) replicative helicase that unwinds 
duplex DNA. Strict temporal separation of helicase loading and activation at multiple 
replication origins ensures once per cell cycle replication. The processes involved in 
activating Mcm2-7 to unwind DNA during S phase are poorly understood. Through in vivo 
and in vitro analyses, the current study examines the factors involved in modulating S. 
cerevisiae Mcm2-7 activity. 
 Mec1, a member of the PIKK (phosphoinositide three-kinase-related kinase) family 
of proteins, is involved in the response to replicative stress and DNA damage. It also plays a 
role during an unperturbed cell cycle and is required to phosphorylate Mcm2-7 prior to 
helicase activation. We characterized alleles of S. cerevisiae mec1 that alter the conserved 
FATC domain. Mutants of Mec1 resulted in temperature sensitive growth, sensitivity to 
hydroxyurea and reduced kinase activity in vitro. These mutants were also less stable than 
wild-type Mec1 and demonstrated reduced nuclear localization. We also identified rpn3-
L140P, which encodes a component of the 19S proteasomal regulatory particle of the 26S 
proteasome, as a suppressor of the temperature-sensitive growth caused by mec1-W2368A.  
 As Cdt1 is required for the nuclear import and origin loading of Mcm2-7, we also 
sought to investigate the interaction between these two components in more detail. Using 
reconstituted Mcm2-7•Cdt1 complexes from bacterial-expressed proteins, we demonstrated 
that these complexes exhibit lower ATPase and helicase activity than Mcm2-7. We also 
showed that Mcm2-7 dissociates into subcomplexes, and that Mcm3, 5 and 7 bound origins 
in the absence of Cdt1. We propose that the reduced ATPase activity of Mcm2-7 by Cdt1 
binding is induced by structural changes in the Mcm2-7 ring. We also suggest that Cdt1 helps 
to stabilize the Mcm2-7 hexamer.    
 iii 
 
To investigate the role of phosphorylation on Mcm2-7, we utilized a phosphomimetic 
mutant of Mcm4 that when incorporated into Mcm2-7 can bypass the requirement for DDK. 
While phosphomimetic Mcm4 demonstrated slightly lower ATPase activity than the wildtype 
protein, phosphomimetic Mcm2-7 complexes exhibited wildtype ATPase, helicase and DNA 
binding activity.   
 Taken together, our work identifies the functional role of the C-terminal residues of 
Mec1 and the protein’s turnover by the proteosome. Our studies also provide new insights 
into the factors and processes involved in the activation of Mcm2-7 to unwind DNA.  
 
Keywords 
Mcm2-7, helicase, DNA unwinding, DNA replication, cell cycle, Cdt1, Mec1, Cdc7, Dbf4, 
DDK, ATPase, kinase, phosphorylation 
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Chapter 1  
1 Introduction 
1.1 DNA replication in eukaryotes 
The fidelity of DNA replication is essential to the maintenance of the genetic integrity of 
all organisms. Errors during DNA replication can lead to genomic instability, and 
contribute to disease processes such as cancer 1. The initiation of DNA replication is a 
multifaceted and dynamic process initiated at hundreds, if not thousands, of discrete sites 
along DNA called origins of replication 2-4.  Eukaryotic organisms have developed highly 
conserved and tightly controlled mechanisms to ensure that DNA replication occurs once 
and only once from each origin of replication per cell division cycle. Fundamental to this 
control is the stringent temporal separation of replicative DNA helicase loading and DNA 
unwinding. A key factor during DNA replication, the minichromosome maintenance 2 
through 7 (Mcm2-7) replicative DNA helicase is loaded onto origin DNA in late M and 
early G1 phases, but no unwinding occurs. In a poorly understood manner, Mcm2-7 is 
activated to unwind duplex DNA during S phase to permit DNA polymerases to use the 
separated strands as templates for newly synthesized DNA (Figure 1.1) 5-7. The current 
study explores the protein factors and the cell cycle signals that dictate the timing of 
DNA unwinding by Mcm2-7. This knowledge will contribute significantly toward 
understanding the fundamental process of DNA replication which is of great importance 
to studying diseases caused by an unregulated cell cycle.        
Much of our knowledge of eukaryotic DNA replication comes from studies on the 
model organism Saccharomyces cerevisiae. During G1 phase of the cell cycle, origin 
sequences direct the assembly of multiprotein complexes that ultimately create 
replication forks with opposite polarity at each origin 2, 6, 8.  While origins in most 
eukaryotes lack any consensus, those of S. cerevisiae are the best characterized 9-12. In S. 
cerevisiae, the cis-acting DNA replication elements are known as autonomous replicating 
sequences (ARS) and were initially identified by their ability to promote stable 
transformation and the autonomous replication of plasmid DNA in yeast 13-18. A  
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During the G1 phase, Mcm2-7 is loaded as a double hexamer onto origins in a Cdt1-
dependent manner.  Origins are licensed for DNA replication, but Mcm2-7 remains 
inactive in the pre-RC. In S phase, activation and conversion of the pre-RC to the pre-IC 
occurs from the collective action of CDK and DDK and the recruitment of other factors. 
DDK phosphorylates the N-terminal tails of Mcm2, 4 and 6.  DDK is required for the 
early-firing origin recruitment of Sld3 and Cdc45 before S-CDK activity. S-CDK 
phosphorylates Sld2 and Sld3 which are bridged by Dpb11, and this in turn promotes the 
recruitment of GINS and DNA polymerase ε to origins. Together with Cdc45 and GINS, 
Mcm2-7 acts as the core in a large and stable CMG helicase complex to unwind duplex 
DNA. Priming of leading and lagging strands is carried out by DNA polymerase α. 
Ultimately, leading and lagging strand DNA synthesis is performed by DNA polymerase 
ε and δ, respectively.  Adapted from 2, 6, 19, 20.      
 
  
Figure 1.1: DNA replication is regulated with respect to the cell cycle 
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conserved eukaryotic initiator complex known as the origin recognition complex (ORC) 
binds these origins of replication 8, 21.  ORC is comprised of six subunits that together 
with Cdc6 and Cdt1, loads the replicative DNA helicase, consisting of a complex of the 
minichromosome maintenance 2 through 7 (Mcm2-7) proteins, into the pre-replicative 
complex (pre-RC) at the origin 6, 22-26 (Figure 1.1). At this stage, origins are said to be 
“licensed” or poised for DNA replication, but Mcm2-7 is inactive in the pre-RC. The 
loading of Mcm2-7 can only occur during G1 phase when cyclin-dependent kinase 
(CDK) activity is low and anaphase promoting complex/cyclosome (APC/C) activity is 
high 27-30. In budding yeast, CDK activity prevents Mcm2-7 loading by phosphorylating 
and inhibiting each pre-RC component, thereby limiting DNA replication to once per cell 
cycle 31-36.  The pre-RC is activated and converted to a pre-initiation complex (pre-IC) in 
S phase by the combined action of two protein kinases, CDK and the Dbf4-dependent 
kinase (DDK), and the recruitment of other factors 19, 37-43. After Mcm2-7 is loaded, DDK 
is required for the recruitment of Cdc45 and Sld3 to early-firing origins before S-phase-
specific CDK (S-CDK) activity.  After S-CDK activation, GINS, Sld2, Dpb11 and DNA 
polymerase ε (Pol ε) are recruited to the origin 20.  
While the Mcm2-7 helicase is the major target of DDK (discussed below), the key 
targets of CDK during initiation of replication in budding yeast are factors required 
specifically for initiation, but which are not incorporated into the replisome 44, 45. CDK 
phosphorylates Sld2 and Sld3, which in turn, promotes their association with Dpb11 46, 47. 
All groups of eukaryotes possess a single ortholog of Dbp11 that is essential for the 
initiation of DNA replication 48. These orthologs contain a series of BRCT repeats which 
act as phosphoprotein-binding elements 49, 50. The N-terminal pair of BRCT repeats of 
Dpb11 binds Sld3, whereas the C-terminal pair binds Sld2 51-53. Studies suggest that Sld3 
associates with some factors at origins (possibly Mcm2-7) and helps recruit the 
replication factor Cdc45, while Dbp11 bridges phosphorylated Sld3 to phosphorylated 
Sld2 and recruits DNA Pol ε and the tetrameric GINS complex to origins 38, 52, 54, 55. 
These events lead to the stable association of a large helicase complex consisting of 
Cdc45, Mcm2-7 and GINS (CMG). Activation of Mcm2-7 throughout S phase ultimately 
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unwinds the origin and enables the priming of leading and lagging strands by DNA 
polymerase ε.  
1.2 Mechanisms of Mcm2-7 activity 
Replicative DNA polymerases require a single-stranded DNA (ssDNA) template, but 
several lack the ability to unwind double-stranded DNA (dsDNA) 56. In this regard, 
ssDNA is generated by a DNA helicase, a molecular motor enzyme that uses NTP-
dependent conformational changes to unwind duplex DNA. All helicases share at least 
three common biochemical properties: (i) nucleic acid binding; (ii) NTP/dNTP binding 
and hydrolysis; and (iii) NTP/dNTP hydrolysis-dependent unwinding of duplex nucleic 
acids in a 3’ to 5’ or 5’ to 3’ direction (reviewed in 39, 57). Mcm2-7 complexes are 
toroidal in shape and are broadly distributed along chromatin 58, 59.  Mcm2-7 is 
chromatin-bound in G1 phase, displaced from origins in S phase as it translocates ahead 
of the replication fork, and absent from chromatin in G2 phase 60.  A new round of 
Mcm2-7 origin loading occurs at the end of mitosis 61.  As mentioned above, Mcm2-7 
loading into the pre-RC at origins of replication depends on the concerted effort of ORC, 
Cdc6 and Cdt1 23, 24, 26.  
1.2.1 Identification of MCM proteins 
MCM proteins were first identified in S. cerevisiae as mutants defective in the 
maintenance of circular minichromosomes 62.  Mcm subunits are members of the AAA+ 
(ATPases associated with various cellular activities) superfamily 63. Mcm2-7 complexes 
bind and hydrolyze ATP to unwind dsDNA, a feature common to all AAA+ proteins. In 
this case, the energy produced from ATP hydrolysis is transferred from the AAA+ 
helicase motor to the central channel of the Mcm2-7 complex to facilitate translocation 
and unwinding of duplex DNA ahead of the replication fork 64-66. Deletion of any of the 
MCM genes is lethal in S. cerevisiae and Schizosaccharomyces pombe.  The six Mcm 
proteins are paralogs, as they share considerable sequence similarity with one another, 
particularly within a 200-250 amino acid core region that encodes the ATPase active site, 
or AAA+ domain (reviewed in 58, 67, 68). Mcm2-7 predominantly exists as a 
heterohexamer, but when not functioning as the replicative DNA helicase, can exist as 
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trimers, dimers and monomers 69-71. Studies in the fission yeast Schizosaccharomyces 
pombe revealed that purified Mcm2-7 complexes were toroidal in shape consistent with a 
hexamer comprising a 1:1 subunit stoichiometry 72.  
Other MCM genes, including MCM1 and MCM10, were identified in the screen 
mentioned above, but do not share significant amino acid similarity to Mcm2-7 62. Mcm1 
is a transcription factor that regulates the expression of CDC6 and some MCM genes 73 
and has been implicated to play a role at yeast replication origins 74, 74, 75. Mcm10 is 
essential for growth in budding yeast, assembles onto replication origins and travels with 
the replication fork 76, 77. Additionally, two other MCM genes, MCM8 and MCM9, have 
been identified in humans, Xenopus, mouse and rat, but appear absent in yeast and 
nematodes (reviewed in 78). Mcm9 exists only in vertebrates and is more closely related 
to Mcm8 than to other Mcm2-7 proteins 79-81. Most recently, a novel Mcm-binding 
protein (Mcm-BP) that interacted with all Mcm2-7 subunits except Mcm2 was found in 
humans 82.  It is distantly related to the Mcm2-9 family and is present in multicellular 
organisms, some fungi and other unicellular eukaryotes.  Mcm-BP regulates the 
unloading of Mcm2-7 after DNA replication 83.    
1.2.2 Structural biology of MCM helicases  
Mcm proteins are composed of three domains: an N-terminal domain, an AAA+ domain, 
and a C-terminal domain that is predicted to fold into a winged-helix domain (Fig 1.2A).  
While the majority of the archaeal Mcms conform to this convention, some eukaryotic 
Mcms contain additional N- or C-terminal extensions (reviewed in 84).   
The N-terminal domain of Mcm proteins is poorly conserved from archaea to 
eukaryotes, and even between Mcm subunits of a given organism 85, 86.  Despite this low 
sequence similarity, structure-based sequence alignments indicated the conservation of 
hydrophobic residues within buried regions and charged residues within the central 
channel. The central channel of MCM is large enough to accommodate both ssDNA and 
dsDNA. Indeed, studies of MCMs in Methanothermobacter thermautrophicus (MtMCM) 
and Sulfolobus solfataricus (SsoMCM) revealed that these positively charged residues 
interact with DNA 87, 88. Reconstitution studies in S. Solfataricus have shown that the 
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addition of the N-terminal half of SsoMCM in trans influences both processivity and 
substrate recognition 89. Studies have also shown that archaeal MCMs can form 
dodecamers and hexamers. For instance, the crystal structure of MtMCM reveals a head-
to-head double hexamer, formed from opposing N-terminal faces.  
In contrast, SsoMCM crystallized as a single hexamer (Fig. 1.2B). Further studies 
show that SsoMCM binds forked substrates with the C-terminal facing the 
ssDNA/dsDNA junction 88. However, there are data to suggest that the latter may form a 
double hexamer 89 and indeed the SsoMCM hexamer fits well into the electron density 
microscope map of the double-hexameric MtMCM 90. Interestingly, eukaryotic Mcm2-7 
is a single hexamer in solution, yet is loaded onto origins of replication as a head-to-head 
double hexamer, with the C-termini containing the AAA+ ATPase domains facing 
outward 91-93, in similar fashion to SsoMCM 88.        
Moreover, the N-terminal domain plays a role in regulating Mcms via kinases 87, 
94.  In fact, a proline to leucine mutation (P83L), also called the bob1 mutation, within 
this region in budding yeast Mcm5, bypasses the requirement for DDK 94, 95. The distal 
portion of the N-terminus contains a positively charged β-hairpin that protrudes into the 
central channel and an allosteric communication loop, which together modulate this 
region via contacts with hairpins in the AAA+ core 87, 96, 97.  In the E1 helicase of bovine 
papillomavirus (Fig. 1.2C), these hairpins look like a spiral staircase as they track the 
sugar-phosphate backbone of ssDNA through the central channel 98. This feature is 
thought to be analogous in the central channel of archaeal 87 and eukaryotic MCM 99.    
The AAA+ domain is responsible for the catalytic activity of MCM proteins. 
Members of the AAA+ superfamily of ATPases share several conserved residues that 
contribute to the binding and hydrolysis of ATP. These include the Walker A and B 
motifs and other elements unique to the family, such as sensor I, sensor II and an arginine 
finger motif, characterized by the residues serine, arginine and phenylalanine (Figures 
1.2A, B; reviewed in 84). The ATPase site of Mcm proteins is located at the interface 
between adjacent subunits (Fig. 1.2D) whereby one subunit contributes the Walker A or 
phosphate binding loop (P-loop) and Walker B motifs, while the other subunit contributes 
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the arginine finger motif. The P-loop contains a Walker A lysine that coordinates and 
binds the γ phosphate of ATP. The Walker B motif coordinates Mg2+ and water around 
the docked ATP molecule. In the adjacent subunit, the catalytic arginine residue of the 
arginine finger protrudes into the interface to promote ATP hydrolysis 66, 69, 100. Studies of 
SV40 large T antigen 101 and archaeal MCMs 90 suggest that in addition to the role in 
ATP binding and hydrolysis, these motifs make variable contributions to the inter-site 
communication required to pump DNA through the central channel and unwind DNA 100. 
Most known hexameric helicases are formed from six identical subunits and thus 
are assumed to be functionally equal. The heterohexameric Mcm2-7 complex with its six 
different ATPase sites is unique in this regard.        
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(A) The primary structure of MCM proteins consists of an N-terminal domain (purple), a 
AAA+ domain (red) and a C-terminal domain (blue). The N-terminal domain includes a 
number of functional sequence elements, such as the Zn binding motif (Zn) and the 
allosteric communication loop (ACL). The AAA+ domain contains the Walker A (A, 
yellow), Walker B (B, orange), sensor I (SI), sensor II (SII) and arginine finger (R, red) 
motifs. Unique insertions characteristic of the MCM clade include the external β-hairpin 
(EXT, green), helix 2 insert (H2i, purple) and the pre-sensor I β-hairpin (PS1). The C-
terminal domain is predicted to fold into a winged-helix motif (WH). Figure adapted 
from Costa and Onesti 84. (B) Near-full length structure of Sulfolobus solfataricus MCM 
(PDB code 3F9V). Motifs are colour-coded as in A. (C) Bovine papillomavirus E1 DNA 
helicase complex bound to ssDNA (PDB code 2GXA). Shown are the individual subunits 
of the hexamer (red, pink, cyan, orange, yellow, purple), ssDNA (green) in the central 
channel, Pre-sensor1 β-hairpin (PS1, blue), and ADP (grey) bound at subunit interfaces. 
(D) The subunit arrangement of the Mcm2-7 heterohexamer based on the view from the 
C-terminal face. Shown are the ATP binding site (P-loop) contributed by one subunit and 
the catalytic arginine residue (SRF) contributed by the adjacent subunit. Figure adapted 
from Davey et al. 69.   
 
1.2.3 DNA binding and unwinding by helicases  
Crystallographic studies and biochemical examination of viral helicases and archaeal 
MCMs have yielded a considerable amount of structural information regarding amino 
acid residues important for DNA binding and unwinding. Such structural information 
exists for the simian virus 40 large T antigen (SV40 LTag) 102, bovine papillomavirus 
(BPV) E1 helicase 98, M. thermoautrophicus MCM 87 and S. solfataricus MCM 90, 103. As 
mentioned above, the N-terminal domain of MCMs is poorly conserved from archaea to 
eukaryotes, but conserved positively charged residues within this domain form β-hairpins 
Figure 1.2: Architecture of MCM proteins and BPV E1 helicase 
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that protrude into the central channel and interact with DNA 87, 88.  Moreover, 
biochemical characterization of this domain in MtMCM and SsoMCM revealed that it 
binds both ssDNA and dsDNA, with a preference for ssDNA 87, 97, 103.  In addition, the 
crystal structure of a near-full length SsoMCM showed the presence of four β-hairpins 
located throughout the N- and C-terminal domains and are proposed to be involved in 
DNA binding and unwinding 90. Three hairpins, NT, H2I and PS1 are located in the 
central channel and two hairpins, PS1 and EXT are located near the side channels. The 
PS1 hairpin is located at the junction between the central and side channels. This hairpin 
also aligns with the only β-hairpin in the central channel of SV40 LTag. As well, studies 
showed that the latter protrudes into the central channel and moves in response to the 
nucleotide binding state 102.  
Mutation of conserved basic residues in β-hairpins of either the N- or C-terminal 
domains of full length SsoMCM resulted in reduced DNA binding. Mutation of both N- 
and C-terminal domains together negates binding of DNA by MCM 88. Of note, 
mutations in the β-hairpins of these domains had variable effects on DNA unwinding 
activity. Reduction in the affinity for DNA from mutations in the N-terminal β-hairpins 
of SsoMCM resulted in a concomitant reduction in helicase activity, whereas mutations 
in the C-terminal domain that reduced the affinity for DNA showed no effect on helicase 
activity 88. In MtMCM, deletion within the H2I hairpin abrogated DNA unwinding 
activity 104.  
1.2.4 DNA binding and unwinding by Mcm2-7 
The heterohexameric organization of eukaryotic Mcm2-7 is unique among helicases since 
it is formed from six distinct subunits, as opposed to the homohexamers of Archaea 105. 
Biochemical analyses of eukaryotic Mcms have enabled the classification of Mcm2-7 
subunits into two functional groups: helicase subunits and regulatory subunits. 
Subcomplexes containing derivations of Mcms 4, 6 and 7 exhibit in vitro DNA 
unwinding activity 70, 106, 107, whereas Mcms 2, 3 and 5 play a regulatory role and under 
certain conditions, inhibit in vitro helicase activity 70, 72, 108, 109.   
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As with other hexameric helicases, both S. cerevisiae Mcm467 and Mcm2-7 
showed ATP-dependent ssDNA binding. However, these complexes demonstrated a 
preference for poly(dT) ssDNA, unlike homohexameric helicases 110. Interestingly, 
Mcm2-7 showed a significantly higher affinity for circular ssDNA than Mcm467 108. This 
difference was found to be dependent on the order of addition of ATP. In this case, when 
Mcm2-7 and ATP were mixed together prior to the addition of DNA, Mcm2-7 bound 
circular ssDNA weakly.  However, when Mcm2-7 and circular ssDNA were mixed 
before the addition of ATP, higher levels of DNA binding by Mcm2-7 were seen 108. In 
addition, Mcm2-7 bound linear ssDNA very slowly compared to Mcm467. Both 
Mcm467 and Mcm2-7 form ring-shaped structures and exhibit in vitro helicase activity 
106, 108.  These data implicate Mcms 2, 3 and 5 in regulating the loading or activation of 
Mcm2-7 in vivo 110. Indeed, Mcm2-7 is thought to possess an ATP-dependent “gate” at 
the Mcm2/5 interface which allows the ring to open and permit entry of ssDNA into the 
central channel 69, 108. Consistent with this, Bochman and Schwacha 108 observed in vitro 
helicase activity under reaction conditions that putatively closed the Mcm2-7 ring. The 
Schwacha lab also identified ATPase active sites (Walker B and arginine finger) in 
Mcm6/2 and Mcm5/3 that play a role in the putative Mcm2/5 gate within Mcm2-7 111.  
 As aforementioned, replicative DNA helicases such as SV40 LTag, archaeal 
MCMs and eukaryotic Mcm2-7 subunits form hexameric toroidal structures with a large 
central channel through which DNA can pass 87, 90, 101, 112. As such, several models on 
how Mcm2-7 unwinds DNA have been proposed: (i) steric exclusion, (ii) rotary pump, 
(iii) T-antigen, and (iv) ploughshare (Figure 1.3; reviewed in 113).   
In the steric exclusion model, ssDNA passes through the central channel of 
Mcm2-7 while displacing the complementary strand on the outside of the ring 107, 114. 
This is akin to the DNA helicase DnaB in Escherichia coli and has been proposed for 
Mcm467 107. Indeed, biochemical analyses have shown that archaeal and eukaryotic 
MCM proteins translocate along ssDNA with 3’ to 5’ polarity 107, 108, 115, 116. Recently, 
studies in Xenopus egg extracts revealed that a large helicase complex consisting of 
Cdc45, Mcm2-7 and GINS (CMG) unwound DNA by translocating along ssDNA with 3’ 
to 5’ polarity, consistent with DNA unwinding by steric exclusion.  
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The rotary pumping model was proposed to explain the ‘MCM paradox’. While 
Mcm2-7 co-localizes with sites of DNA synthesis in budding yeast, Mcm2-7 does not co-
localize with replication foci in vertebrate systems (reviewed in 117). Under this model, 
Mcm2-7 complexes first load onto replication origins in G1 phase and move away from 
the origin by rotation along the helical axis of the duplex DNA. Next, during S phase, 
these dispersed Mcm2-7 complexes become attached to an immobile nuclear structure 
and the rotary action is repeated such that only the duplex DNA would be able to rotate 
and effectively unwind DNA at a distance from the replication fork 117.    
SV40 LTag must form a double hexamer in order to unwind DNA. In the T-
antigen model, dsDNA is pumped into each SV40 LTag hexamer and ssDNA is forced 
out from the hexamer interface. EM images show SV40 LTag bound to dsDNA from 
which two loops of ssDNA originate. Based on crystal structures of SV40 LTag, ATP-
dependent movements of a β-hairpin protruding into the central channel pulls in duplex 
DNA and rotation of one section of the channel relative to the other causes DNA 
unwinding. Next, ssDNA is extruded from positively charged channels within subunit 
interfaces, which would also prevent re-annealing (reviewed in 113). Indeed, putative 
ssDNA channels at subunit interfaces have been shown in MtMCM 87 and SsoMCM 90. 
The ploughshare model was predicated on the belief that a single Mcm2-7 
hexamer would be unable to induce sufficient torsional strain to unwind DNA. In this 
regard, DNA unwinding is achieved by a protein located behind Mcm2-7 that acts as a 
wedge to separate the two strands of the duplex DNA as they exit from the central 
channel of the helicase 113.  
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(A) The steric exclusion model, whereby Mcm2-7 translocates along ssDNA while 
displacing the complementary strand on the outside of the hexamer. (B) The rotary pump 
model predicts that two groups of Mcm2-7 complexes encircling dsDNA rotate the DNA 
in opposite directions and unwind the duplex by torsional stress at a distance from the 
replication fork. (C) The T-antigen model stipulates that two physically associated 
Mcm2-7 molecules encircling dsDNA pump DNA towards the double hexamer interface. 
Single stranded DNA is then extruded through channels at subunit interfaces. (D) The 
ploughshare model suggests that while Mcm2-7 translocates along dsDNA, a protein at 
the trailing edge of the helicase acts as a wedge, or pin, to separate the DNA strands. 
Arrows indicate the direction or rotation of Mcm2-7. Figure adapted from Takahashi et 
al. 113. 
 
 
 
 
 
 
 
Figure 1.3: Models of DNA unwinding by Mcm2-7 
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The ploughshare model was predicated on the belief that a single Mcm2-7 
hexamer would be unable to induce sufficient torsional strain to unwind DNA. In this 
regard, DNA unwinding is achieved by a protein located behind Mcm2-7 that acts as a 
wedge to separate the two strands of the duplex DNA as they exit from the central 
channel of the helicase 113.  
1.3 Regulation of Mcm2-7 activity 
1.3.1 Regulation by ATPase activity 
To ensure once per cell cycle genome duplication, the activity of the Mcm2-7 replicative 
DNA helicase must be modulated on several fronts.  As mentioned above, the eukaryotic 
Mcm2-7 complex contains six distinct subunits with six unique ATPase sites. Indeed, 
previous studies on Walker A and arginine finger mutations identified three ATPase 
active sites, Mcm3/7, Mcm7/4 and Mcm6/2, which serve a functional importance to 
ATPase activity within Mcm2-7 and cell viability 69, 118. ATP hydrolysis and ssDNA 
binding are requisite events for DNA unwinding.  The ATPase active sites Mcm3/7 and 
Mcm7/4 are thought to play an essential role in coupling ATPase activity to helicase 
activity since mutations within these sites inhibit hydrolysis of ATP by Mcm2-7. As well, 
mutations in the Walker A motif in either of Mcm7 or Mcm4 inhibit ssDNA binding by 
Mcm2-7 in an ATP-dependent manner 110, 118.    Interestingly, mutations in the Walker B 
motif of Mcm6 and in the arginine finger motif of Mcm4 showed no effect on yeast cell 
viability or growth rate, yet blocked hydrolysis of ATP at the Mcm4/6 site 118. As 
aforementioned, Walker B and arginine finger motifs play more of a catalytic role, 
whereas the Walker A motif is predominantly involved in nucleotide binding 66, 69, 100. In 
light of this, it has been proposed that the Mcm4/6 active site need only bind, not 
hydrolyze, ATP for Mcm2-7 function in vivo 118.    
 Moreover, data suggest a physical discontinuity between Mcm2 and Mcm5, an 
ATP-dependent “gate” which allows the Mcm2-7 hexamer to load onto ssDNA 69, 108. 
Indeed, the rate of ssDNA association with Mcm2-7 was slow relative to a subcomplex 
consisting of Mcm467. However, incubation of Mcm2-7 with ATP prior to addition of 
ssDNA or mutations in the Mcm2/5 ATPase active site increased the rate of Mcm2-7 
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association with ssDNA 110. Further investigation on mutations in Walker B and arginine 
finger motifs demonstrated that the ATPase active sites in Mcm6/2 and Mcm5/3 
modulate the activity of the alleged Mcm2/5 gate 111.  
 In another study, ATP binding and hydrolysis by Mcm2 was implicated in 
modulating DNA binding by Mcm2-7 109. In this study, biochemical analyses employing 
a mutation in the P-loop of Mcm2 as well as the poorly hydrolysable analogue of ATP, 
ATPγS, revealed that ADP binding by Mcm2 is required to inhibit DNA binding and 
unwinding by Mcm467. Additionally, when the P-loop mutant of Mcm2 was 
reconstituted into Mcm2-7, enhanced ssDNA binding relative to wild type Mcm2-7 was 
observed. From these findings, the authors suggested that Mcm2 affects DNA unwinding 
by or activation of Mcm2-7. During translocation, the ability of Mcm2 to inhibit DNA 
binding by Mcm2-7 may play a role in release of the complex from DNA. On the other 
hand, ATP hydrolysis by Mcm2 may be switched off during the activation of Mcm2-7, 
thus relieving the inhibitory role played by Mcm2 109. 
1.3.2 Post-translational modifications of Mcm2-7 
Mcm2-7 subunits are phosphorylated by several different kinases including Mec1, cyclin-
dependent kinase (CDK), Dbf4-dependent kinase (DDK) and casein kinase 2 (CK2) 19, 20, 
119-121. An overview of the phosphoregulation of Mcm2-7 is illustrated in Figure 1.4. The 
relationship between Mcm2-7 and these kinases is underscored by the essential processes 
involved, such as DNA replication initiation, helicase activation and checkpoint 
pathways. Mec1 is characterized in Chapter 2, and the role of phosphorylation of Mcm2-
7 by DDK is investigated in Chapter 4.  
As discussed above, during S phase, Mcm2-7 is activated to unwind DNA in a 
series of events that requires CDK and DDK (Figure 1.1) 19. The activity by these kinases 
promotes the binding of Cdc45 and GINS to Mcm2-7 91, 93, 115, 122. While the essential 
targets of CDK are Sld2 and Sld3 (discussed above), a role for CDK in modifying Mcm 
subunits has been proposed (Figure 1.4A) 121. The N-terminal tail of budding yeast Mcm4 
is phosphorylated in vivo during S phase by CDK 121, and in the absence of DDK, CDK 
phosphorylation of a distal portion the N-terminus of Mcm4 is essential 123.  
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(A) Prior to replication, Mcm4 and Mcm6 are thought to be phosphorylated by either G1-
CDKs or Pho85. This phosphorylation may also occur during S phase in the previous cell 
cycle by S-CDKs and is not removed during G1. During the G1-S phase transition, DDK 
phosphorylates the N-termini of Mcm2, Mcm4 and Mcm6 to trigger helicase activation. 
Mec1 may also phosphorylate the N-termini of Mcm4 and Mcm6 followed by DDK 
phosphorylation of these regions to trigger replication initiation. (B) Mec1 regulates 
several events in both unperturbed and perturbed cell cycles. In a normal S phase, Mec1 
increases RNR activity, which in turn increases dNTP synthesis. Mec1 also helps to 
target DDK to Mcm2-7. Under a perturbed cell cycle, such as during DNA damage or 
stalled replication forks, the Mec1 checkpoint pathway stabilizes stalled forks and 
inhibits late origin firing. Mec1 may also mediate the firing of additional origins upon 
replication restart after recovery from the checkpoint.  (Figure adapted from 6). 
 
Furthermore, mass spectrometry analysis of in vitro kinase reactions revealed that the N-
terminus of human Mcm2 contains CDK consensus sites 120. 
DDK consists of a catalytic subunit, Cdc7, and a regulatory subunit, Dbf4, and is 
required throughout S phase for the activation of early and late origins of replication 124, 
125. DDK phosphorylates every Mcm2-7 subunit except Mcm5 126, 127. A single point 
mutation (P83L) in the N-terminal region of Mcm5, also called the bob1 mutation, can 
bypass the requirement for DDK in budding yeast 37, 128. The analogous mutation in 
MtMCM suggested that the bob1 mutation causes subtle allosteric changes in the Mcm2-
7 complex 95, possibly mimicking what typically occurs when other Mcm subunits are 
phosphorylated by DDK 19.  
 The N-terminal tails of eukaryotic Mcm2, 4 and 6 are the major substrates for 
DDK, and also contain sites for other kinases (Figure 1.4A) 119, 120. Whereas non-
chromatin-bound Mcm2 is the primary target of DDK 120, phosphorylation of Mcm4 and 
Mcm6 is stimulated within the pre-RC 129. In this regard, phosphorylation of Mcm2-7 by 
Figure 1.4: An overview of the phosphoregulation of Mcm2-7 
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DDK during late G1 or S phase allows origin recruitment of Sld3 and Cdc45 20. 
Additionally, while phosphorylation of Mcm2 is not required for viability in budding 
yeast, it has been implicated in the cell’s response to DNA damage and replication stress 
119, 130, 131.  
 The Stillman lab has extensively characterized the N-terminal tail of budding 
yeast Mcm4, aptly named the NSD or N-terminal Ser/Thr-rich domain (residues 2-174) 
123, 132. The NSD of Mcm4 is hyperphosphorylated by DDK, yet DDK substrate 
specificity is conferred by a DDK-docking domain (DDD) adjacent to the NSD. In 
addition, the hyperphosphorylated form of Mcm4 is highly enriched in the Cdc45-Mcm2-
7 complex, the assembly of which is induced by DDK exclusively on chromatin in S 
phase 132. Furthermore, the NSD was found to contain an inhibitory activity that is 
alleviated by DDK phosphorylation of this domain. Yeast cells lacking a portion of the 
NSD (residues 74-174) were viable in the absence DDK, but grew more slowly and the 
Cdc45-Mcm2-7 complex did not form in a timely fashion under this bypass state 123. 
Studies in other eukaryotes reveal that the mechanism of Mcm2-7 phosphorylation by 
DDK orthologs may be similar to that in budding yeast. As such, work in human cells 
have shown the N-termini of Mcm2 and Mcm4 are phosphorylated by Cdc7, as well as 
during S phase in Xenopus 19. In addition, the DDK ortholog in S. pombe phosphorylates 
Mcm2 and Mcm4 and is required for the hyperphosphorylation of Mcm6 133. 
Using in vitro assembled pre-RCs as a DDK substrate, the Bell lab 119 mapped 
phosphorylation sites on Mcm2-7 by mass spectrometry. Phosphorylation sites were 
found in the N-termini of Mcm2, Mcm4 and Mcm6 and the C-terminus of Mcm3. A 
cluster of phosphosites in the C-terminus of Mcm3 matched a CDK-mediated nuclear 
transport signal. Four sites within the N-terminus of Mcm2 corresponded to casein kinase 
2 (CK2) consensus sites 119. This study also identified two classes of DDK target 
sequences on Mcm4 and Mcm6: intrinsic (S/T-D/E) and phosphorylation-generated (PG, 
S/T-P/Q), or “priming” sites. Recognition of the latter by DDK required prior 
phosphorylation by another kinase. Both classes of target sites were found to be 
important for Mcm2-7 function as a budding yeast strain bearing mutations of intrinsic 
and PG sites in both Mcm4 and Mcm6 showed a severe proliferation defect. Mutations of 
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these sites alone or together in Mcm4 or Mcm6 showed little to no proliferation defect 
119. In addition, S/T-P priming sites within Mcm4 and Mcm6 were found to be 
phosphorylated independently of chromatin loading in G1, S and G2/M phases 119. The 
kinase responsible for priming of these sites has not been elucidated.  
Randell and colleagues 119 also found and analyzed S/T-Q priming sites on Mcm4 
and Mcm6 targeted by Mec1 (Figure 1.4).  This phosphorylation was spatially restricted 
to chromatin-bound Mcm2-7 and temporally constrained to S phase 119. Mec1 is 
discussed in more detail below and in Chapter 2 where we characterize the C-terminal tail 
of this protein and show that it plays an essential role in the localization, stability and 
function of Mec1.  
Mec1, the budding yeast ortholog of ataxia-telangiectasia and Rad3-related 
(ATR), is a member of the phosphoinositide-3-kinase-related kinase (PIKK) family. The 
Mec1 signaling cascade, or checkpoint, of S. cerevisiae serves an essential role in 
mediating cellular responses to DNA damage, in responding to stalled replication forks 
and in protecting against genomic instability (Figure 1.4B) 134. The mode of action of the 
Mec1 checkpoint pathway is to prevent the firing of late origins upon replication fork 
stalling or DNA damage 135, 136. In budding yeast, DNA damage typically causes Mec1-
dependent phosphorylation and activation of the transducer protein kinases Rad53 and 
Chk1 137, which in turn phosphorylate effector proteins regulating cell cycle progression 
and DNA repair.  Moreover, cells harboring mutations in MEC1 exhibit profound 
sensitivity to genotoxins and inhibitors of DNA replication, such as hydroxyurea (HU) 
and show defects in the DNA damage checkpoint at all stages of the cell cycle 138, 139. 
Overexpression of dominant-negative forms of ATR has similar effects in human cells 
140. Mec1 also plays a role during normal S phase to regulate dNTP synthesis by 
increasing ribonucleotide reductase (RNR) activity via the removal of the RNR inhibitor, 
Sml1 141-143. Mec1 is also proposed to help target DDK to Mcm2-7 (Figure 1.4B) 119. 
1.3.3 Interaction of Mcm2-7 with Cdt1 
Cdt1 was originally found in fission yeast 144, and is essential for Mcm2-7 loading in 
fission yeast 145, budding yeast 146 and Xenopus 26, as well as for DNA replication in 
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Drosophila 147 and humans 148. During G1 phase of the cell cycle, Mcm2-7 is imported 
into the nucleus and loaded onto origins of DNA replication in a Cdt1-dependent manner 
91, 149. It is noteworthy that Mcm2-7 is loaded onto origin DNA in an inactive form. In 
vitro studies show that Mcm2-7 is loaded as a head-to-head double hexamer, encircling 
dsDNA through its central channel 91-93. While essential, the role Cdt1 plays in Mcm2-7 
origin loading is transient. Upon origin recruitment, Cdt1 is rapidly expelled through 
ATP hydrolysis by Cdc6 and Orc1 150, 151. Cdt1 is discussed in more detail below and a 
role for Cdt1 as a negative regulator of Mcm2-7 activity is explored in Chapter 3.  
In Xenopus, the C-terminal 377 residues of Cdt1 are required for Mcm2-7 origin 
loading, and the extreme Cdt1 C-terminus bound to the Mcm2467 subcomplex of Mcm2-
7  152. Studies of mammalian Cdt1 demonstrated that the C-terminus plays a role in 
regulating DNA binding and helicase activity of Mcm proteins 153-155.  The C-terminus of 
Cdt1 was also found to bind Mcm2-7 in budding yeast and this interaction was required 
for efficient origin recruitment of both proteins 156. Also, multiple Cdt1 molecules were 
required for origin loading of Mcm2-7 as a Cdt1 mutation that only allowed recruitment 
of one Cdt1 molecule to the origin prevented Mcm2-7 loading. In addition, while 
dispensable for origin loading of Mcm2-7 double hexamers, the essential N-terminus of 
Cdt1 was required to load Mcm2-7 complexes that were competent to interact with the 
helicase-activating proteins Cdc45 and GINS 156.  The role Cdc45 and GINS play in 
modulating Mcm2-7 activity will be discussed in more detail in the following section.  
Recently, the Diffley lab demonstrated that while Cdt1 was dispensable for 
origin-association of Mcms 3, 5 and 7 in the presence of the poorly hydrolysable analog 
of ATP, ATPγS, Cdt1 was required for all six MCM subunits to bind ORC and Cdc6 at 
the origin in equimolar ratio. In this sense, Cdt1 plays a role in stabilizing Mcm2-7 on 
origins of DNA replication 157, 158.  In another recent study, Cdt1 was required to alleviate 
an autoinhibitory domain in the C-terminus of Mcm6 that blocked origin recruitment of 
Mcm2-7 by ORC and Cdc6. Upon formation of an Mcm2-7-Cdt1 complex, the C-
terminus of Mcm6 both induced pre-RC assembly and allowed Orc1/Cdc6-dependent 
ATP hydrolysis 150.  
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1.3.4 Interaction of Mcm2-7 with Cdc45 and GINS  
Loading of Mcm2-7 onto origins of replication requires the concerted effort of ORC, 
Cdc6 and Cdt1 6. The action of CDK and DDK switches Mcm2-7 from an inactive to an 
active helicase (reviewed in 19). While Mcm2-7 exhibited helicase activity in vitro (this 
study, 108), in vivo data showed that both Cdc45 and GINS are required during the 
initiation and elongation steps of DNA replication 54, 159-163. Studies in budding yeast 
showed that during initiation, GINS is required for Mcm2-7 to stably interact with 
essential regulatory factors such as Cdc45, the checkpoint mediator Mrc1, the Tof1-Csm3 
complex which allows replication fork pausing at protein-DNA barriers, the histone 
chaperone FACT and Ctf4, which facilitates sister chromatid cohesion. GINS was also 
required for Mcm2-7 to specifically interact with, albeit weakly, topoisomerase I and 
Mcm10. These large complexes were named replisome progression complexes or RPCs 
45. Furthermore, Mcm2-7, Cdc45 and GINS were found as part of  large and stable 
replisome complexes at paused replication forks 164. In Xenopus, along with DNA 
polymerases and Mcm10, Mcm2-7, Cdc45 and GINS were found as components of the 
replisome. Also in that study, only Mcm2-7, Cdc45 and GINS were enriched at paused 
forks induced by aphidicolin which causes uncoupling of the helicase from DNA 
polymerases 43.  
 Studies with Drosophila melanogaster embryo extracts demonstrated that Mcm2-
7 copurifies with Cdc45 and GINS through stringent fractionation steps 115. 
Reconstitution experiments using Drosophila recombinant proteins revealed that the 
Mcm2-7 complex was activated when associated with Cdc45 and GINS, relative to 
Mcm2-7 alone. In addition, this large CMG (Cdc45/Mcm2-7/GINS) complex showed 
enhanced ATPase and helicase activity and better DNA substrate recognition 122.   
 Recent structural studies using single-particle electron microscopy of D. 
melanogaster proteins have provided further insight into how Cdc45 and GINS activate 
Mcm2-7 165. Mcm2-7 alone formed open ring hexamers with discontinuity between the 
Mcm2 and Mcm5 subunits. In the presence of Cdc45 and GINS, this opening was sealed 
off along with adopting a more planar helicase configuration. In the presence of a 
nonhydrolyzable ATP analog, ADP•BeF3, the Mcm2/5 gate closed forming a large 
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central channel and expanded the contact area of GINS to include the AAA+ domains of 
Mcm3 and Mcm5. This, in turn, created two topologically distinct openings. The authors 
speculate that the more intimate contacts in the CMG complex 165 help explain the 
enhanced ATPase and DNA binding activities relative to Mcm2-7 alone 122.  
 Further significance of the CMG complex was recently substantiated through 
phylogenomic analysis showing that a complex consisting of a Cdc45 homolog (RecJ), 
Mcm2-7 and GINS exists in archaea. This CMG complex is an essential constituent of 
the DNA replication machinery in archaea that is most likely homologous and 
functionally analogous to the eukaryotic CMG complex 166.   
1.4 Scope of thesis 
The regulation of DNA replication is crucial to ensure the genome is duplicated once per 
cell division cycle in S. cerevisiae and other eukaryotes. Aberrations during this process 
can lead to diseases arising from genomic instability, such as cancer. The Mcm2-7 
replicative DNA helicase plays a key role in this endeavor. Using budding yeast as a 
model organism, and through in vitro and in vivo techniques, this study examines the 
factors and the mechanisms involved in the modulation of Mcm2-7 activity to unwind 
DNA.   
 The work presented in Chapter 2 examines Mec1, the budding yeast homolog of 
ATR that plays a role in normal cell cycle progression and in the checkpoint response to 
DNA damage and replication fork stalling. Through in vivo and in vitro techniques, I 
show that the C-terminus of Mec1 is important for the localization, stability and function 
of the protein.   
In Chapter 3, I explore the role of Cdt1 in modulating Mcm2-7 activity. Using 
recombinant proteins expressed in E. coli, I demonstrate that Cdt1 inhibits both ATPase 
and helicase activity of Mcm2-7. 
 Chapter 4 looks at the role of phosphorylation in the regulation of Mcm2-7 
activity. Using in vitro techniques, I reveal that a phosphomimetic Mcm2-7 complex 
exhibits wildtype ATPase and helicase activities.  
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 Chapter 5 summarizes what is known about Mcm2-7, including the processes and 
associated replication factors involved in the early stages of the initiation of DNA 
replication. As many of the protein factors and pathways involved in DNA replication 
show potential as biomarkers and/or pharmacological inhibition, I relate the importance 
of deciphering the mechanisms involved in the regulation of DNA replication to the 
development of anti-cancer therapeutics. Furthermore, I summarize my results and 
discuss the implications of my studies. I also propose a model in which Cdt1 negatively 
regulates the activity of Mcm2-7.   
  
24 
 
1.5 References 
1.      Aguilera,A. & Gomez-Gonzalez,B. Genome instability: a mechanistic view of 
its causes and consequences. Nat. Rev. Genet. 9, 204-217 (2008). 
2.      Lee,D.G. & Bell,S.P. Architecture of the yeast origin recognition complex 
bound to origins of DNA replication. Mol Cell Biol. 17, 7159-7168 (1997). 
3.      Arias,E.E. & Walter,J.C. Strength in numbers: preventing rereplication via 
multiple mechanisms in eukaryotic cells. Genes Dev. 21, 497-518 (2007). 
4.      Riera,A., Fernandez-Cid,A., & Speck,C. The ORC/Cdc6/MCM2-7 complex, a 
new power player for regulated helicase loading. Cell Cycle 12, (2013). 
5.      Boos,D., Frigola,J., & Diffley,J.F. Activation of the replicative DNA helicase: 
breaking up is hard to do. Curr. Opin. Cell Biol. 24, 423-430 (2012). 
6.      Bell,S.P. & Dutta,A. DNA replication in eukaryotic cells. Annu. Rev. Biochem 
71, 333-374 (2002). 
7.      Chen,K.C., Csikasz-Nagy,A., Gyorffy,B., Val,J., Novak,B. et al. Kinetic 
analysis of a molecular model of the budding yeast cell cycle. Mol Biol. Cell 11, 
369-391 (2000). 
8.      Dutta,A. & Bell,S.P. Initiation of DNA replication in eukaryotic cells. Annu. 
Rev. Cell Dev Biol. 13, 293-332 (1997). 
9.      Robinson,N.P. & Bell,S.D. Origins of DNA replication in the three domains of 
life. FEBS J 272, 3757-3766 (2005). 
10.      Bolon,Y.T. & Bielinsky,A.K. The spatial arrangement of ORC binding modules 
determines the functionality of replication origins in budding yeast. Nucleic 
Acids Res.(2006). 
11.      Aladjem,M.I. & Fanning,E. The replicon revisited: an old model learns new 
tricks in metazoan chromosomes. EMBO Rep. 5, 686-691 (2004). 
12.      Gilbert,D.M. Making sense of eukaryotic DNA replication origins. Science 294, 
96-100 (2001). 
13.      Hsiao,C.L. & Carbon,J. High-frequency transformation of yeast by plasmids 
containing the cloned yeast ARG4 gene. Proc. Natl. Acad. Sci U. S. A 76, 3829-
3833 (1979). 
14.      Fangman,W.L. & Brewer,B.J. Activation of replication origins within yeast 
chromosomes. Annu. Rev. Cell Biol. 7, 375-402 (1991). 
25 
 
15.      Rao,H. & Stillman,B. The origin recognition complex interacts with a bipartite 
DNA binding site within yeast replicators. Proc. Natl. Acad. Sci. U. S. A 92, 
2224-2228 (1995). 
16.      Rao,H., Marahrens,Y., & Stillman,B. Functional conservation of multiple 
elements in yeast chromosomal replicators. Mol. Cell Biol. 14, 7643-7651 
(1994). 
17.      Stinchcomb,D.T., Struhl,K., & Davis,R.W. Isolation and characterisation of a 
yeast chromosomal replicator. Nature 282, 39-43 (1979). 
18.      Chan,C.S. & Tye,B.K. Autonomously replicating sequences in Saccharomyces 
cerevisiae. Proc. Natl. Acad. Sci U. S. A 77, 6329-6333 (1980). 
19.      DePamphilis,M.L. Cell cycle dependent regulation of the origin recognition 
complex. Cell Cycle 4, 70-79 (2005). 
20.      Labib,K. How do Cdc7 and cyclin-dependent kinases trigger the initiation of 
chromosome replication in eukaryotic cells? Genes Dev. 24, 1208-1219 (2010). 
21.      Heller,R.C., Kang,S., Lam,W.M., Chen,S., Chan,C.S. et al. Eukaryotic origin-
dependent DNA replication in vitro reveals sequential action of DDK and S-
CDK kinases. Cell 146, 80-91 (2011). 
22.      Bell,S.P. The origin recognition complex: from simple origins to complex 
functions. Genes Dev 16, 659-672 (2002). 
23.      Tanaka,T., Knapp,D., & Nasmyth,K. Loading of an Mcm protein onto DNA 
replication origins is regulated by Cdc6p and CDKs. Cell 90, 649-660 (1997). 
24.      Donovan,S., Harwood,J., Drury,L.S., & Diffley,J.F. Cdc6p-dependent loading 
of Mcm proteins onto pre-replicative chromatin in budding yeast. Proc. Natl. 
Acad. Sci U. S. A 94, 5611-5616 (1997). 
25.      Bell,S.P. & Stillman,B. ATP-dependent recognition of eukaryotic origins of 
DNA replication by a multiprotein complex. Nature 357, 128-134 (1992). 
26.      Maiorano,D., Moreau,J., & Mechali,M. XCDT1 is required for the assembly of 
pre-replicative complexes in Xenopus laevis. Nature 404, 622-625 (2000). 
27.      Amon,A., Irniger,S., & Nasmyth,K. Closing the cell cycle circle in yeast: G2 
cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins 
in the next cycle. Cell 77, 1037-1050 (1994). 
28.      Honey,S. & Futcher,B. Roles of the CDK phosphorylation sites of yeast Cdc6 in 
chromatin binding and rereplication. Mol Biol. Cell 18, 1324-1336 (2007). 
26 
 
29.      Zachariae,W. & Nasmyth,K. TPR proteins required for anaphase progression 
mediate ubiquitination of mitotic B-type cyclins in yeast. Mol Biol. Cell 7, 791-
801 (1996). 
30.      Visintin,R., Prinz,S., & Amon,A. CDC20 and CDH1: a family of substrate-
specific activators of APC-dependent proteolysis. Science 278, 460-463 (1997). 
31.      Piatti,S., Lengauer,C., & Nasmyth,K. Cdc6 is an unstable protein whose de 
novo synthesis in G1 is important for the onset of S phase and for preventing a 
'reductional' anaphase in the budding yeast Saccharomyces cerevisiae. EMBO J 
14, 3788-3799 (1995). 
32.      Weinreich,M., Liang,C., Chen,H.H., & Stillman,B. Binding of cyclin-dependent 
kinases to ORC and Cdc6p regulates the chromosome replication cycle. Proc. 
Natl. Acad. Sci U. S. A 98, 11211-11217 (2001). 
33.      Drury,L.S., Perkins,G., & Diffley,J.F. The cyclin-dependent kinase Cdc28p 
regulates distinct modes of Cdc6p proteolysis during the budding yeast cell 
cycle. Curr. Biol. 10, 231-240 (2000). 
34.      Labib,K., Diffley,J.F., & Kearsey,S.E. G1-phase and B-type cyclins exclude the 
DNA-replication factor Mcm4 from the nucleus. Nat. Cell Biol. 1, 415-422 
(1999). 
35.      Nguyen,V.Q., Co,C., Irie,K., & Li,J.J. Clb/Cdc28 kinases promote nuclear 
export of the replication initiator proteins Mcm2-7. Curr. Biol. 10, 195-205 
(2000). 
36.      Nguyen,V.Q., Co,C., & Li,J.J. Cyclin-dependent kinases prevent DNA re-
replication through multiple mechanisms. Nature 411, 1068-1073 (2001). 
37.      Jackson,A.L., Pahl,P.M., Harrison,K., Rosamond,J., & Sclafani,R.A. Cell cycle 
regulation of the yeast Cdc7 protein kinase by association with the Dbf4 protein. 
Mol Cell Biol. 13, 2899-2908 (1993). 
38.      Araki,H. Regulatory mechanism of the initiation step of DNA replication by 
CDK in budding yeast. Biochim. Biophys. Acta 1804, 520-523 (2010). 
39.      Bochman,M.L. & Schwacha,A. The Mcm complex: unwinding the mechanism 
of a replicative helicase. Microbiol. Mol. Biol. Rev. 73, 652-683 (2009). 
40.      Remus,D. & Diffley,J.F. Eukaryotic DNA replication control: lock and load, 
then fire. Curr. Opin. Cell Biol. 21, 771-777 (2009). 
41.      Queralt,E. & Igual,J.C. Functional connection between the Clb5 cyclin, the 
protein kinase C pathway and the Swi4 transcription factor in Saccharomyces 
cerevisiae. Genetics 171, 1485-1498. 2005.  
27 
 
42.      Liang,C. & Stillman,B. Persistent initiation of DNA replication and chromatin-
bound MCM proteins during the cell cycle in cdc6 mutants. Genes Dev 11, 
3375-3386 (1997). 
43.      Pacek,M., Tutter,A.V., Kubota,Y., Takisawa,H., & Walter,J.C. Localization of 
MCM2-7, Cdc45, and GINS to the site of DNA unwinding during eukaryotic 
DNA replication. Mol. Cell 21, 581-587 (2006). 
44.      Kanemaki,M. & Labib,K. Distinct roles for Sld3 and GINS during 
establishment and progression of eukaryotic DNA replication forks. EMBO J 
25, 1753-1763 (2006). 
45.      Gambus,A., Jones,R.C., Sanchez-Diaz,A., Kanemaki,M., van,D.F. et al. GINS 
maintains association of Cdc45 with MCM in replisome progression complexes 
at eukaryotic DNA replication forks. Nat. Cell Biol. 8, 358-366 (2006). 
46.      Kamimura,Y., Masumoto,H., Sugino,A., & Araki,H. Sld2, which interacts with 
Dpb11 in Saccharomyces cerevisiae, is required for chromosomal DNA 
replication. Mol Cell Biol. 18, 6102-6109 (1998). 
47.      Kamimura,Y., Tak,Y.S., Sugino,A., & Araki,H. Sld3, which interacts with 
Cdc45 (Sld4), functions for chromosomal DNA replication in Saccharomyces 
cerevisiae. EMBO J 20, 2097-2107 (2001). 
48.      Garcia,V., Furuya,K., & Carr,A.M. Identification and functional analysis of 
TopBP1 and its homologs. DNA Repair (Amst) 4, 1227-1239 (2005). 
49.      Manke,I.A., Lowery,D.M., Nguyen,A., & Yaffe,M.B. BRCT repeats as 
phosphopeptide-binding modules involved in protein targeting. Science 302, 
636-639 (2003). 
50.      Yu,X., Chini,C.C., He,M., Mer,G., & Chen,J. The BRCT domain is a phospho-
protein binding domain. Science 302, 639-642 (2003). 
51.      Masumoto,H., Muramatsu,S., Kamimura,Y., & Araki,H. S-Cdk-dependent 
phosphorylation of Sld2 essential for chromosomal DNA replication in budding 
yeast. Nature 415, 651-655 (2002). 
52.      Tanaka,S., Umemori,T., Hirai,K., Muramatsu,S., Kamimura,Y. et al. CDK-
dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in 
budding yeast. Nature 445, 328-332 (2007). 
53.      Tak,Y.S., Tanaka,Y., Endo,S., Kamimura,Y., & Araki,H. A CDK-catalysed 
regulatory phosphorylation for formation of the DNA replication complex Sld2-
Dpb11. EMBO J. 25, 1987-1996 (2006). 
28 
 
54.      Takayama,Y., Kamimura,Y., Okawa,M., Muramatsu,S., Sugino,A. et al. GINS, 
a novel multiprotein complex required for chromosomal DNA replication in 
budding yeast. Genes Dev 17, 1153-1165 (2003). 
55.      Zegerman,P. & Diffley,J.F. Phosphorylation of Sld2 and Sld3 by cyclin-
dependent kinases promotes DNA replication in budding yeast. Nature 445, 
281-285 (2007). 
56.      Kawasaki,Y. & Sugino,A. Yeast replicative DNA polymerases and their role at 
the replication fork. Mol. Cells 12, 277-285 (2001). 
57.      Tuteja,N. & Tuteja,R. Unraveling DNA helicases. Motif, structure, mechanism 
and function. Eur. J. Biochem. 271, 1849-1863 (2004). 
58.      Forsburg,S.L. Eukaryotic MCM proteins: beyond replication initiation. 
Microbiol. Mol Biol. Rev. 68, 109-131 (2004). 
59.      Kuipers,M.A., Stasevich,T.J., Sasaki,T., Wilson,K.A., Hazelwood,K.L. et al. 
Highly stable loading of Mcm proteins onto chromatin in living cells requires 
replication to unload. J. Cell Biol. 192, 29-41 (2011). 
60.      Diffley,J.F. & Labib,K. The chromosome replication cycle. J. Cell Sci. 115, 
869-872 (2002). 
61.      Blow,J.J. & Dutta,A. Preventing re-replication of chromosomal DNA. Nat. Rev. 
Mol. Cell Biol. 6, 476-486 (2005). 
62.      Maine,G.T., Sinha,P., & Tye,B.K. Mutants of S. cerevisiae defective in the 
maintenance of minichromosomes. Genetics 106, 365-385 (1984). 
63.      Neuwald,A.F., Aravind,L., Spouge,J.L., & Koonin,E.V. AAA+: A class of 
chaperone-like ATPases associated with the assembly, operation, and 
disassembly of protein complexes. Genome Res. 9, 27-43 (1999). 
64.      Labib,K., Tercero,J.A., & Diffley,J.F. Uninterrupted MCM2-7 function required 
for DNA replication fork progression. Science 288, 1643-1647 (2000). 
65.      Sclafani,R.A., Fletcher,R.J., & Chen,X.S. Two heads are better than one: 
regulation of DNA replication by hexameric helicases. Genes Dev. 18, 2039-
2045 (2004). 
66.      Iyer,L.M., Leipe,D.D., Koonin,E.V., & Aravind,L. Evolutionary history and 
higher order classification of AAA+ ATPases. J. Struct. Biol. 146, 11-31 
(2004). 
67.      Sakakibara,N., Kelman,L.M., & Kelman,Z. Unwinding the structure and 
function of the archaeal MCM helicase. Mol. Microbiol. 72, 286-296 (2009). 
29 
 
68.      Koonin,E.V. A common set of conserved motifs in a vast variety of putative 
nucleic acid-dependent ATPases including MCM proteins involved in the 
initiation of eukaryotic DNA replication. Nucleic Acids Res. 21, 2541-2547 
(1993). 
69.      Davey,M.J., Indiani,C., & O'Donnell,M. Reconstitution of the Mcm2-7p 
heterohexamer, subunit arrangement, and ATP site architecture. J. Biol. Chem. 
278, 4491-4499 (2003). 
70.      Ishimi,Y. A DNA helicase activity is associated with an MCM4, -6, and -7 
protein complex. J. Biol. Chem. 272, 24508-24513 (1997). 
71.      Schwacha,A. & Bell,S.P. Interactions between two catalytically distinct MCM 
subgroups are essential for coordinated ATP hydrolysis and DNA replication. 
Mol. Cell 8, 1093-1104 (2001). 
72.      Lee,J.K. & Hurwitz,J. Isolation and characterization of various complexes of the 
minichromosome maintenance proteins of Schizosaccharomyces pombe. J. Biol. 
Chem. 275, 18871-18878 (2000). 
73.      Tye,B.K. MCM proteins in DNA replication. Annu. Rev. Biochem 68, 649-686 
(1999). 
74.      Chang,V.K., Fitch,M.J., Donato,J.J., Christensen,T.W., Merchant,A.M. et al. 
Mcm1 binds replication origins. J. Biol. Chem. 278, 6093-6100 (2003). 
75.      Chang,V.K., Donato,J.J., Chan,C.S., & Tye,B.K. Mcm1 promotes replication 
initiation by binding specific elements at replication origins. Mol. Cell Biol. 24, 
6514-6524 (2004). 
76.      Ricke,R.M. & Bielinsky,A.K. Mcm10 regulates the stability and chromatin 
association of DNA polymerase-alpha. Mol Cell 16, 173-185 (2004). 
77.      Cook,C.R., Kung,G., Peterson,F.C., Volkman,B.F., & Lei,M. A novel zinc 
finger is required for Mcm10 homocomplex assembly. J. Biol. Chem. 278, 
36051-36058 (2003). 
78.      Maiorano,D., Lutzmann,M., & Mechali,M. MCM proteins and DNA 
replication. Curr. Opin. Cell Biol. 18, 130-136 (2006). 
79.      Lutzmann,M., Maiorano,D., & Mechali,M. Identification of full genes and 
proteins of MCM9, a novel, vertebrate-specific member of the MCM2-8 protein 
family. Gene 362, 51-56 (2005). 
80.      Gozuacik,D., Chami,M., Lagorce,D., Faivre,J., Murakami,Y. et al. 
Identification and functional characterization of a new member of the human 
Mcm protein family: hMcm8. Nucleic Acids Res. 31, 570-579 (2003). 
30 
 
81.      Maiorano,D., Cuvier,O., Danis,E., & Mechali,M. MCM8 is an MCM2-7-related 
protein that functions as a DNA helicase during replication elongation and not 
initiation. Cell 120, 315-328 (2005). 
82.      Sakwe,A.M., Nguyen,T., Athanasopoulos,V., Shire,K., & Frappier,L. 
Identification and characterization of a novel component of the human 
minichromosome maintenance complex. Mol. Cell Biol. 27, 3044-3055 (2007). 
83.      Nishiyama,A., Frappier,L., & Mechali,M. MCM-BP regulates unloading of the 
MCM2-7 helicase in late S phase. Genes Dev. 25, 165-175 (2011). 
84.      Costa,A. & Onesti,S. Structural biology of MCM helicases. Crit Rev. Biochem. 
Mol. Biol. 44, 326-342 (2009). 
85.      Slaymaker,I.M. & Chen,X.S. MCM Structure and Mechanics: What We Have 
Learned from Archaeal MCM. Subcell. Biochem. 62, 89-111 (2012). 
86.      Costa,A., van Duinen G., Medagli,B., Chong,J., Sakakibara,N. et al. Cryo-
electron microscopy reveals a novel DNA-binding site on the MCM helicase. 
EMBO J. 27, 2250-2258 (2008). 
87.      Fletcher,R.J., Bishop,B.E., Leon,R.P., Sclafani,R.A., Ogata,C.M. et al. The 
structure and function of MCM from archaeal M. Thermoautotrophicum. Nat. 
Struct. Biol. 10, 160-167 (2003). 
88.      McGeoch,A.T., Trakselis,M.A., Laskey,R.A., & Bell,S.D. Organization of the 
archaeal MCM complex on DNA and implications for the helicase mechanism. 
Nat. Struct. Mol. Biol. 12, 756-762 (2005). 
89.      Barry,E.R., McGeoch,A.T., Kelman,Z., & Bell,S.D. Archaeal MCM has 
separable processivity, substrate choice and helicase domains. Nucleic Acids 
Res. 35, 988-998 (2007). 
90.      Brewster,A.S., Wang,G., Yu,X., Greenleaf,W.B., Carazo,J.M. et al. Crystal 
structure of a near-full-length archaeal MCM: functional insights for an AAA+ 
hexameric helicase. Proc. Natl. Acad. Sci. U. S. A 105, 20191-20196 (2008). 
91.      Remus,D., Beuron,F., Tolun,G., Griffith,J.D., Morris,E.P. et al. Concerted 
loading of Mcm2-7 double hexamers around DNA during DNA replication 
origin licensing. Cell 139, 719-730 (2009). 
92.      Gambus,A., Khoudoli,G.A., Jones,R.C., & Blow,J.J. MCM2-7 form double 
hexamers at licensed origins in Xenopus egg extract. J. Biol. Chem. 286, 11855-
11864 (2011). 
93.      Evrin,C., Clarke,P., Zech,J., Lurz,R., Sun,J. et al. A double-hexameric MCM2-7 
complex is loaded onto origin DNA during licensing of eukaryotic DNA 
replication. Proc. Natl. Acad. Sci. U. S. A 106, 20240-20245 (2009). 
31 
 
94.      Hoang,M.L., Leon,R.P., Pessoa-Brandao,L., Hunt,S., Raghuraman,M.K. et al. 
Structural changes in Mcm5 protein bypass Cdc7-Dbf4 function and reduce 
replication origin efficiency in Saccharomyces cerevisiae. Mol. Cell Biol. 27, 
7594-7602 (2007). 
95.      Fletcher,R.J. & Chen,X.S. Biochemical activities of the BOB1 mutant in 
Methanobacterium thermoautotrophicum MCM. Biochemistry 45, 462-467 
(2006). 
96.      Barry,E.R., Lovett,J.E., Costa,A., Lea,S.M., & Bell,S.D. Intersubunit allosteric 
communication mediated by a conserved loop in the MCM helicase. Proc. Natl. 
Acad. Sci. U. S. A 106, 1051-1056 (2009). 
97.      Sakakibara,N., Kasiviswanathan,R., Melamud,E., Han,M., Schwarz,F.P. et al. 
Coupling of DNA binding and helicase activity is mediated by a conserved loop 
in the MCM protein. Nucleic Acids Res. 36, 1309-1320 (2008). 
98.      Enemark,E.J. & Joshua-Tor,L. Mechanism of DNA translocation in a 
replicative hexameric helicase. Nature 442, 270-275 (2006). 
99.      Leon,R.P., Tecklenburg,M., & Sclafani,R.A. Functional conservation of beta-
hairpin DNA binding domains in the Mcm protein of Methanobacterium 
thermoautotrophicum and the Mcm5 protein of Saccharomyces cerevisiae. 
Genetics 179, 1757-1768 (2008). 
100.      Erzberger,J.P. & Berger,J.M. Evolutionary relationships and structural 
mechanisms of AAA+ proteins. Annu. Rev. Biophys. Biomol. Struct. 35, 93-114 
(2006). 
101.      Gai,D., Zhao,R., Li,D., Finkielstein,C.V., & Chen,X.S. Mechanisms of 
conformational change for a replicative hexameric helicase of SV40 large tumor 
antigen. Cell 119, 47-60 (2004). 
102.      Li,D., Zhao,R., Lilyestrom,W., Gai,D., Zhang,R. et al. Structure of the 
replicative helicase of the oncoprotein SV40 large tumour antigen. Nature 423, 
512-518 (2003). 
103.      Liu,W., Pucci,B., Rossi,M., Pisani,F.M., & Ladenstein,R. Structural analysis of 
the Sulfolobus solfataricus MCM protein N-terminal domain. Nucleic Acids 
Res. 36, 3235-3243 (2008). 
104.      Jenkinson,E.R. & Chong,J.P. Minichromosome maintenance helicase activity is 
controlled by N- and C-terminal motifs and requires the ATPase domain helix-2 
insert. Proc. Natl. Acad. Sci. U. S. A 103, 7613-7618 (2006). 
105.      Patel,S.S. & Picha,K.M. Structure and function of hexameric helicases. Annu. 
Rev. Biochem. 69, 651-697 (2000). 
32 
 
106.      Kanter,D.M., Bruck,I., & Kaplan,D.L. Mcm subunits can assemble into two 
different active unwinding complexes. J. Biol. Chem. 283, 31172-31182 (2008). 
107.      Kaplan,D.L., Davey,M.J., & O'Donnell,M. Mcm4,6,7 uses a "pump in ring" 
mechanism to unwind DNA by steric exclusion and actively translocate along a 
duplex. J Biol. Chem. 278, 49171-49182 (2003). 
108.      Bochman,M.L. & Schwacha,A. The Mcm2-7 complex has in vitro helicase 
activity. Mol. Cell 31, 287-293 (2008). 
109.      Stead,B.E., Sorbara,C.D., Brandl,C.J., & Davey,M.J. ATP binding and 
hydrolysis by Mcm2 regulate DNA binding by Mcm complexes. J. Mol. Biol. 
391, 301-313 (2009). 
110.      Bochman,M.L. & Schwacha,A. Differences in the single-stranded DNA binding 
activities of MCM2-7 and MCM467: MCM2 and MCM5 define a slow ATP-
dependent step. J. Biol. Chem. 282, 33795-33804 (2007). 
111.      Bochman,M.L. & Schwacha,A. The Saccharomyces cerevisiae Mcm6/2 and 
Mcm5/3 ATPase active sites contribute to the function of the putative Mcm2-7 
'gate'. Nucleic Acids Res. 38, 6078-6088 (2010). 
112.      Sato,M., Gotow,T., You,Z., Komamura-Kohno,Y., Uchiyama,Y. et al. Electron 
microscopic observation and single-stranded DNA binding activity of the 
Mcm4,6,7 complex. J. Mol. Biol. 300, 421-431 (2000). 
113.      Takahashi,T.S., Wigley,D.B., & Walter,J.C. Pumps, paradoxes and 
ploughshares: mechanism of the MCM2-7 DNA helicase. Trends Biochem. Sci. 
30, 437-444 (2005). 
114.      Lee,J.K. & Hurwitz,J. Processive DNA helicase activity of the 
minichromosome maintenance proteins 4, 6, and 7 complex requires forked 
DNA structures. Proc. Natl. Acad. Sci. U. S. A 98, 54-59 (2001). 
115.      Moyer,S.E., Lewis,P.W., & Botchan,M.R. Isolation of the Cdc45/Mcm2-
7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork 
helicase. Proc. Natl. Acad. Sci. U. S. A 103, 10236-10241 (2006). 
116.      Kelman,Z., Lee,J.K., & Hurwitz,J. The single minichromosome maintenance 
protein of Methanobacterium thermoautotrophicum DeltaH contains DNA 
helicase activity. Proc. Natl. Acad. Sci. U. S. A 96, 14783-14788 (1999). 
117.      Laskey,R.A. & Madine,M.A. A rotary pumping model for helicase function of 
MCM proteins at a distance from replication forks. EMBO Rep. 4, 26-30 (2003). 
118.      Bochman,M.L., Bell,S.P., & Schwacha,A. Subunit organization of Mcm2-7 and 
the unequal role of active sites in ATP hydrolysis and viability. Mol. Cell Biol. 
28, 5865-5873 (2008). 
33 
 
119.      Randell,J.C., Fan,A., Chan,C., Francis,L.I., Heller,R.C. et al. Mec1 is one of 
multiple kinases that prime the Mcm2-7 helicase for phosphorylation by Cdc7. 
Mol. Cell 40, 353-363 (2010). 
120.      Montagnoli,A., Valsasina,B., Brotherton,D., Troiani,S., Rainoldi,S. et al. 
Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J. 
Biol. Chem. 281, 10281-10290 (2006). 
121.      Devault,A., Gueydon,E., & Schwob,E. Interplay between S-cyclin-dependent 
kinase and Dbf4-dependent kinase in controlling DNA replication through 
phosphorylation of yeast Mcm4 N-terminal domain. Mol. Biol. Cell 19, 2267-
2277 (2008). 
122.      Ilves,I., Petojevic,T., Pesavento,J.J., & Botchan,M.R. Activation of the MCM2-
7 helicase by association with Cdc45 and GINS proteins. Mol. Cell 37, 247-258 
(2010). 
123.      Sheu,Y.J. & Stillman,B. The Dbf4-Cdc7 kinase promotes S phase by alleviating 
an inhibitory activity in Mcm4. Nature 463, 113-117 (2010). 
124.      Bousset,K. & Diffley,J.F. The Cdc7 protein kinase is required for origin firing 
during S phase. Genes Dev. 12, 480-490 (1998). 
125.      Donaldson,A.D., Fangman,W.L., & Brewer,B.J. Cdc7 is required throughout 
the yeast S phase to activate replication origins. Genes Dev. 12, 491-501 (1998). 
126.      Lei,M., Kawasaki,Y., Young,M.R., Kihara,M., Sugino,A. et al. Mcm2 is a 
target of regulation by Cdc7-Dbf4 during the initiation of DNA synthesis. 
Genes Dev 11, 3365-3374 (1997). 
127.      Weinreich,M. & Stillman,B. Cdc7p-Dbf4p kinase binds to chromatin during S 
phase and is regulated by both the APC and the RAD53 checkpoint pathway. 
EMBO J 18, 5334-5346 (1999). 
128.      Hardy,C.F., Dryga,O., Seematter,S., Pahl,P.M., & Sclafani,R.A. mcm5/cdc46-
bob1 bypasses the requirement for the S phase activator Cdc7p. Proc. Natl. 
Acad. Sci. U. S. A 94, 3151-3155 (1997). 
129.      Francis,L.I., Randell,J.C., Takara,T.J., Uchima,L., & Bell,S.P. Incorporation 
into the prereplicative complex activates the Mcm2-7 helicase for Cdc7-Dbf4 
phosphorylation. Genes Dev. 23, 643-654 (2009). 
130.      Stead,B.E., Brandl,C.J., & Davey,M.J. Phosphorylation of Mcm2 modulates 
Mcm2-7 activity and affects the cell's response to DNA damage. Nucleic Acids 
Res. 39, 6998-7008 (2011). 
131.      Stead,B.E., Brandl,C.J., Sandre,M.K., & Davey,M.J. Mcm2 phosphorylation 
and the response to replicative stress. BMC. Genet. 13, 36 (2012). 
34 
 
132.      Sheu,Y.J. & Stillman,B. Cdc7-Dbf4 phosphorylates MCM proteins via a 
docking site-mediated mechanism to promote S phase progression. Mol Cell 24, 
101-113 (2006). 
133.      Brown,G.W. & Kelly,T.J. Purification of Hsk1, a minichromosome 
maintenance protein kinase from fission yeast. J. Biol. Chem. 273, 22083-22090 
(1998). 
134.      Myung,K., Chen,C., & Kolodner,R.D. Multiple pathways cooperate in the 
suppression of genome instability in Saccharomyces cerevisiae. Nature 411, 
1073-1076 (2001). 
135.      Santocanale,C. & Diffley,J.F. A Mec1- and Rad53-dependent checkpoint 
controls late-firing origins of DNA replication. Nature 395, 615-618 (1998). 
136.      Shirahige,K., Hori,Y., Shiraishi,K., Yamashita,M., Takahashi,K. et al. 
Regulation of DNA-replication origins during cell-cycle progression. Nature 
395, 618-621 (1998). 
137.      Sanchez,Y., Bachant,J., Wang,H., Hu,F., Liu,D. et al. Control of the DNA 
damage checkpoint by chk1 and rad53 protein kinases through distinct 
mechanisms. Science 286, 1166-1171 (1999). 
138.      Weinert,T.A., Kiser,G.L., & Hartwell,L.H. Mitotic checkpoint genes in budding 
yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 
8, 652-665 (1994). 
139.      Sanchez,Y., Desany,B.A., Jones,W.J., Liu,Q., Wang,B. et al. Regulation of 
RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle 
checkpoint pathways. Science 271, 357-360 (1996). 
140.      Cliby,W.A., Roberts,C.J., Cimprich,K.A., Stringer,C.M., Lamb,J.R. et al. 
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-
damaging agents and defects in cell cycle checkpoints. EMBO J. 17, 159-169 
(1998). 
141.      Zhao,X., Muller,E.G., & Rothstein,R. A suppressor of two essential checkpoint 
genes identifies a novel protein that negatively affects dNTP pools. Mol. Cell 2, 
329-340 (1998). 
142.      Zegerman,P. & Diffley,J.F. DNA replication as a target of the DNA damage 
checkpoint. DNA Repair (Amst) 8, 1077-1088 (2009). 
143.      Chabes,A., Domkin,V., & Thelander,L. Yeast Sml1, a protein inhibitor of 
ribonucleotide reductase. J. Biol. Chem. 274, 36679-36683 (1999). 
35 
 
144.      Hofmann,J.F. & Beach,D. cdt1 is an essential target of the Cdc10/Sct1 
transcription factor: requirement for DNA replication and inhibition of mitosis. 
EMBO J. 13, 425-434 (1994). 
145.      Nishitani,H., Lygerou,Z., Nishimoto,T., & Nurse,P. The Cdt1 protein is 
required to license DNA for replication in fission yeast. Nature 404, 625-628 
(2000). 
146.      Devault,A., Vallen,E.A., Yuan,T., Green,S., Bensimon,A. et al. Identification of 
Tah11/Sid2 as the ortholog of the replication licensing factor Cdt1 in 
Saccharomyces cerevisiae. Curr. Biol. 12, 689-694 (2002). 
147.      Whittaker,A.J., Royzman,I., & Orr-Weaver,T.L. Drosophila double parked: a 
conserved, essential replication protein that colocalizes with the origin 
recognition complex and links DNA replication with mitosis and the down-
regulation of S phase transcripts. Genes Dev. 14, 1765-1776 (2000). 
148.      Wohlschlegel,J.A., Dwyer,B.T., Dhar,S.K., Cvetic,C., Walter,J.C. et al. 
Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 
290, 2309-2312 (2000). 
149.      Tanaka,S. & Diffley,J.F. Interdependent nuclear accumulation of budding yeast 
Cdt1 and Mcm2-7 during G1 phase. Nat. Cell Biol. 4, 198-207 (2002). 
150.      Fernandez-Cid,A., Riera,A., Tognetti,S., Herrera,M.C., Samel,S. et al. An 
ORC/Cdc6/MCM2-7 complex is formed in a multistep reaction to serve as a 
platform for MCM double-hexamer assembly. Mol. Cell 50, 577-588 (2013). 
151.      Randell,J.C., Bowers,J.L., Rodriguez,H.K., & Bell,S.P. Sequential ATP 
hydrolysis by Cdc6 and ORC directs loading of the Mcm2-7 helicase. Mol Cell 
21, 29-39 (2006). 
152.      Ferenbach,A., Li,A., Brito-Martins,M., & Blow,J.J. Functional domains of the 
Xenopus replication licensing factor Cdt1. Nucleic Acids Res. 33, 316-324 
(2005). 
153.      Jee,J., Mizuno,T., Kamada,K., Tochio,H., Chiba,Y. et al. Structure and 
mutagenesis studies of the C-terminal region of licensing factor Cdt1 enable the 
identification of key residues for binding to replicative helicase Mcm proteins. 
J. Biol. Chem. 285, 15931-15940 (2010). 
154.      Yanagi,K., Mizuno,T., You,Z., & Hanaoka,F. Mouse geminin inhibits not only 
Cdt1-MCM6 interactions but also a novel intrinsic Cdt1 DNA binding activity. 
J. Biol. Chem. 277, 40871-40880 (2002). 
155.      You,Z. & Masai,H. Cdt1 forms a complex with the minichromosome 
maintenance protein (MCM) and activates its helicase activity. J. Biol. Chem. 
283, 24469-24477 (2008). 
36 
 
156.      Takara,T.J. & Bell,S.P. Multiple Cdt1 molecules act at each origin to load 
replication-competent Mcm2-7 helicases. EMBO J. 30, 4885-4896 (2011). 
157.      Frigola,J., Remus,D., Mehanna,A., & Diffley,J.F. ATPase-dependent quality 
control of DNA replication origin licensing. Nature 495, 339-343 (2013). 
158.      Samson,R.Y. & Bell,S.D. MCM loading--an open-and-shut case? Mol. Cell 50, 
457-458 (2013). 
159.      Pacek,M. & Walter,J.C. A requirement for MCM7 and Cdc45 in chromosome 
unwinding during eukaryotic DNA replication. EMBO J 23, 3667-3676 (2004). 
160.      Tercero,J.A., Labib,K., & Diffley,J.F. DNA synthesis at individual replication 
forks requires the essential initiation factor Cdc45p. EMBO J. 19, 2082-2093 
(2000). 
161.      Kanemaki,M., Sanchez-Diaz,A., Gambus,A., & Labib,K. Functional proteomic 
identification of DNA replication proteins by induced proteolysis in vivo. 
Nature 423, 720-724 (2003). 
162.      Aparicio,O.M., Weinstein,D.M., & Bell,S.P. Components and dynamics of 
DNA replication complexes in S. cerevisiae: redistribution of MCM proteins 
and Cdc45p during S phase. Cell 91, 59-69 (1997). 
163.      Aparicio,T., Ibarra,A., & Mendez,J. Cdc45-MCM-GINS, a new power player 
for DNA replication. Cell Div. 1, 18 (2006). 
164.      Calzada,A., Hodgson,B., Kanemaki,M., Bueno,A., & Labib,K. Molecular 
anatomy and regulation of a stable replisome at a paused eukaryotic DNA 
replication fork. Genes Dev 19, 1905-1919 (2005). 
165.      Costa,A., Ilves,I., Tamberg,N., Petojevic,T., Nogales,E. et al. The structural 
basis for MCM2-7 helicase activation by GINS and Cdc45. Nat. Struct. Mol. 
Biol. 18, 471-477 (2011). 
166.      Makarova,K.S., Koonin,E.V., & Kelman,Z. The CMG (CDC45/RecJ, MCM, 
GINS) complex is a conserved component of the DNA replication system in all 
archaea and eukaryotes. Biol. Direct. 7, 7 (2012). 
 
 
 
37 
 
Chapter 2  
2 The C-terminal residues of Saccharomyces cerevisiae 
Mec1 are required for its localization, stability and 
function 
Mec1, a member of the PIKK (phosphoinositide three-kinase-related kinase) family of 
proteins, is involved in the response to replicative stress and DNA damage, and in 
telomere maintenance. An essential 30-35 residue FATC domain is found at the C-
terminus of all PIKK family members. To investigate the roles of the C-terminal residues 
of Mec1, we characterized alleles of Saccharomyces cerevisiae mec1 that alter the FATC 
domain. A change of the terminal tryptophan to alanine resulted in temperature sensitive 
growth, sensitivity to hydroxyurea, and diminished kinase activity in vitro. Addition of a 
terminal glycine or deletion of one, two or three residues resulted in loss of cell viability 
and kinase function. Each of these Mec1 derivatives was less stable than wild-type Mec1, 
eluted abnormally from a size exclusion column, and showed reduced nuclear 
localization. We identified rpn3-L140P, which encodes a component of the 19S 
proteasomal regulatory particle of the 26S proteasome, as a suppressor of the 
temperature-sensitive growth caused by mec1-W2368A. The rpn3-L140P allele acted in a 
partially dominant fashion. It was neither able to suppress the inviability of the C-
terminal truncations or additions, nor the hydroxyurea sensitivity of mec1-W2368A. The 
rpn3-L140P allele restored Mec1-W2368A to near wild-type protein levels at 37°C, an 
effect partially mimicked by the proteasome inhibitor MG-132. Our study supports a role 
for the C-terminus in Mec1 folding and stability, and suggests a role for the proteasome 
in regulating Mec1 levels.     
2.1 Introduction 
Members of the PIKK (phosphoinositide three-kinase-related kinase) family of proteins 
are important in the cellular response to various forms of stress (reviewed in 1). The 
PIKK proteins are large (for example, Tra1 and Mec1 are 3744 and 2368 residues, 
respectively), and are characterized by a C-terminally positioned domain that resembles 
the phosphatidylinositol-3-kinases (PI3K) 1-3.  
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Three members of the PIKK family have principal roles in DNA damage response 
(DDR) pathways. ATM (ataxia telangiectasia mutated, Tel1 in S. cerevisiae), ATR 
(ataxia telangiectasia and Rad3-related, Mec1 in S. cerevisiae), and the DNA-PKcs 
(DNA-dependent protein kinase catalytic subunit) transmit and amplify the damage 
signal through the phosphorylation of target proteins. Recruitment to sites of DNA 
damage is critical for their activation and function in checkpoint signaling and DNA 
repair (reviewed in 4). ATM/Tel1 acts principally in response to double strand breaks, 
whereas ATR/Mec1 responds to a number of DNA insults and particularly replicative 
stress caused by stalled replication forks (reviewed in 5). Both have roles in the 
maintenance of stable telomeres 6-8. DNA-PKcs acts with Ku70 and Ku80 in 
nonhomologous end-joining of double strand breaks; a direct homolog has not been 
found in S. cerevisiae.  
Mec1/ATR is an essential gene (reviewed in 9). It is recruited to stalled 
replication forks and sites of DNA damage through the direct interaction of its associated 
protein Lcd1/Ddc2 with RPA-coated single stranded DNA 10-14. This recruitment is part 
of a series of events, which results in the phosphorylation of regulatory and effector 
molecules that activate a cell cycle checkpoint and/or apoptotic signals. Mec1 target 
molecules include histone H2A 15, 16, RPA 17, components of the Mcm2-7 DNA helicase 
complex 18, 19, the Ino80 subunit Ies4 20, and the effector kinases Rad53 and Chk1 21-23. 
Fork stabilization is the essential function of Mec1 24, 25 and occurs through multiple 
mechanisms including retaining DNA polymerase at the replication fork 26. In addition, 
Mec1 is required to activate the expression of ribonucleotide reductase thus enhancing 
deoxyribonucleotide synthesis following DNA damage and perhaps during normal S 
phase (reviewed in 27). This function can be bypassed by increasing deoxyribonucleotide 
levels either by overexpressing Rnr3, one of the catalytic subunits of ribonucleotide 
reductase, or by deletion of the ribonucleotide reductase inhibitor Sml1 24, 28. 
Interestingly, Mec1 and ATR are required to prevent chromosome breaks even in the 
absence of genotoxic stress. Augmenting deoxyribonucleotide levels does not rescue the 
checkpoint defects or DNA damage sensitivity of cells lacking functional Mec1 28.  
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Other PIKK family members include SMG-1 (suppressor with morphological 
effect on genitalia family member), TOR (target of rapamycin) and TRRAP 
(Transformation/transcription domain-associated protein). SMG-1 is found in metazoans. 
It has many similar roles related to genotoxic stress 29, 30 and telomere stability 31 as ATM 
and ATR, and is also the key signaling molecule required for the nonsense mediated 
decay pathway (reviewed in 32).  TOR is found in two complexes, TORC1 and TORC2. 
TORC1 integrates nutrient and growth factor signals, inducing anabolic pathways 
including protein synthesis and inhibiting catabolic pathways (reviewed in 33). TORC2 is 
involved in spatial control of cell growth by regulating the actin cytoskeleton (reviewed 
in 34). The only member of the PIKK family that is not a Ser/Thr kinase is the 
transcriptional cofactor TRRAP 35, 36. The S. cerevisiae homolog Tra1 is an essential 
component of the multisubunit, multifunctional SAGA and NuA4 histone 
acetyltransferase complexes 36, 37. A key role for Tra1 is to recruit HAT complexes to 
promoters via its association with transcriptional activators 38-41. 
As well as having the PI3K domain, the PIKK proteins share a number of other 
features. N-terminal to the PI3K domain is a FAT (FRAP-ATM-TRRAP) domain that 
consists largely of helical HEAT (Huntington, Elongation Factor 3, PR65/A, TOR) and 
TPR (tetratricopeptide) repeats; in fact, these repeats extend through to the proteins’ N-
termini making most of the protein helical 42-45. C-terminal to the PI3K domain is a less 
highly conserved PRD (PIKK regulatory domain) 46.  At the C-terminus of the PIKK 
molecules is the 30-35 residue FATC domain 42. The structure of the isolated FATC 
domain of S. cerevisiae Tor1 47 is helical with a C-terminal loop held in place by a 
disulphide linkage. Though the cysteines are not conserved and the cellular FATC 
domain is not likely to always exist in an oxidized state, the helical structure is likely 
conserved 2, 48. The crystal structure of mTOR (mammalian target of rapamycin) 
including the FAT through to the C-terminus reveals that the FATC domain is an integral 
part of the kinase, positioned adjacent to the activation loop 49. The substrate binding 
groove also includes portions of the FATC domain. The importance of the FATC domain 
has been demonstrated with molecular studies. Deletion of the C-terminus of mTOR, or 
mutation of a conserved tryptophan five residues from the C-terminus, eliminate kinase 
activity 50. Similar mutations within the FATC domains of DNA-PKcs and SMG-1 cause 
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a loss of kinase activity 51-53. As suggested by Lempiäinen and Halazonetis 2 the FATC 
domain likely regulates the kinase domain through interactions with the activation loop 
similar to the helical domains of the PI3-kinases. The FATC domain is also critical for 
the function of Tra1. Addition of as little as a single glycine to the C-terminus of Tra1 
results in loss of cellular viability 54. A strain with a mutation of the terminal 
phenylalanine residue of Tra1 to alanine (tra1-F3744A) shows growth defects, including 
temperature sensitivity and slow growth on media containing ethanol, Calcofluor white or 
rapamycin. The F3744A mutation also results in mislocalization of the protein to the 
cytoplasm, particularly under conditions of stress 55. We identified a partially dominant 
mutation within tti2 as a suppressor of tra1-F3744A 55. TTI2 encodes a component of the 
TTT (Tel2, Tti1 and Tti2) complex that associates with chaperone proteins in the folding 
of PIKK proteins 56-60 . This suggested that the C-terminal residue of the molecule is 
required for folding, and was consistent with the tti2 suppressor mutation decreasing the 
proteolytic degradation of Tra1-F3744A, and increasing its nuclear localization.  
To determine if the C-terminus of the FATC domain is a general requirement for 
the folding and function of the PIKK proteins, we have examined alleles of mec1 that 
disrupt this domain. Addition or deletion of residues results in loss of viability and kinase 
activity. Proteins containing these insertions or deletions, as well as a C-terminal change 
of tryptophan to alanine have reduced nuclear localization, and elute from a gel filtration 
column with an abnormally high molecular mass. They are also less stable after isolation 
than the wild-type protein. A second site mutation of rpn3-L140P, which encodes a 
component of the 19S proteasomal regulatory particle, restores the levels of the Mec1-
W2368A protein and growth of the mec1-W2368A strain at 37°C, further supporting a 
role for the C-terminus in protein folding and stability. 
2.2 Materials and Methods 
2.2.1 Yeast strains and growth 
Yeast strains are listed in Table 2.1 and are derivatives of the diploid strain BY4743 61. 
Strains containing one Flag5-tagged (CY6172) or eGFP-tagged (CY6295) MEC1 allele, 
marked with URA3, were made by one–step integration of the SphI-EcoRI fragments of  
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Table 2.1 
  
Table 2.1: Strains used in this study. 
Strain Genotype Reference 
BY4743 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met15Δ0/MET15 ura3Δ0/ura3Δ0 
Winzeler and Davis 
(1997) 
BY4741 MATa ura3Δ0 met15Δ0 his3Δ0 leu2Δ0 Winzeler and Davis (1997) 
BY4742 MATα ura3Δ0 lys2Δ0 his3Δ0 leu2Δ0 Winzeler and Davis (1997) 
CY4350 MATa ura3Δ0 his3Δ0 leu2Δ0 tra1-F3744A-HIS3  Hoke et al. (2010) 
CY4353 MATa ura3Δ0 his3Δ0 leu2Δ0 TRA1-HIS3 Hoke et al. (2010) 
CY6076 MATa ura3Δ0 his3Δ0 leu2Δ0 mec1-W2368A-HIS3 Genereaux et al. (2012) 
CY6077 MATα ura3Δ0 his3Δ0 leu2Δ0 mec1-W2368A-HIS3 This work 
CY6106 MATa ura3Δ0 his3Δ0 leu2Δ0 mec1-W2368A-URA3 This work 
CY6172 Isogenic to BY4743 except MEC1/URA3-Flag5-MEC1 This work 
CY6175 MATa ura3Δ0 his3Δ0 leu2Δ0 URA3-Flag
5-mec1-W2368A-
HIS3 This work 
CY6192 Isogenic to BY4743 except MEC1/URA3-Flag
5-mec1-
W2368A-HIS3 This work 
CY6184 Isogenic to BY4743 except MEC1/URA3-Flag
5-mec1-Δ1-
HIS3 This work 
CY6194 MATa ura3Δ0 his3Δ0 leu2Δ0 URA3-Flag5-MEC1 This work 
CY6203 Isogenic to BY4743 except MEC1/URA3-Flag
5-mec1-
2369G-HIS3 This work 
CY6233 Isogenic to BY4743 except MEC1/URA3-Flag
5-mec1-Δ3-
HIS3 This work 
CY6250 Isogenic to BY4743 except MEC1/URA3-Flag
5-mec1-Δ2-
HIS3 This work 
CY6265 MATα ura3Δ0 his3Δ0 leu2Δ0 mec1-W2368A-URA3 rpn3-L140P This work 
CY6291 Isogenic to BY4743 except LEU2-MEC1/URA3-eGFP-MEC1-Δ1-HIS3 This work 
CY6292 Isogenic to BY4743 except LEU2-MEC1/URA3-eGFP-MEC1-Δ3-HIS3 This work 
CY6293 Isogenic to BY4743 except LEU2-MEC1/URA3-eGFP-mec1-2369G-HIS3 This work 
CY6294 Isogenic to BY4743 except LEU2-MEC1/URA3-eGFP-MEC1-Δ2-HIS3 This work 
CY6295 Isogenic to BY4743 except MEC1/URA3-eGFP-MEC1 This work 
CY6296 Isogenic to BY4743 except MEC1/URA3-eGFP-mec1-W2368A-HIS3 This work 
CY6302 MATa ura3Δ0 his3Δ0 leu2Δ0 URA3-eGFP-mec1-W2368A-HIS3 This work 
CY6303 MATα ura3Δ0 his3Δ0 leu2Δ0 URA3-eGFP-mec1-W2368A-HIS3 
 
This work 
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CY6306 MATα ura3Δ0 his3Δ0 leu2Δ0 URA3-eGFP-MEC1 This work 
CY6307 MATa ura3Δ0 his3Δ0 leu2Δ0 URA3-eGFP-MEC1 This work 
CY6319 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3-eGFP-MEC1 This work 
CY6321 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3- Flag5-MEC1 This work 
CY6330 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3-eGFP-mec1-Δ1-HIS3 This work 
CY6342 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3-eGFP-mec1-2369G-HIS3 This work 
CY6344 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3-eGFP-mec1-Δ2-HIS3 This work 
CY6349 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3-Flag5-mec1-2369G-HIS3 This work 
CY6391 MATα ura3Δ0 his3Δ0 leu2Δ0 mec1-W2368A-HIS3 rpn3-L140P This work 
CY6398 MATa ura3Δ0 his3Δ0 leu2Δ0 rpn3-L140P This work 
CY6399 MATα ura3Δ0 his3Δ0 leu2Δ0 rpn3-L140P This work 
CY6400 
MATa/α ura3Δ0/ura3Δ0 his3Δ0/his3Δ0 leu2Δ0/leu2Δ0 
URA3- Flag5-mec1-W2368A/MEC1 rpn3-L140P/rpn3-
L140P 
This work 
CY6418 MATa ura3Δ0 his3Δ0 leu2Δ0 tra1-F3744A-HIS3 rpn3-L140P This work 
CY6449 MATa ura3Δ0 his3Δ0 leu2Δ0 sml1Δ0::KanMX URA3-Flag5-mec1-2369G-HIS3 rpn3-L140P This work 
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pCB2363 and pCB2395, respectively. Expression of these alleles is driven by the TRA1 
promoter. Integration of the mec1-W2368A allele has been previously described 55. This 
strain, strains with C-terminal truncations of one, two or three residues (mec1-Δ1, Δ2 and 
Δ3), and the strain with the addition of a glycine residue (mec1-2369G) were similarly 
integrated as SphI-SacI fragments of a HIS3-tagged allele. Haploid strains containing 
mec1-W2368A (CY6175) or wild-type MEC1 (CY6194) were generated by sporulation of 
their respective diploid strains. Haploid strains containing mec1 deletion and addition 
alleles were made by integrating the mec1 allele into CY6319 or CY6321, MATa 
sml1::KanMX deletion strains derived from the consortium collection, and containing 
eGFP-MEC1 or Flag5-MEC1, respectively. Diploid strains expressing eGFP-tagged 
Mec1, Mec1-W2388A, Mec1-Δ1, Mec1-Δ2 or Mec1-2369G, and RFP-tagged Nic96 
were made by mating of CY6307, CY6302, CY6330, CY6344 and CY6342 with the 
RFP-tagged NIC96 strain in the EY0987 background (MATα his3Δ1 lys2Δ0 ura3Δ0; 62; 
kindly provided by Peter Arvidson). CY6265 containing mec1-W2368A and rpn3-L140P 
was isolated in the selection scheme described below. CY6398 (rpn3-L140P) was 
obtained after backcrossing with BY4741. The diploid strain CY6400 (MEC1/Flag5-
mec1-W2368A rpn3-L140P/rpn3-L140P) was obtained by mating of CY6391 and 
CY6399. CY6418 (tra1-W3744A rpn3-L140P) was obtained after crossing with CY4350 
55 and selecting for spore colonies that grew in the absence of histidine and carried the 
rpn3-L140P allele as determined by sequencing. CY6465 was derived from CY6076 by 
integrating rpn3-L140P contained in the URA3-containing yeast integrating plasmid 
YIPlac211 (CB2457) after digestion with BsaB1. 
 Growth comparisons were performed on YP media containing 2% glucose (YPD) 
or selective plates after 3-5 days at 30°C unless stated otherwise. Standard concentrations 
used for the selections were 0.03% methyl methanesulfonate (Sigma-Aldrich), 6% 
ethanol and 200 mM hydroxyurea (Sigma-Aldrich). Growth on plates containing MG-
132 (Calbiochem) were adapted from Liu et al. 63, conditions which permeablize cells. 
Strains were grown overnight in synthetic complete media lacking uracil and containing 
0.1% proline as the nitrogen source, then four hours in the same media also containing 
0.003% sodium dodecyl sulphate (SDS). Serial dilutions were spotted onto synthetic 
complete media containing 0.003% sodium dodecyl sulphate and 10, 25 or 50 µM MG-
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132 and grown at 30°C. 
2.2.2 DNA molecules 
An integrative vector to generate Flag5 (pCB6192) fusion of Mec1 was constructed from 
pCB2143 55, by replacing TRA1 flanking sequences with MEC1 as SphI-HindIII and 
NotI-EcoRI fragments using oligonucleotides 6288-1/6288-2 and 6288-3/6288-4 (Table 
2.2).  A 1.1 kilobase pair HindIII genomic fragment encoding URA3 was inserted into 
this molecule to allow selection.  The plasmid pCB6295 allowing integration of eGFP 
was created from pCB2143 by the replacement of the Flag cassette with a BamHI-Not1 
cassette encoding eGFP 54. The mec1 mutant alleles were constructed by PCR using the 
oligonucleotides indicated in Table 2 and inserted into pCB2317 (mec1-W2368A). Myc9-
tagged LCD1 and RPN3 were expressed from the DED1 promoter in YCplac111, a LEU2 
centromeric plasmid, by inserting a NotI-SstI fragment amplified from genomic DNA 
using oligonucleotides 6486-1/6486-2 and 6518-1/6522-1, respectively, downstream of 
the DED1 promoter-myc9 cassette 54. For integration in cells, rpn3-L140P including its 
native promoter was synthesized by PCR using oligonucleotides 6577-1 and 6510-2 and 
cloned as a HindIII-EcoR1 fragment into YIPlac211.  
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Table 2.2 
 
 
Table 2.2: Oligonucleotides used in this study. 
Number Sequence Description 
6288-1 5’-ATAAGGCGGCCGCCATGGAATCACACGTCAAATATC- 
TTG-3’ 
5’ coding region of MEC1 
to insert tags 
6288-2 5’-ATATGTCGACCGCCTCATAAACCATATTCTGTG-3’ 
 
5’ coding region of   
MEC1 to insert tags 
6288-3 5’-TTCGCATGCCTTTTCAAGGCTCCATAACTAT-3’ 
 
MEC1 promoter region to 
insert tags 
6288-4 5’-GGAAAGCTTGGAGCGTGCGTTCCATCTA-3’ 
 
MEC1 promoter region to 
insert tags 
6313-1 5’-AAGCTTGCATGCGTTGATGAATGTG-3’ 
 
3’ coding region of MEC1 
for cloning of deletions 
6313-2 5’-GCGTGATCAAAATGGAAGCCAACCAATATAC-3’ 
 
mec1-Δ1 
6338-1 5’-GCGTGATCATGGAAGCCAACCAATATACATC-3’ 
 
mec1-Δ2 
6338-2 5’-GCGTGATCAACCCCAAAATGGAAGCCAACCAATATA- 
CATC-3’ 
mec1-2369G 
6349-3 5’-GCGTGATCAAAGCCAACCAATATACATCTTGC-3’ 
 
mec1-Δ3 
6408-1 5’-CCCAGTCCGCCCTGAGCAAAG-3’ eGFP to confirm 
integration of tag 
6408-2 5’-CCGTAAAATTCGACACATGCTTTG-3’ 
 
5’ coding of MEC1 to 
confirm integration of tags 
6486-1 5’-ATAAGAATGCGGCCGCGATGAGACGAGAAACGGTG 
GG-3’ 
5’ coding of LCD1 
   
6486-2 5’-CGGAATTCCAAACCGGTTCTGCTAAG 3’ coding of LCD1 
   
6518-1 
 
5’-ATAAGAATGCGGCCGCAATGGCTAGCACTGCAGTA- 
AT-3’ 
5’ coding of RPN3 
6522-1 5’-CGGAATTCGCGCCCTTATAAGAATCCCAAATCG-3’ 3’ coding of RPN3 
   
6577-1 5’-CCCAAGCTTCGGAGTACGACCAGACGCTGA-3’ Promoter of RPN3 
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2.2.3 Fluorescence Microscopy 
Yeast cells expressing eGFP and/or RFP fusions were grown in synthetic complete media 
to stationary phase then diluted 1:20 into synthetic complete media and grown for six 
hours with shaking. Fluorescent images were obtained using a Zeiss Axioskop 2 
microscope driven by ImageJ 1.41 software (National Institutes of Health) and a Scion 
CFW Monochrome CCD Firewire Camera (Scion Corporation, Frederick Maryland) 
using RFP and GFP filter sets. 
2.2.4 Protein extracts and immunoprecipitation 
Yeast strains were grown in YP media containing 2% glucose to an A600~3.0. Extracts 
were prepared cryogenically as previously described 64 . For immunoprecipitations, all 
steps were performed at 4°C. 4.0 mg of extract from the Mec1 derivative strains or 2 mg 
of the wild-type extract was suspended in IP buffer (50 mM HEPES pH 7.5, 100 mM 
KCl, 0.1 mM EDTA, 0.2% Tween20, 1.0 mM dithiothreitol) containing protease 
inhibitors (1.0 mM phenylmethylsulfonyl fluoride, 1.0 mM benzamidine, 50 µg/ml 
trypsin inhibitor, 5 µg/ml pepstatin and 5 µg/ml leupeptin; Sigma-Aldrich). 
Immunoprecipitations were performed with 100 µl of a 50% slurry of anti-Flag M2 
magnetic beads (Sigma-Aldrich) and rotated for 2.5 hours. Beads were washed five-times 
with 1.0 ml of IP buffer. Protein was eluted in 1x-SDS loading buffer (without reducing 
agent) at 65° for 6 minutes, and then transferred to a fresh tube. Dithiothreitol was added 
to 20 mM and the sample heated at 65° for 2 minutes.   
2.2.5 Protein kinase assays 
Proteins captured by immunoprecipitation described above were processed as in Mallory 
and Petes 65 with modifications. Washed anti-Flag M2 beads (30 µl) containing the 
immunoprecipitated proteins were resuspended at a ratio of 1:1 in kinase buffer (10 mM 
Hepes-NaOH, pH 7.4; 50 mM NaCl; 10 mM MnCl2; 1 mM DTT). Kinase reactions 
contained the washed beads in which buffer was removed and 11.5 µl of kinase buffer, 
1.5 µl of 200 µM ATP, 10 µCi of γ-32P-labeled ATP (4500 Ci/mmol; 1 Ci = 37 GBq) 
and 1 µl of rat 4E-BP1 (1µg/µl; Santa Cruz Biotechnology, Inc.). The reactions were 
performed at 30°C for 30 min.  Protein was eluted in 1x SDS loading buffer, boiled for 
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two minutes and then separated on a 15% Tris-Tricine PAGE gel.  The gel was stained 
with Coomassie brilliant blue, destained and incubated 30 min in 20% polyethylene 
glycol 400: 50% methanol. The gel was dried, exposed to a storage phosphor screen and 
analyzed on a Storm 860 Phosphorimager (GE Healthcare Life Sciences). Densitometry 
analysis of the gel image was done using ImageQuant 5.2 (Molecular Dynamics). 
2.2.6 Gel filtration chromatography 
4.5 mg of yeast extract prepared in 50 mM sodium phosphate pH 7.0, 150 mM NaCl was 
loaded at a flow rate of 0.3 ml/min. onto a 24 ml FPLC Superose 6HR10/30 column 
(Amersham Pharmacia Biotech.). Protein from 20 µl aliquots of 250 µl fractions was 
resolved by SDS-PAGE and proteins detected by western blotting. Densitometric 
scanning of films was performed using AlphaImager 3400 software (Alpha Innotech, San 
Leandro, CA). 
2.2.7 Western blotting 
Western blotting was performed using PVDF membranes and anti-Flag (M2; Sigma-
Aldrich) or anti-Myc antibodies as described by Mutiu et al. 66 and Hoke et al. 54.  
2.2.8 Selection of suppressor strains 
CY6106 (mec1-W2368A-URA3) was grown to stationary phase in YPD. In two separate 
experiments, 10 µl of culture, approximately 2 million cells, was plated onto each of five 
YPD plates and UV irradiated at a wavelength of 302 nm for 10 s. Survival was 
approximately 10%. Colonies growing at 37°C were colony purified under nonselective 
conditions and reanalyzed for growth at 37°C. The suppressor strains were crossed with 
the HIS3-tagged mec1-W2368A strain, CY6077, to determine linkage of the suppressor 
with mec1-W2368A. In the two selections, nine strains had an unlinked suppressor 
mutation that segregated in a 2:2 fashion. Spore colonies of each were backcrossed with 
BY4741 or BY4742 six times and a nonmutated mec1-W2368A strain three times at each 
stage, selecting for temperature resistant spore colonies. The final isolates were sent for 
genomic sequencing as described below. The rpn3 mutation was verified after isolation 
of genomic DNA, PCR with oligonucleotides 6510-1 and 6510-2 (Table 2) and 
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sequencing of the PCR product using oligonucleotide 6510-1 as primer.  
2.2.9 Genomic sequence analysis 
Genomic DNAs were prepared from CY6076, CY6077 and four sister spore colonies 
from the final backcross of each of suppressor strains as described previously 55. The 
DNAs from CY6076 and CY6077 were pooled, as were those from each of the identical 
suppressor strains, and 5 µg of DNA from each pooled sample was sent to the 
Biodiversity Research Centre (University of British Columbia; Vancouver, Canada) for 
DNA library construction and next-generation sequencing using 100 base pair paired-end 
reads with the Illumina HiSeq 2000 platform. The Saccharomyces cerevisiae genome 
sequence was downloaded from the Saccharomyces Genome Database (SGD; 
http://www.yeastgenome.org) on March 24, 2011. Custom bash and Perl scripts were 
written for the sequencing analysis. The program Bowtie 67, allowing up to three 
mismatches per read, was used to map the reads to each chromosome of the yeast genome 
and output mapped reads in SAM format (Sequence Alignment/Map; 68). The VCF 
(variant call format) from SAMtools 68 was used to obtain a raw list of polymorphisms 
from the mapped reads. Those reads with a Phred quality score below 20 were eliminated 
to obtain a filtered list of polymorphisms. A custom Perl script was written to identify 
those polymorphisms that were unique to the suppressor strain. 
2.3 Results 
The penultimate and terminal amino acid residues of the PIKK molecules are 
hydrophobic in family members (Figure 2.1A). Changing the terminal phenylalanine of 
Tra1 to alanine (tra1-F3744A) results in stress-related phenotypes and partial 
mislocalization of the protein to the cytoplasm 55. This mutation was suppressible by a 
F328S change in the chaperone component Tti2. A similar mutation in the terminal 
tryptophan of Mec1 (Mec1-W2368A) results in temperature sensitive growth, but is not 
suppressible by tti2-F328S 55. Here we characterize Mec1 derivatives, altered at their C-
terminus to determine if the FATC domain has a general role in stability of PIKK family 
members. For these studies we constructed strains that express a genomically encoded 
allele with either five tandem copies of the Flag epitope (Flag5) or eGFP tag positioned at 
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(A) Conservation of hydrophobic residues at the C-terminus of PIKK family members. 
The C-terminal residues of the five PIKK family members found in S. cerevisiae are 
shown with the consensus below. (B) Yeast strains BY4741 (MEC1; WT), CY6076 
(mec1-W2368A), CY6194 (Flag5-MEC1), CY6175 (Flag5-mec1-W2368A), a mec2-1 
strain 235 (included to verify the hydroxyurea plates), CY6307 (GFP-MEC1), and 
CY6302 (GFP-mec1-W2368A) were grown to stationary phase diluted 1/102 and ten-fold 
serial dilutions spotted onto selection plates as follows: YPD at 30°C, YPD at 37°C, and 
YPD at 30°C containing 0.2 M hydroxyurea (HU). 
Figure 2.1: Phenotype of Flag5 and GFP-tagged MEC1 strains 
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the N-terminus. As shown in Figure 2.1B, neither the Flag5 nor eGFP-tag alters growth of 
a strain with the otherwise wild-type allele in YPD media at 30°C, 37°C or in the 
presence of 0.2 M hydroxyurea, a competitive inhibitor of ribonucleotide reductase 
(compare WT with Flag5-WT and GFP-WT). Growth of a strain with the mec1-W2368A 
allele was also examined. The mec1-W2368A strain was sensitive to hydroxyurea and as 
shown previously 55, was temperature sensitive. Neither Flag5 nor eGFP-tags decreased 
the growth of the mec1-W2368A strain under these conditions.  
Four additional mec1 alleles were constructed and integrated into a diploid strain. 
mec1-Δ1, mec1-Δ2 , mec1-Δ3 contain deletions of 1, 2 or 3 residues at the C-terminus of 
Mec1 (Figure 2.2A). Three deletions were constructed to decrease the likelihood that the 
C-terminal carboxyl might be artificially repositioned in a hydrophobic pocket in all of 
the derivatives. Mec1-2369G contains an additional glycine residue at the C-terminus. A 
comparable addition to Tra1 results in inviability 54. After sporulation there was a 2:2 
segregation of viable and inviable spore colonies for each, indicating that insertion or 
deletions to the C-terminus of Mec1 compromise viability.  To determine if the C-
terminal mutations affect expression of Mec1, diploid strains containing a single copy of 
Flag5-tagged wild-type or mutant Mec1, and an untagged wild-type allele, were analyzed 
by western blotting. As shown in Figure 2.2B, all of the mec1 alleles were expressed 
when cells were grown at 30°C. Flag5-Mec1-W2368A and Flag5-Mec1-2369G were 
found at near wild-type levels. The deletion proteins were somewhat reduced, with the 
reduction paralleling the extent of the deletion. We also examined if the different mec1 
alleles interacted with Lcd1/Ddc2 (ATRIP in mammalian cells), an association required 
for the checkpoint functions of Mec1 70-72. Immunoprecipitations were performed with 
anti-Flag antibody and extracts prepared from strains containing myc9-tagged Lcd1/Ddc2 
and a Flag5-tagged Mec1 derivative. As shown in Figure 2.2C, the ratio of myc9-tagged 
Lcd1/Ddc2 to Flag5-Mec1 was similar for each of the derivatives, indicating that 
Lcd1/Ddc2 interacted with Mec1-W2368A, Mec1-Δ1, and Mec1-G2369 as efficiently as 
the wild type protein. 
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(A) Amino acid sequences of the Mec1 derivatives. (B) Yeast strains CY6172 (Flag5-
MEC1; lanes 1 and 2), CY6192 (Flag5-mec1-W2368A; lanes 3 and 4), CY6184 (Flag5-
mec1-Δ1; lanes 5 and 6), CY6250 (Flag5-mec1-Δ2; lanes 7 and 8), CY6233 (Flag5-mec1-
Δ3; lanes 9 and 10), CY6203 (Flag5-mec1-2369G; lanes 11 and 12), and BY4743 (lane 
13) were grown in YPD media to mid-log phase and extracts prepared by grinding in 
liquid nitrogen. Extracts were solubilized in the presence of protease inhibitors (1.0 mM 
phenylmethylsulfonyl fluoride, 5µg/ml pepstatin, 1.0 mM benzamidine, 50 µg/ml trypsin 
inhibitor and 5 µg/ml leupeptin).  50 µg and 10 µg of protein was separated by SDS-
PAGE; 50 µg for BY4743. The top portion of the gel was western blotted with anti-Flag 
(M2) antibody; the bottom portion was stained with Coomassie Brilliant Blue. (C) 
Interaction with Lcd1/Ddc2. Three mg of protein extract from yeast strains CY6172 
(Flag5-MEC1; lanes 1 and 2), CY6192 (Flag5-mec1-W2368A; lanes 3 and 4), CY6184 
(Flag5-mec1-Δ1; lanes 5 and 6), CY6203 (Flag5-mec1-2369G; lanes 7 and 8), and 
BY4743 (lane 9) containing YCplac111-myc9-Lcd1 were immunoprecipitated with anti-
Flag antibody. Twenty (odd numbered lanes) and 5 µl of the immunoprecipitates were 
separated by SDS-PAGE and western blotted with anti-Flag antibody (top panel) or anti-
myc antibody (lower panel). 
 
2.3.1 The terminal residues of Mec1 are required for full kinase 
activity 
As the phenotypes of the Mec1 derivatives were not due to their lack of expression or 
reduced interaction with Lcd1, we performed in vitro kinase assays to determine if this 
activity was impaired. We assayed the activity of Flag5-tagged Mec1, Mec1-Δ1, Mec1-
Δ2, Mec1-Δ3, Mec1-2369G and Mec1-W2368A after isolating the proteins by 
immunoprecipitation on Flag-antibody resin from diploid yeast strains. The 
immunoprecipitates of the Flag5-tagged proteins used in the kinase assays are shown in 
Figure 2.3A. Kinase assays were performed with rat 4E-BP1 (PHAS-1) as the substrate 
Figure 2.2: Expression of Mec1 derivatives with C-terminal mutations 
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239, 240. The results for an assay performed at 30° are shown in Figure 2.3B. 
Immunoprecipitates from a strain wild-type for MEC1, but without tagged protein 
(BY4743; lane1), and from CY6172 (Flag5-tagged Mec1; lane 10) in the absence 4E-
BP1, were performed to control for nonspecific phosphorylation and to identify 4E-BP1, 
respectively. Phosphorylation of 4E-BP1 was 7.5-fold greater than background with the 
wild-type protein (Figure 2.3B, compare lanes 1 and 2). Interestingly, phosphorylation by 
Flag5-Mec1-W2368A was less than 10% of that found for the wild-type protein (Figure 
2.3B, compare lanes 2 and 9). Although 4E-BP1 is not necessarily indicative of all native 
Mec1 substrates, this result suggests that only low levels of kinase activity are essential 
for viability in rich media. Phosphorylation of 4E-BP1 was not above background levels 
for Mec1-2369G (lane 8), likely explaining the inviability of the strain containing this 
derivative. Similarly, the kinase activity of the Mec1 deletion derivatives (lanes 5-7) was 
not above background, though exact comparison with the wild type protein was difficult 
because of their somewhat reduced abundance in the immunoprecipitates. 
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(A) Protein extracts were prepared from yeast strains CY6172 (Flag5-MEC1; lanes 1 and 
2), CY6192 (Flag5-mec1-W2368A; lanes 3 and 4), CY6184 (Flag5-mec1-Δ1; lanes 5 and 
6), CY6250 (Flag5-mec1-Δ2; lanes 7 and 8), CY6233 (Flag5-mec1-Δ3; lanes 9 and 10), 
CY6203 (Flag5-mec1-2369G; lanes 11 and 12), and BY4743 (lane 13), in the presence of 
protease inhibitors. Two milligrams of protein from CY6192 and 4 mg from the other 
strains was immunoprecipitated. One-third of the beads was suspended in 100 µl of 1x-
SDS loading buffer, boiled and 10 or 5 µl separated by SDS-PAGE (5% gel) and western 
blotted with anti-Flag antibody. The BY4743 sample contained 10 µl of bead suspension. 
(B) Phosphorylation assays. Two-thirds of the immunoprecipitate in part A was 
suspended in 60 µl of kinase buffer. Aliquots (8, 4 and 2 µl for wt, 8 µl of the other 
samples) were used in kinase assays at 30°C with 4E-BP1 as substrate (with the 
exception of lane 10 which contained buffered glycerol). Lane 1, BY4743; lanes 2-4 and 
10, CY6172 (Flag5-MEC1); lane 5, CY6184 (Flag5-mec1-Δ1); lane 6, CY6250 (Flag5-
mec1-Δ2); lane 7, CY6233 (Flag5-mec1-Δ3); lane 8, CY6203 (Flag5-mec1-2369G); lane 
9, CY6192 (Flag5-mec1-W2368A). Reactions were stopped with 3x-SDS loading buffer 
and protein separated on a 15% Tris-Tricine gel. The gel was fixed, and processed as 
described in Materials and Methods. Lane 10 was analyzed on the same gel but moved 
proximal to the other samples. 
 
Figure 2.3: The terminal residues of Mec1 are required for its kinase activity 
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2.3.2 The terminal tryptophan is required for stability and 
localization of the protein 
Based on the properties of Tra1 derivatives with C-terminal mutations 55, we predicted 
that the lack of kinase activity found for the Mec1 derivatives might result from improper 
folding of the molecules. The Mec1-W2368A, 2369G and Δ1 derivatives were found 
within cells at levels approaching the wild-type when extracts were prepared with 
protease inhibitors and analyzed directly after isolation (Figure 2.2B). Predicting that the 
C-terminus was required for stability of the protein, we addressed whether the Mec1 
derivatives would be susceptible to proteolysis in the absence of protease inhibitors. 
Protein was isolated from diploid strains containing Flag5 derivatives of Mec1, Mec1-
2369G, Mec1-W2368A and Mec1-Δ1. The extract was then incubated at 30°C for 10 
minutes or two hours, and aliquots analyzed by western blotting (Figure 2.4). The wild-
type protein was very stable in extracts with no obvious degradation in two hours. In 
contrast, each of the Mec1 derivatives showed some sign of degradation at the 10-minute 
time point.  
As another measure of whether the Mec1 derivatives were present in their 
functional forms, we performed size exclusion chromatography on extracts prepared from 
strains containing Flag5-tagged versions. As shown in Figure 2.5, wild-type Mec1 elutes 
from a Superose 6 column with an estimated mass of less than ~670 kDa. A portion of 
each of the mutant versions eluted from the column in a fraction with a significantly 
greater estimated mass, with none of the profiles paralleling the wild type. Mec1-2369G 
had a distinct profile in that it was dispersed almost equally across the high molecular 
mass fractions. The presence of the higher mass forms suggests the possibility of 
improper folding of the Mec1 derivatives, or perhaps prolonged association with 
chaperone complexes that are required for the formation of functional PIKK proteins 75, 
76.  
We also examined the localization of N-terminally eGFP-tagged versions of the 
proteins. Diploid strains expressing wild-type Mec1 and a single copy of eGFP-tagged 
Mec1 or a derivative were grown at 30°C. RFP-tagged Nic96 was used to mark the 
nuclear periphery. As shown in Figure 2.6, eGFP-tagged wild-type Mec1 is found   
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Yeast strains CY6172 (Flag5-MEC1; lanes 1-3), CY6203 (Flag5-mec1-2369G; lanes 4-6) 
CY6192 (Flag5-mec1-W2368A; lanes 7-9) and CY6184 (Flag5-mec1-Δ1; lanes 10 and 
11) were grown in YPD media to mid-log phase and extracts prepared by grinding with 
glass beads in the absence of protease inhibitors. Extracts were then incubated at 30°C for 
the indicated time period, 50 µg of protein from each extract was separated by SDS-
PAGE and western blotted with anti-Flag antibody. The lower panel (CBB) is the lower 
portion of the gel after staining with Coomassie Brilliant Blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: The terminal residues of Mec1 are required for its stability in extracts 
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Protein extracts were prepared from yeast strains CY6172 (Flag5-MEC1), CY6192 
(Flag5-mec1-W2368A), CY6184 (Flag5-mec1-Δ1), CY6233 (Flag5-mec1-Δ3), and 
CY6203 (Flag5-mec1-2369G). 4.5 mg of protein from each strain was separated 
independently on a 24 ml FPLC Superose 6HR10/30 column (Amersham Pharmacia 
Biotech.). Protein from 20 µl aliquots of 250 µl fractions was resolved by SDS-PAGE 
and proteins detected by western blotting. The amount of protein in each fraction was 
determined by densitometry and calculated as a ratio of the total protein. The plot shows 
the average of a three-fraction window. The arrows indicate the migration of 670 and 158 
kDa molecular mass standards. 
 
  
Figure 2.5: Resolution of Mec1 derivatives by size exclusion chromatography 
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principally in the nucleus. The distribution of each of Mec1-W2368A, Mec1-2369G, 
Mec1-Δ1 and Mec1-Δ2 is more disperse with both nuclear and cytoplasmic localization 
apparent. The experiment was also performed for cells grown at 37°C, but the signal was 
significantly reduced for the Mec1 derivatives.  
 
 
 
 
 
Diploid yeast strains containing an eGFP-tagged Mec1 derivative (CY6307, Mec1; 
CY6302, Mec1-W2368A; CY6330, Mec1-Δ1; CY6344, Mec1-Δ2 and CY6342, Mec1-
2369G) were mated to a strain containing RFP-tagged Nic96 62. Diploid strains were 
grown at 30°C in synthetic complete (SC) media to stationary phase, diluted 1:20 in SC, 
grown a further six hours and visualized by fluorescence microscopy. A representative 
field of cells is shown.  
 
 
Figure 2.6: Localization of eGFP-Mec1 
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2.3.3 rpn3-L140P suppresses the temperature sensitive growth of 
mec1-W2368A 
Together the above results suggested that the C-terminal residues of Mec1 were required 
for the folding/stability of the molecule. If this was the case we predicted that it should be 
possible to identify second site suppressor mutations that restored the levels of the protein 
and allowed growth of the mec1-W2368A strain at 37°C. We plated approximately twenty 
million cells at a density of one million cells per plate, subjected them to a low dose of 
ultraviolet radiation, and selected colonies that grew at 37°C. Nine colonies were 
identified that carried a single extragenic suppressor mutation. These were backcrossed 
an additional nine times to eliminate variations unlinked to the suppressor mutation, and 
then their genomic sequence determined. Unique mutations were identified in four of the 
strains. These were: rpn3 (L140P; a T to C transition at base pair 419; Figure 2.7A), rfx1 
(S213N), rfx1 (S462L), and sml1 (L62ochre). Loss of function of Sml1 and Rfx1 are 
known to suppress nonfunctional alleles of mec1 24, 69, 77. In this regard, loss of the RNR 
inhibitor Sml1 or loss of the negative regulator of RNR transcription Rfx1 augment RNR 
activity resulting in increased dNTP levels which overcome the loss of Mec1. Consistent 
with these being causative mutations we found that our sml1 and rfx1 strains would also 
suppress mec1-Δ1. In contrast, the rpn3-L140P allele would not suppress mec1-Δ1, mec1-
Δ2 or mec1-2369G.  
As Rpn3 encodes a component of the 19S proteasomal regulatory particle 78, thus 
potentially linking it to the stability of Mec1, we chose to examine rpn3-L140P in greater 
detail. The strain containing this mutation grew at 37°C, at a level comparable to a wild-
type strain, and the mutation responsible did so in a partially dominant fashion (Figure 
2.7B). The suppressor mutation did not facilitate growth on plates containing 0.2 M 
hydroxyurea, but rather resulted in a further reduction of growth (Figure 2.7C). Two 
approaches were used to demonstrate that suppression of mec1-W2368A was the result of 
rpn3-L140P. First, we compared the partially dominant effect of rpn3-L140P/RPN3 as 
shown in Figure 2.7B, with the ability of rpn3-L140P inserted into CY6076 (mec1-  
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(A) Sequence of RPN3 and the rpn3-L140P allele. (B) Yeast strains BY4742 (MEC1 
RPN3), CY6077 (mec1-W2368A RPN3), CY6265 (mec1-W2368A rpn3-L140P), BY4743 
(MEC1/MEC1 RPN3/RPN3), CY6368 (mec1-W2368A/mec1-W2368A) and CY6385 
(mec1-W2368A/mec1-W2368A RPN3/rpn3-L140P) were grown to stationary phase 
diluted 1/102 and ten-fold serial dilutions spotted onto YPD plates at 30°C and 37°C. (C)  
Serial dilutions of BY4742, CY6077 and CY6265 were spotted onto a YPD plate 
containing 0.2 M hydroxyurea. A mec2-1 strain was included to verify the quality of the 
hydroxyurea. (D) Serial dilutions of BY4741, CY6076 (mec1-W2368A RPN3) and 
CY6465 (mec1-W2368A RPN3/rpn3-L140P-URA3) were spotted onto YPD plates at 
30°C and 37°C. 
  
Figure 2.7: Suppression of the temperature sensitive growth resulting from 
mec1-W2368A by rpn3-L140P 
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W2368A) on an integrating plasmid (Figure 2.7D). As was found for the heterozygous 
diploid, addition of the rpn3-L140P-containing plasmid partially, but not completely, 
reversed the slow growth at 37°C due to mec1-W2368A. Second, we analyzed 
independent spore colonies from a cross of CY6265 (rpn3-L140P mec1-W2368A) and 
CY6076 (RPN3 mec1-W2368A). The RPN3 allele from each spore colony was isolated 
by PCR and sequenced. For 14 alleles (7 fast growing strains and 7 slow growing 
strains), the fast growth predicted the presence of the rpn3-L140P allele.  
Rpn3 is an essential 524 amino acid residue protein that contains PAM (PCI/PINT 
associated module) and winged helix domains located C-terminally distal to residue 140. 
As shown in Figure 2.8A and B, L140 is in a hydrophobic region conserved in fungal 
species and more broadly in eukaryotes. The L140P mutation does not alter the level of 
Rpn3 found in the cell (Figure 2.8C). To determine the effect of Rpn3-L140P in isolation, 
yeast strain CY6398 (MEC1 rpn3-L140P) was engineered by backcrossing CY6265 with 
BY4741. As shown in Figure 2.8D, the rpn3-L140P allele had no detectable effect on 
growth of cells in rich media at 30°C. A very slight reduction in growth was observed for 
cells grown at 37°C and in media containing the arginine analog canavanine.  
As mentioned above, rpn3-L140P does not suppress mec1-Δ1, mec1-Δ2 or mec1-
2369G. To address whether rpn3-L140P would suppress a mutation similar to mec1-
W2368A in a related PIKK protein we introduced rpn3-L140P into a strain containing a 
Phe to Ala change of the terminal phenylalanine of Tra1 (tra1-F3744A). As shown in 
Figure 2.8E, rpn3-L140P did not suppress the slow growth at 37°C or in ethanol-
containing media caused by tra1-F3744A, and in fact resulted in synthetic slow growth in 
this context. 
The terminal tryptophan to alanine mutation in Mec1 reduced the stability of the 
protein (Figure 2.4). To investigate the effect of rpn3-L140P on Mec1-W2368A, the 
diploid strain CY6400 with the genotype Flag5-mec1-W2368A/MEC1 rpn3-L140P/rpn3-
L140P was engineered. The level of Flag5-Mec1 in this strain was compared to that found 
in a wild-type RPN3/RPN3 background (Figure 2.9A). For extracts prepared from cells  
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(A) Multiple sequence alignment of Rpn3 from a variety of fungal species. Leucine 140 
(S. cerevisiae) is indicated by an asterisk. The alignment was performed with MUSCLE 
79. In order, the proteins are: Aspergillus nidulans, XP_660371.1; Saccharomyces 
cerevisiae, NP_010938.1; Candida glabrata, XP_447606.1; Kluyveromyces lactis, 
XP_453544.1; Zygosaccharomyces rouxii, XP_002496514.1; Lachancea thermotolerans, 
XP_002554976.1; Ashbya gossypii, NP_983112.1; Lodderomyces elongisporus, 
XP_001526739.1; Pichia guilliermondii, XP_001487379.1; Scheffersomyces stipitis, 
XP_001383755.2. (B) Multiple sequence alignment of Rpn3 from a variety of eucaryotes. 
The proteins are Schizosaccharomyces pombe, NP_595282.2; Drosophila melanogaster, 
NP_477300; Xenopus laevis, NP_001085955.1; Mus musculus, NP_033465.1; Homo 
sapiens, NP_002800.2. (C) Expression of Rpn3-L140P. Extracts were prepared from 
BY4741 expressing myc9-Rpn3 (lanes 1-3) or myc9-Rpn3-L140P from a centromeric 
plasmid. 50, 25 and 10 µg of protein was separated by SDS-PAGE and western blotted 
with anti-Myc antibody (upper panel). The lower section of the gel was stained with 
Coomassie Brilliant Blue (lower panel). (D) Phenotype of rpn3-L140P in isolation. Yeast 
strains BY4741 (RPN3) and CY6398 (rpn3-L140P) were grown to stationary phase and 
serial dilutions spotted onto YPD plates at 30°C and 37°C, and onto a minimal plate 
containing 1.0 mg/l canavanine. (E) rpn3-L140P does not suppress tra1-F3744A. Yeast 
strains CY4353 (TRA1 RPN3), CY4350 (tra1-F3744A RPN3) and CY6418 (tra1-F3744A 
rpn3-L140P) were grown to stationary phase and serial dilutions spotted onto YPD plates 
at 30°C and 37°C, or a YPD plate containing 6% ethanol at 30°C. 
 
 
 
 
Figure 2.8: Leucine 140 is found in a conserved hydrophobic region 
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grown at 30°C and in the absence of protease inhibitors, the level of Mec1-W2368A was 
somewhat reduced relative to the wild-type (Figure 2.9A, compare lanes 1 and 2). rpn3-
L140P resulted in an increase in Mec1-W2368A (Figure 2.9A, compare lanes 2 and 3). 
For extracts prepared from cells grown at 37°C, the level of Mec1-W2368A was further 
reduced relative to the wild-type (Figure 2.9A, compare lanes 5 and 6), with rpn3-L140P 
resulting in a dramatic increase (Figure 2.9A, compare lanes 6 and 7). We conclude that 
rpn3-L140P acts to stabilize Mec1-W2368A, thus facilitating growth at elevated 
temperature. As shown in Figure 2.9B, rpn3-L140P acts more broadly, increasing the 
level of Mec1-2369G when cells are grown at 37°C.  
The suppression of mec1-W2368A by rpn3-L140P introduces the possibility that 
Mec1 turnover is mediated by its degradation by the proteasome. To begin to address this 
issue, we analyzed Flag5-tagged Mec1 and Mec1-W2368A in cells treated with the 
proteasome inhibitor MG-132. Cells were treated under conditions described by Liu et al. 
229 to increase their permeability to MG-132. As shown in Figure 2.9C, when grown in 
media containing proline as the nitrogen source and 0.003% SDS, yeast are sensitive to 
MG-132 in low micromolar concentrations. For the analysis of Mec1 and Mec1-
W2368A, extracts were prepared from cells grown at 37°C in the presence or absence of 
75 µM MG-132 for 2 hours.  Wild-type Mec1 was not altered by the MG-132 treatment 
(Figure 2.9D, compare lanes 1 and 2). In contrast, Mec1-W2368A levels increased 
approximately two-fold upon treatment (Figure 2.9D, compare lanes 4 and 5) suggesting 
that the proteasome contributes at least in part to the protein's turnover. For neither the 
wild-type nor Mec1-W2368A proteins was there evidence of higher molecular mass 
forms that would be indicative of ubiquitylation of the protein. 
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(A) Mec1-W2368A. Protein extracts were prepared by bead lysis in buffer lacking 
protease inhibitors from diploid yeast strains CY6172 (MEC1/Flag5-MEC1 
RPN3/RPN3), CY6192 (MEC1/Flag5-mec1-W2368A RPN3/RPN3), CY6400 
(MEC1/Flag5-mec1-W2368A rpn3-L140P/rpn3-L140P) and BY4743 (MEC1/MEC1 
RPN3/RPN3) grown at 30°C or 37°C. 50 µg of protein was separated by SDS-PAGE and 
the upper portion of the gel western blotted with anti-Flag antibody. The lower part of the 
gel was stained with Coomassie Brilliant Blue (CBB). (B) Mec1-2369G. Yeast strains 
CY6349 (mec1-2369G RPN3 sml1Δ0::KanMX; lanes 1 and 2) and CY6449 (mec1-2369G 
rpn3-L140P sml1Δ0::KanMX; lanes 3 and 4) were grown in YPD media for eight hours 
at 37°C. 40 (odd lanes) and 20 µg (even lanes) of protein extract was separated by SDS-
PAGE and western blotted with anti Flag antibody or stained with Coomassie Brilliant 
Blue. (C) BY4742 was grown in media containing proline as the nitrogen source and 
0.003% SDS for three hours then serial dilutions plated onto identical synthetic complete 
media with the indicated amount of MG-132. (D) CY6172 (MEC1/Flag5-MEC1; lanes 
1and 2), BY4743 (lane 3), and CY6192 (MEC1/Flag5-mec1-W2368A; lanes 4-7) were 
grown in media containing proline as the nitrogen source and 0.003% SDS for three 
hours at 37°C. MG-132 was added to a final concentration of 75 µM (+) or the equivalent 
volume of dimethylsulfoxide (-) and the cells grown for an additional 2 hours. Extracts 
were prepared by glass bead lysis and 30 µg separated by SDS-PAGE. The upper portion 
of the gel was western blotted with anti-Flag antibody. The lower portion was stained 
with Coomassie Brilliant Blue. Lanes 6 and 7 are an overexposure of lanes 4 and 5.   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: rpn3-L140P increases the level of C-terminally altered Mec1 derivatives 
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2.4 Discussion 
The FATC domain is found at the C-terminus of all the PIKK proteins. In each, the two 
most C-terminal residues are large and hydrophobic. We have shown that the terminal 
tryptophan residue of Mec1 is required for the function of the protein. Deletion of this 
residue results in a loss of viability; conversion to alanine results in temperature sensitive 
growth and reduced growth in hydroxyurea, a condition where deoxyribonucleotides are 
depleted. Moreover, the position of the terminal tryptophan is essential. Addition of a 
single glycine residue also results in loss of viability. As these results parallel those found 
for Tra1 55, we conclude that the terminal residues are likely a key feature of all the PIKK 
proteins, a conclusion consistent with the positioning of the FATC domain in the 
structure of mTOR 49. 
 We propose that at least one role for the terminal residue is to assist in the folding 
of the protein. The C-terminally deleted Mec1 proteins were less abundant in crude 
protein lysates, and all of the derivatives analyzed were unstable in cell extracts prepared 
in the absence of protease inhibitors. This suggests that the temperature sensitive 
phenotype of the mec1-W2368A strain may result from decreased stability of the protein 
at elevated temperature, a conclusion supported by the increased levels found in the rpn3-
L140P strain or in the presence of MG-132. Also suggesting the possibility of misfolding, 
we found that whereas wild-type Mec1 was found almost exclusively in the nucleus, the 
partially active and inactive forms of the protein showed partial cytoplasmic localization. 
In addition, each of the mutant forms of Mec1 chromatographed aberrantly on a size 
exclusion column. Structural models 2, 48, 49 position the FATC domain in a hydrophobic 
pocket that in porcine PI3K-γ interacts with helical domains 80. Loss of hydrophobic 
interactions may decrease the stability of the PI3K domain, while addition of a glycine 
residue may not permit packing into the pocket. In both cases, the FATC domain and the 
core PI3K domain would be susceptible to proteolysis. 
Our results with Mec1 closely parallel what we have observed with Tra1 54. In the 
case of Tra1, converting the terminal phenylalanine to alanine results in mislocalization, 
decreased protein levels and a number of stress related phenotypes. Consistent with a role 
for the FATC domain in folding, alleles of tti2, whose product with Tel2 and Tti1 is 
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proposed to act as a chaperone 57-60, suppress tra1-F3744A in a partially dominant fashion 
55. It was interesting that both Tra1-F3744A and Mec1-W2368A are mislocalized. 
Whether the other properties of the Mec1 and Tra1 derivatives result from or cause the 
mislocalization will require additional experimentation; however, our working model is 
that the molecules need to be specifically localized in the cytoplasm in complex with 
chaperones until they achieve a conformation that will support nuclear import, and if 
diverted from this pathway are at risk of being degraded.  
 Mutation of the terminal residue of Mec1 to alanine diminished kinase activity to 
a level approximately 10-fold less than the wild-type protein. The decrease in kinase 
activity of Mec1-W2368A and the other Mec1 derivatives can be explained by a role for 
the terminal residues in folding, and their possible participation in substrate recognition 
as found for mTOR 49. As mec1-W2368A will support viability, minimal kinase activity 
must be sufficient for growth under optimal conditions. In media containing hydroxyurea, 
where replication fork collapse will increase, this same level of activity was insufficient. 
It is also this requirement for maximal levels of Mec1 activity during replicative stress 
that likely explains why rpn3-L140P would not suppress slow growth of the mec1-
W2368A strain in hydroxyurea. We note that interpretation of this experiment is 
somewhat complicated because of the role of Rpn3 in aspects of cell cycle control 81.  
Lcd1/Ddc2 interacts with the N-terminal HEAT domain sequences of Mec1 71, 
thus providing a rationale for why it interacted with each of the altered Mec1 proteins 
with approximately the same efficiency. As some of these derivatives are partially 
excluded from the nucleus, this result suggests that the Mec1-Lcd1/Ddc2 interaction 
takes place in the cytoplasm.   
We have shown that a mutation resulting in a change of leucine 140 to proline in 
Rpn3 suppresses the temperature sensitive growth of a mec1-W2368A strain. Rpn3 is a 
component of the 19S regulatory particle of the 26S proteasome 82-85. The regulatory 
particle can be subdivided into a base and lid. The base, composed of ten components, 
interacts directly with the 20S proteolytic core particle, and contains ATPases (Rpt1-6) 
required for the unfolding of substrate proteins 86-88. In addition to Rpn3, the lid contains 
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Rpn5–Rpn9, Rpn11, Rpn12, and Sem1. The 26S proteasome is the key enzymatic 
machinery required to degrade ubiquitylated proteins, either misfolded or short-lived, in 
the cell (reviewed in 89). Though the exact role of Rpn3 is unknown, the lid is involved 
in recognizing ubiquitylated target proteins 90-92 and removing the ubiquitin chains prior 
to the protein’s degradation by the 20S proteolytic core particle 93.  Also of note, 
independent functions for the 19S regulatory particle have been observed in nucleotide 
excision repair 94, 95 and transcription 96-99. 
We have considered possible models for how rpn3-L140P may suppress mec1-
W2368A. It is unlikely that Rpn3-L140P acts indirectly by altering the DNA damage 
response as is seen with loss of function of Sml1 or Rfx1, because of the observed allele 
specificity and the increased levels of Mec1-W2368A in the rpn3-L140P background. 
Models for how rpn3-L140P suppresses the temperature sensitivity of mec1-W238A need 
to reflect the role of the terminal sequences in the folding, localization and/or stability of 
the protein. We present two models that are not mutually exclusive. Key in these is that 
rpn3-L140P increases the level of Mec1-W2368A, and does so more for Mec1-W2368A 
than wild-type Mec1, and also more at 37°C than 30°C. First, the proteasomal regulatory 
particle has chaperone activities that normally participate in the delivery of the protein 
target to the 20S core particle 100. Independently, this activity could aid in the folding of 
Mec1-W2368A at elevated temperature and be enhanced by Rpn3-L140P. This model 
would account for the partial dominance of the rpn3-L140P allele, and be analogous to 
the suppression of tra1-F3744A by alleles encoding the chaperone component Tti2. 
Interestingly, the same tti2 alleles do not suppress mec1-W2368A 55, and loss of 
interactions with the TTT-component Tel2 only modestly affects Mec1 function 101, 
leaving the possibility that another chaperone may replace or augment their activity. In 
the second model, the proteasome is involved in the turnover of improperly folded or 
mislocalized Mec1-W2368A. Subtle changes in targeting or activity of the proteasome 
caused by the L140P substitution in Rpn3 could decrease the rate of turnover affording 
additional time for Mec1-W2368A to fold into a stable conformation or be correctly 
localized. The rpn3 allele would have partial dominance by altering the activity of half of 
the proteasome particles. We favor this model because inhibiting the proteolytic activity 
of the proteasome with MG-132 also increased the level of Mec1-W2368A. In addition, 
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the L140P mutation is in a highly conserved region of the protein, suggesting a functional 
role. While the phenotypes attributable to rpn3-L140P were not severe under most 
conditions, it does result in synthetic slow growth in combination with tra1-F3744A and 
reduced growth in combination with mec1-W2368A in media containing hydroxyurea. 
We did not observe an obvious loss of mobility of Mec1-W2368A in any of our western 
blots that would be indicative of Mec1 polyubiquitylation, the general signal for targeting 
to the proteasome. The model is actually simplified in the absence of Mec1-W2368A 
ubiquitylation since it is less likely that polyubiquitylated Mec1-W2368A could be 
restored to an active form. The question would remain, however, of how Mec1-W2368A 
might be targeted to the proteasome. Examples exist of proteasomal targeting that do not 
require direct ubiquitylation, but rather being mediated by a second molecule, which in 
some cases is ubiquitylated 102-106. Due to the nature of the role of Rpn3 in the 
proteasome, we cannot exclude a third model whereby rpn3-L140P acts indirectly by 
altering the level or activity of an intermediary protein. 
The rpn3-L140P mutation suppressed some (growth at 37°C) but not all (growth 
in hydroxyurea) phenotypes resulting from mec1-W2368A. We believe that this can be 
attributed to the threshold of Mec1 activity required for growth in hydroxyurea being 
greater than for growth at 37°C. In turn, this suggests that Rpn3-L140P is not sufficient to 
increase the activity of Mec1-W2368A above this threshold. We have considered whether 
Rpn3-L140P is able to increase the kinase activity of Mec1-W2368A by analyzing the 
activity of Flag5-tagged Mec1-W2368A isolated by immunoprecipitation from wild-type 
RPN3 and rpn3-L140P strains. The experiment was performed with cells grown at 30°C, 
where the control mec1-W2368A RPN3 strain is able to grow. After normalizing to the 
amount of Mec1-W2368A present, an increase in activity was not observed for the 
protein from the rpn3-L140P strain (Figure 2.10). This result is consistent with rpn3-
L140P suppressing mec1-2368A by increasing the level and localization of Mec1-
W2368A protein rather than by increasing its per molecule activity. 
As indicated above, the 19S regulatory particle has a role in transcriptional 
regulation. Rpn3-L140P could thus increase the level of active Mec1-W2368A by 
activating its transcription; however, several points argue against this. Of particular note,  
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Protein extracts were prepared by bead lysis in buffer containing protease inhibitors from 
strains CY6194 (Flag5-MEC1 RPN3), CY6175 (Flag5-mec1-W2368A RPN3) and 
CY6391 (Flag5-mec1-W2368A rpn3-L140P) grown at 30°C. Two milligrams of protein 
was immunoprecipitated with anti-Flag M2 magnetic beads. Two-thirds of the 
immunoprecipitate was suspended in 60 µl of kinase buffer. Aliquots of four microliters 
were used in kinase assays performed at 30°C with 4E-BP1 as substrate. Shown is the 
amount of 4E-BP1 phosphorylation normalized to Mec1 protein levels. Error bars 
represent the mean ± SD of three replicates.  
 
 
 
 
 
 
 
 
 
 
Figure 2.10: rpn3-L140P does not increase Mec1-W2368A kinase activity 
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the suppression by rpn3-L140P was observed when Mec1-W2368A was expressed from 
both its native promoter, the case for the original selections, and when expressed from the 
TRA1 promoter, the case for the Flag-tagged derivatives. Furthermore, a role in 
transcription would be expected to be manifest by increased protein levels of 
approximately the same magnitude at both 30°C and 37°C. Increased expression was 
greater for cells grown at 37°C where Mec1-W2368A would have greater tendency to 
misfold. The finding that MG-132 mimics rpn-L140P also supports a role for the 
mutation in altering protein turnover rather than transcription. Finally, unlike the ATPase 
encoding genes RPT6 (SUG1) and RPT4 (SUG2), alleles of RPN3 were not identified in 
screens for altered transcriptional regulation 107-109. 
In summary, we have shown that the C-terminus of Mec1 is important for the 
stability of the protein, a feature likely common to the PIKK family. The reduced kinase 
activity of Mec1-W2368A suggests the C-terminal residues participate in the protein’s 
activity, with viability of the mec1-W2368A strain indicating that minimal kinase activity 
is required for growth in rich media. Furthermore, suppression of the temperature 
sensitivity of mec1-W2368A by an allele encoding the proteasome component Rpn3 
implicates the proteasome in regulating Mec1 levels, and Rpn3 as having a key role in 
this function. 
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Chapter 3  
3 Modulation of Mcm2-7 activity by Cdt1 
3.1 Introduction 
The regulation of DNA replication is crucial for genome maintenance. Replication occurs 
once and only once per cell division cycle and is confined to S-phase through several 
mechanisms that prevent re-replication and mistimed initiation. In budding yeast, Mcm2-
7 requires Cdt1 for nuclear import and loading into the pre-RC during the M-G1 
transition 1.  Interestingly, Mcm2-7 exists as a single hexamer in solution, but is loaded 
by ORC, Cdc6 and Cdt1 as a head-to-head double hexamer around double-stranded DNA 
(dsDNA) 2-5. Cdt1 interacts with Mcm2-7 through a conserved motif in the C-terminus of 
Mcm6, while the C-terminus of Cdt1 contains a binding site for Mcm6 6, 7. Point 
mutations in either interaction motif abrogate nuclear import of a Mcm2-7-Cdt1 complex 
8. Fernandez-Cid and colleagues 6 reported that Cdt1 alleviates an autoinhibitory activity 
in Mcm6 to promote stable interaction of Mcm2-7 with ORC/Cdc6 and Mcm2-7 origin 
loading. Recently, the Diffley lab found that a point mutation in the C-terminus of Mcm3 
blocks Mcm2-7-Cdt1 binding to an ORC/Cdc6 complex. Moreover, Mcm3 was shown to 
promote ATP hydrolysis by ORC/Cdc6, which in turn, induced Mcm2-7 release from 
origins in the absence of Cdt1 9. However, an N-terminal Cdt1 deletion mutant that still 
contains the Mcm2-7 interaction domain can be recruited to replication origins, but fails 
to facilitate Mcm2-7 loading 10, 11.  
In this study, we sought to further investigate the role Cdt1 plays in interacting 
with and regulating Mcm2-7. Here, we assembled Mcm2-7•Cdt1 complexes and 
compared its activity to that of Mcm2-7 alone. We show that Mcm2-7•Cdt1 has lower 
ATPase and helicase activity than Mcm2-7. We further show that Cdt1 is required for 
origin loading of Mcm2-7. Moreover, Mcm2-7 dissociates into a Mcm357 subcomplex in 
the absence of ATP and that this subcomplex can bind origins in the absence of Cdt1. We 
propose that Cdt1 acts to negatively regulate Mcm2-7 helicase activity. We also provide 
data to support a role for Cdt1 in stabilizing the Mcm2-7 hexamer. Together, the effects 
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of Cdt1 on Mcm2-7 suggest mechanisms by which Cdt1 may carry out its essential role 
in the initiation of DNA replication. 
3.2 Materials and Methods 
3.2.1 Cloning of Mcm genes 
Each of the MCM genes was amplified from Saccharomyces cerevisiae genomic DNA 
and cloned into pET plasmids as described in Davey et al. 12.  A PKA recognition motif 
was fused to MCM3 as described in Stead et al. 13. 
3.2.2 Purification of Mcms  
Mcm subunits were purified as previously described 12, with the following modifications. 
Mcm2 and Mcm3pk were purified as described in Stead et al. 13. Cell lysis was 
performed using an Avestin Emulsiflex C3 homogenizer. 
3.2.3 Cdt1 purification 
Cdt1 was purified from E. coli cells expressing Cdt1 (12 L) grown to an OD600 0.5-0.6. 
The cells were lysed in Tris/Sucrose (50 mM Tris-HCl, pH 7.5; 10% (w/v) sucrose) 
containing 500 mM NaCl and 2 mM DTT. Insoluble material was removed by 
centrifugation at 27,000 x g for 40 min at 4°C. Ammonium sulfate was added to the 
soluble fraction to a final concentration of 0.3 mg/ml. The precipitate was pelleted by 
centrifugation then resuspended in Buffer A (20 mM Tris-HCl pH 7.5; 10% (v/v) 
glycerol; 2 mM DTT). The protein was dialyzed against Buffer A to a conductivity 
equivalent to 100 mM NaCl and then applied to a 30 ml Fast Flow Q Sepharose column 
equilibrated in Buffer A containing 50 mM NaCl. The column was washed with 150 ml 
of the same buffer and then bound proteins were eluted with a 300 ml, 50 mM to 500 mM 
NaCl gradient in Buffer A. Fractions containing Cdt1, as determined by Coomassie blue-
stained SDS-PAGE, were pooled and dialyzed against Buffer H (20mM Tris-HCl, pH 
7.5; 0.1mM EDTA; 10% Glycerol; 2mM DTT) containing 100 mM NaCl. The protein 
was then applied to a 10 ml Heparin agarose column equilibrated in the same buffer. 
After washing the column with 100 ml Buffer H containing 100 mM NaCl, the bound 
proteins were eluted with a 100 ml, 100-500 mM NaCl gradient in Buffer H. Peak 
85 
 
fractions containing Cdt1 were confirmed by Coomassie blue-stained SDS-PAGE and 
Western blotting, pooled and stored at -80ºC. 
3.2.4 ORC purification 
An E. coli strain that co-expresses all six of the ORC subunits each under the control of 
the T7 RNA polymerase promoter (M.J. Davey, J. Finkelstein and M. O’Donnell, 
unpublished) was grown to an OD600 of 0.5, chilled to 15°C and then induced by addition 
of 1 mM IPTG. After 18-20 h shaking at 15°C, the cells (12 L) were harvested by 
centrifugation and resuspended (10 % w/v) in 20 mM HEPES pH 7.5, 150 mM KCl, 10% 
sucrose, 1 mM PMSF, 1 mM DTT, and 1.5 mM MgCl2. The lysate was centrifuged at 
27,000 xg for one hour and the supernatant was applied to a 40 ml SP Sepharose column 
equilibrated in 20 mM HEPES pH 7.5, 150 mM KCl and 10% (v/v) glycerol and eluted 
with a 400 ml linear gradient of 150 mM to 700 mM KCl in the above buffer. The peak 
fractions, as determined by SDS-PAGE, were pooled (approximately 40 mg in 110 ml) 
and loaded onto a 1 ml Hi-Trap (GE Healthcare) Ni-affinity column equilibrated in 20 
mM HEPES pH 7.5, 400 mM KCl, 5 mM imidazole and 10% (v/v) glycerol. The column 
was then washed with 20 ml of 20 mM HEPES pH 7.5, 400 mM KCl, 60 mM imidazole, 
10% (v/v) glycerol, followed by elution with 20 ml of 20 mM HEPES pH 7.5, 400 mM 
KCl, 1 M imidazole and 10% (v/v) glycerol. The peak fractions, as determined by SDS-
PAGE, were pooled and loaded onto a P-100 (polyacrylamide gel filtration beads) 
column equilibrated in 25 mM Tris pH 8.0, 400 mM KCl, 5mM MgOAc, 10% (v/v) 
glycerol, 0.02% NP-40, and 1 mM DTT. The resulting elution was analyzed by SDS-
PAGE and stained with Coomassie Brilliant Blue R-250. 
3.2.5 Reconstitution of Mcm2-7 complexes 
Mcm2-7 complexes were reconstituted as described in Davey et al. 12 with the following 
exceptions. Two nmol of each protein was mixed and concentrated using an Amicon 
Ultra 10 kDa cutoff device (Millipore) at 4°C to a final volume of 0.2 ml and a 
conductivity equivalent to 350 mM NaCl. The mixture was then incubated at 15°C for 30 
minutes, followed by centrifugation at 16,000 x g for 10 minutes at 4°C. The protein was 
then applied to a 24 ml Superose 6 10/300 GL size exclusion chromatography column 
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(GE Healthcare Life Sciences) equilibrated in Buffer H containing 100 mM NaCl. 
Fractions of 250 µl were collected and analyzed by 8% SDS-PAGE stained with 
Coomassie Brilliant Blue and confirmation of equal stoichiometry determined by 
densitometry using ImageQuant 5.2 software (Molecular Dynamics). Peak fractions were 
also examined for ATPase and DNA unwinding activity as described below. 
3.2.6 DNA binding   
DNA binding assays were performed with radiolabelled Mcm2-73PK as described in Stead 
et al. 13. Two hundred fmol protein sample was incubated with the amount of DNA 
substrate indicated (50-200 fmol; M13mp19 ssDNA and Y70-Cdt1 dsDNA (yeast LEU2 
CEN/ARS), both plasmids approximately 8 kb in size) in the presence or absence of 5 
mM ATP in Tris-HCl pH 7.5, 0.1 mM EDTA, and 10 mM magnesium acetate for 10 
minutes at 37°C. The sample was then analyzed on a 5ml, 4 % cross-linked agarose gel 
filtration column equilibrated in 20 mM Tris-HCl pH7.5, 10 mM magnesium acetate, 0.1 
mM EDTA, 100 mM NaCl, 10% (v/v) glycerol, 50 µg/ml bovine serum albumin and 2 
mM DTT. The amount of 32P-Mcm2-73PK in each fraction was determined by scintillation 
counting. Analysis of the data (area under the curve for recovery and ANOVA for 
comparison of mean DNA binding) were conducted in GraphPad Prism (La Jolla, CA) 
3.2.7 ATP hydrolysis 
ATP hydrolysis by the pre-RC components in isolation or in combination with DNA 
substrate and with each other was assayed through the use of thin-layer chromatography 
(TLC). Each 12 µl reaction contained 20 mM Tris-HCl pH 7.5, 10mM magnesium 
acetate, 2 mM DTT, 1 mM [γ-32P]-ATP (20 Ci/mmol; Perkin Elmer Life Sciences). For 
the experiments where Cdt1 was added to Mcm2-7, the proteins were incubated on ice 
for 60 min before the addition of ATP. After addition of ATP, the samples were 
incubated at 30°C for the indicated times. The reactions were quenched with an equal 
volume of ATPase stop buffer (40mM EDTA, 1% SDS).  A portion (1 µl) was spotted 
onto polyethyleneimine cellulose TLC sheets (EM Science) and the sheets were 
developed in 0.6 M potassium phosphate monobasic (pH 3.4) for 15 min. The dried 
sheets were exposed to a PhosphorStorage screen before scanning on a Storm 860 
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scanner (GE Healthcare Life Sciences). Densitometry analysis using ImageQuant 5.2 
(Molecular Dynamics) was used to determine the volume of the spots corresponding to Pi 
and ATP. The amount of Pi produced (in pmol) was determined by: [(volume Pi)/(volume 
Pi+volume ATP)] x 500 µM.  
3.2.8 DNA unwinding  
DNA unwinding assays were performed using a DNA substrate containing 30 base pairs 
of duplex with 60 nucleotides of single stranded DNA on one strand and a 5’ biotin on 
the other as previously described 14. Primer 2T, 5’-d(ATGTCCTAGCAAGCCAGAAT-
TCGGCAGCGTC-(T)60)-3’ was labelled with 32P at the 5’ end and annealed to 1B, 5’-
biotin-d(GACGCTGCCGAATTCTGGCTTGCTAGGACAT)-3’ by boiling 2 minutes in 
10 mM Tris-HCl, pH 8.5, 30 mM sodium citrate and 300 mM NaCl, and then cooled 
slowly to room temperature. Each 6 µl reaction contained 20 mM Tris-acetate, pH 7.5, 10 
mM magnesium acetate, 100 µM EDTA, 5 mM DTT, 5 mM ATP, 67 nM streptavidin, 
5% PEG 3350, 100 mM sodium glutamate, 5 mM creatine phosphate, 20 µg/ml creatine 
kinase, 1 nM DNA substrate (concentration of labelled strand) and the indicated 
concentrations of Mcm2-7. If necessary, proteins were diluted in 20 mM Tris-acetate, pH 
7.5, 100 µM EDTA, 2 mM DTT, 10% (v/v) glycerol and 40 µg/ml BSA. Reactions were 
incubated at 37°C for 10 minutes and then quenched by adding 0.7 µl of unlabelled 2T (1 
µM) and 1.5 µl of Proteinase K (10 mg/ml) and incubated at 37°C for an additional 2 
minutes. Samples were then treated with 2 µl of 5% SDS, 100 mM EDTA, 25% (v/v) 
glycerol, 0.1% bromophenol blue and 0.1% xylene cyanol FF. DNA products were 
resolved on 8% native polyacrylamide gels using 1x TBE (100 mM Tris, 90 mM borate, 
1 mM EDTA) at 150 V for 40 minutes at room temperature. The gels were dried, exposed 
to PhosphorStorage screens and scanned on a Storm 860 scanner (GE Healthcare). The 
volume of bands corresponding to ssDNA and dsDNA as well as a background volume 
were determined by densitometry using ImageQuant 5.2 (Molecular Dynamics). The 
percentage of ssDNA product in an unreacted sample (no protein) was ≤ 5%. To 
normalize for the variability in these values, the percentage of unwinding was calculated 
by: % unwinding = (% ssDNAS-% ssDNANp)/(1-% ssDNANp), where % ssDNAS 
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represents the percentage of ssDNA in the sample lane and % ssDNANp represents the 
percentage of ssDNA in the no protein lane.  
3.2.9 Linear DNA templates for loading assay 
ARS1 was PCR amplified from pMD187 using ARS1 Up, 5’ biotin-d(GTTGTAAAAC-
GACGGCCAGTGC)-3’ and ARS1 down, 5’-d(AAGCGCCACGCTTCCCGAAG)-3’. 
Amplified ARS1 PCR products were purified by ethanol precipitation and resuspended in 
ddH2O. Forty pmol ARS1 was coupled to 2 mg Dynabeads Kilobase Binder (Invitrogen, 
601.01) as per manufacturer’s instructions.  
3.2.10 In vitro pre-RC loading assay 
Loading reactions were based on Frigola et al 9 and each 40 µl reaction contained 100 
nM ORC, 200 nM Cdc6, 400 nM Mcm2-7 or Mcm2-7•Cdt1 in 25 mM HEPES-KOH pH 
7.6, 0.1 M  potassium glutamate, 0.02% NP-40, 10 mM magnesium acetate, 5% (v/v) 
glycerol, 1 mM DTT and 5 mM ATP. DNA beads were included at 2.5 pmol of DNA 
molecules. Reactions were mixed on ice and incubated at 30°C for 30 minutes. Beads 
were washed once with 0.4 ml low-salt wash buffer (25 mM HEPES-KOH, pH 7.6; 0.3 
M potassium glutamate; 0.02% NP-40; 5 mM magnesium acetate; 1 mM EDTA; 10% 
(v/v) glycerol; 1 mM DTT) and once with 0.4 ml high-salt wash buffer (as low-salt 
buffer, but 0.5 M NaCl instead of 0.3 M potassium glutamate). 
3.3 Results 
3.3.1 Interaction of Cdt1 with Mcm2-7 
It has been known for some time that Cdt1 interacts with Mcm2-7 15-18. For example, 
Cdt1 and Mcm2-7 were co-purified from S. cerevisiae whole cell extracts and only 
Mcm2-7 complexed with Cdt1  was reconstituted into pre-replicative complexes in vitro; 
pre-RCs could not be reconstituted if Mcm2-7 and Cdt1 were added separately 5, 19. These 
observations led to the proposal that an accessory factor may be required for Mcm2-7 and 
Cdt1 to interact 2, 5.  
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Mcm subunits and Cdt1 were expressed and purified separately from E. coli as described 
in Materials and Methods. (A) Reconstitution of Mcm2-7•Cdt1 from individual 
components. Shown is a Coomassie brilliant blue-stained SDS-PAGE (8%) of the 
indicated fractions from size exclusion chromatography.  Controls with Mcm2-7 alone 
(B) and Cdt1 alone (C) are also shown. (D) Western blot analysis of Cdt1. 0.5, 1, 2 or 3 
pmol recombinant Cdt1 (lanes 1-4) or Mcm2-7•Cdt1 complexes (lanes 5-8) were 
separated on a 6% SDS-PAGE gel and western blotted with rabbit polyclonal anti-Cdt1 
antibody. Cdt1 (9 pmol) and Mcm2-7•Cdt1 (0.9 pmol) were run on the same gel and 
stained with Coomassie brilliant blue (lanes 9 and 10). The migration size of markers is 
shown on the left and of the proteins on the right. For size exclusion chromatography, the 
elution volume of molecular weight size standards run separately under the same 
conditions is shown above each of panels A-C. 
 
To test this idea, we examined whether Cdt1 could interact and form a complex 
with Mcm2-7 without the addition of other factors. This was performed by mixing Cdt1 
with each of the individual Mcm subunits and purifying complexes via size exclusion 
chromatography (Figure 3.1A) as described in Materials and Methods. For comparison, 
the elutions of Mcm2-7 alone (Figure 3.1B) and Cdt1 alone (Figure 3.1C) were also 
examined. In the presence of Mcm2-7, Cdt1 co-eluted with the Mcm2-7 complex, with 
the peak of elution corresponding to a size of ~670 kDa (Figure 3.1A).  Notably, Mcm2-
7•Cdt1 eluted much earlier than Cdt1 analyzed alone (Figure 3.1C). The identification of 
the Cdt1 band was confirmed by Western blotting using a polyclonal anti-Cdt1 antibody 
(Figure 3.1D). Densitometry analysis of Coomassie-stained SDS-PAGE gels 
demonstrated that Cdt1 was in a 1:1 ratio with each of the Mcm2-7 proteins. The change 
in apparent size of Cdt1, when in the presence of Mcm2-7 far exceeded the size seen 
when Cdt1 was alone and is indicative of a physical interaction between Mcm2-7 and 
Cdt1 (compare Figures 3.1A and C). The elution profile of Mcm2-7 (Figure 3.1B) and 
Figure 3.1: Reconstitution of Mcm2-7•Cdt1 complexes 
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Mcm2-7•Cdt1 (Figures 3.1A, B) are very similar. Not surprisingly, the addition of 68 
kDa in the form of Cdt1 does not change the elution profile of the ~600 kDa Mcm2-7 
complex. Together, these results indicate that a complex of Cdt1 and Mcm2-7 had 
formed. The interaction of Cdt1 and Mcm2-7 did not require addition of any other 
components or any post-translational modification of the proteins.  
3.3.2 Cdt1 inhibits ATP hydrolysis by Mcm2-7 
We next asked whether the Mcm2-7•Cdt1 complex behaved differently from Mcm2-7. 
We first compared the ATPase activities of the two complexes. Cdt1 itself does not 
hydrolyze ATP, however Mcm2-7 does 12.  To this end, Mcm2-7 and Mcm2-7•Cdt1 were 
mixed with radiolabelled ATP and the products from hydrolysis separated by thin layer 
chromatography (TLC) as described in Materials and Methods. Despite equal amounts of 
protein, in both a protein titration (Figure 3.2A) and a time course experiment (Figure 
3.2B), less ATPase activity was observed with Mcm2-7•Cdt1 than with Mcm2-7 alone. 
The rate of ATP hydrolysis by Mcm2-7•Cdt1 was approximately two-fold lower than 
that of Mcm2-7 alone (Figure 3.2B, right panel). 
A lack of complete inhibition in ATPase activity by Mcm2-7•Cdt1 raised the 
possibility that this reconstitution contained a mixture of Mcm2-7 complexes with and 
without Cdt1. After all, the 68 kDa Cdt1 protein did not change the elution profile of 
Mcm2-7 (compare Figures 3.1A and B). As such, we asked whether or not ATPase 
activity would be inhibited to a greater extent if Cdt1 was added separately. As shown in 
Figure 3.2C, the rate of ATPase activity of Mcm2-7 and Mcm2-7•Cdt1 was reduced to a 
similar extent for substoichiometric and equimolar amounts of Cdt1. While the addition 
of two-fold excess Cdt1 reduced the rate of ATP hydrolysis by Mcm2-7 even further, a 
maximum reduction in Mcm2-7•Cdt1 ATPase activity was achieved at a 1:1 ratio. The 
amount of ATP hydrolyzed by Cdt1 alone was comparable to a sample lacking any 
protein (Figure 3.2D). These preliminary data suggest that majority, if not all, of the Cdt1 
was complexed with Mcm2-7 in the Mcm2-7•Cdt1 reconstitution. 	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ATP hydrolysis by Mcm2-7 or Mcm2-7•Cdt1 was measured by thin layer 
chromatography as described in Materials and Methods. (A) ATPase activity of various 
amounts of Mcm2-7 (empty circles) and Mcm2-7•Cdt1 (filled circles). (B) ATP 
hydrolysis of Mcm2-7 complexes (200 nM) was determined in a time course experiment 
and is shown on the left. The rate of hydrolysis is shown on the right. There is a 
significant difference between the means (P < 0.0001) (C) The rate of ATP hydrolysis by 
Mcm2-7 complexes (200 nM) with and without Cdt1 added in solution was determined in 
a time course. Cdt1 was purified as described in Materials and Methods, except a portion 
was further purified by size exclusion chromatography. Reactions in panels A and B were 
performed at least twice with the mean +/- standard error plotted. Some of the error bars 
are occluded by the symbols. (D) ATP hydrolysis by a sample lacking protein and Cdt1 
alone (400 nM) was determined.  
 
3.3.3 Cdt1 inhibits DNA unwinding by Mcm2-7 
Since Mcm2-7 requires energy to carry out its helicase function (reviewed in 20), we 
predicted that the reduction in ATPase activity by Cdt1 would result in a concomitant 
reduction in DNA unwinding activity. To this end, we compared the DNA unwinding 
activity of Mcm2-7 and Mcm2-7•Cdt1 using a radiolabelled synthetic dsDNA fork 
substrate 14. The DNA substrate contains a duplex region of 31 base pairs, one single-
strand with a biotin-streptavidin moiety and one single-stranded extension or tail 
composed of 60 deoxythymidylates (dT60) 14. Consistent with ATPase activity, DNA 
unwinding by equal amounts of complexes was approximately two-fold lower with 
Mcm2-7•Cdt1 than with Mcm2-7 (Figures 3.3A, B). We next attempted to examine the 
effect on activity of Mcm2-7 complexes when Cdt1 was added separately. As shown in 
Figure 3.3C, the dsDNA band that typically migrates just below the fork substrate was 
more pronounced following the addition of ≥ 100 nM Cdt1.  This was indicative of high 
Figure 3.2: Cdt1 inhibits ATPase activity of Mcm2-7 
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single-strand exonuclease activity that degraded the poly dT60 tail on the fork substrate. 
As such, we could not assess the effect on DNA unwinding by Mcm2-7 when Cdt1 was 
added separately.     
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DNA unwinding activity by Mcm2-7 and Mcm2-7•Cdt1 was measured using a dsDNA 
fork substrate (1 nM) as outlined in Materials and Methods. (A) Shown is a 
representative gel of a DNA unwinding assay. The upper band corresponds to the double 
stranded DNA substrate. The lower band is single stranded DNA product. (B) Reactions 
in panel A were performed in triplicate with the mean +/- standard error plotted. Some of 
the error bars are occluded by the symbols. Quantification was performed by 
densitometry using ImageQuant 5.2 (Molecular Dynamics). (C) DNA unwinding by 
Mcm2-7 and Mcm2-7•Cdt1 complexes with and without Cdt1 added in solution. Cdt1 
was purified as described in Materials and Methods, except a portion was further purified 
by size exclusion chromatography.  
 
 
3.3.4 DNA binding activity of Mcm2-7•Cdt1 
Mcm2-7 requires ATP to bind ssDNA, yet shows little to no affinity for dsDNA 13, 21.  As 
such, we next examined whether DNA binding by Mcm2-7 was altered by the presence 
of Cdt1 using gel filtration. In this case, DNA binding of radiolabelled Mcm2-7 or 
Mcm2-7•Cdt1 is detected by co-elution with DNA. Protein bound to DNA elutes early 
from the column (fractions 10-12), whereas free protein elutes later (fractions 16-31). 
First, increasing amounts of ssDNA were titrated into a constant amount of Mcm2-7 
(Figure 3.4A) or Mcm2-7•Cdt1 (Figure 3.4B). While binding increased in a DNA-
dependent manner, little to no difference in the ability of the two complexes to bind 
ssDNA was observed (Figure 3.4C).  
 Since Cdt1 is required to load Mcm2-7 onto origins of DNA, we thought to also 
investigate dsDNA binding activity of the two complexes. In a similar fashion as 
described above for ssDNA, dsDNA was titrated into a fixed amount of Mcm2-7 (Figure 
3.5A) or Mcm2-7•Cdt1 (Figure 3.5B). Except at the lowest concentration of dsDNA 
tested, Mcm2-7•Cdt1 showed slightly lower binding compared to Mcm2-7 alone (Figure 
Figure 3.3: Cdt1 inhibits DNA unwinding by Mcm2-7 
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3.5C).  However, the overall amount of binding to dsDNA by either complex is 
considerably lower than that for ssDNA (compare Figures 3.4C and 3.5C), consistent 
with the fact that Mcm2-7 binds dsDNA poorly 13, 21.   
Taken together, Cdt1 has little to no effect on the ability of Mcm2-7 to bind DNA. 
These results also suggest that the inhibitory effect conferred by Cdt1 on DNA 
unwinding by Mcm2-7 is not due to a defect in DNA binding.   
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DNA binding of Mcm2-7 complexes was measured using gel filtration as described in 
Materials and Methods. Shown are representative DNA binding assays for (A) Mcm2-7 
and (B) Mcm2-7•Cdt1. (C) The amount of Mcm2-7 bound in the DNA peak at ssDNA 
concentrations of 50, 100 and 200 fmol, less the amount of protein bound in the absence 
of DNA. Shown is the mean +/- standard error for three replicates where indicated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: ssDNA binding activity of Mcm2-7 and Mcm2-7•Cdt1 
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Binding of Mcm2-7 complexes to dsDNA was measured via gel filtration as described in 
Materials and Methods. Shown are representative DNA binding assays for (A) Mcm2-7 
and (B) Mcm2-7•Cdt1. (C) The amount of Mcm2-7 bound in the DNA peak at dsDNA 
concentrations of 50, 100 and 200 fmol, less the amount of protein bound in the absence 
of DNA. Shown is the mean +/- standard error for three replicates. 
 
3.3.5 In vitro assembly of the pre-RC 
In addition, we thought it was important to assemble the pre-RC on origins of replication 
from pure proteins because we wanted to control the modification state of the 
components. In this case, Mcm2-7 with or without Cdt1 was added to origin DNA 
coupled to magnetic beads in the presence of ORC, Cdc6 and ATP. Previous studies have 
used salt extraction to distinguish between two types of Mcm2-7 interactions with DNA: 
(i) salt sensitive, whereby Mcm2-7 complexes “associate” with DNA via protein-protein 
interactions with origin-bound pre-RC components; and (ii) salt resistant, in which 
Mcm2-7 complexes have been “loaded” onto origin DNA. To this end, beads were 
washed twice with buffer containing 0.3 M potassium glutamate (low salt) or once with 
low salt and once with buffer containing 0.5 M sodium chloride (high salt). In order to 
specifically isolate proteins bound to DNA rather than those interacting non-specifically 
with the magnetic beads, samples were treated with DNase I. Regardless of whether 
Mcm2-7 was purified from G1-arrested yeast extracts (Figure 3.6A) or reconstituted from 
individual subunits purified from bacterial-expression systems (Figure 3.7), loading was 
dependent on ORC, Cdc6 and Cdt1, consistent with published reports 2, 5, 6, 9.  We also 
found that the loading of Mcm2-7 using ORC and Mcm2-7 purified from yeast extracts 
was greater than that observed using pure proteins (compare Figure 3.6A, lane 4 and 
Figure 3.7, lane 7). Frigola and colleagues 9 reported that Mcm2-7 reconstituted from  
 
Figure 3.5: dsDNA binding activity of Mcm2-7 and Mcm2-7•Cdt1 
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(A) Western blot analysis of complete pre-RC formation using yeast-purified Mcm2-7 
and ORC. Reactions contained 25 nM ARS1-coated beads, 5 mM ATP, 25 nM ORC, 50 
nM Cdc6, 100 nM Mcm2-7 and where indicated, 100 nM Cdt1. Beads were washed 
twice with low-salt buffer (0.3 M K-glutamate; lanes 1 and 2) or once with low-salt and 
once with high-salt buffer (0.5 M NaCl; lanes 3 and 4). (B) Control reactions in the 
absence of ORC and Cdc6 (lanes 5 and 6, and 9 and 10) or in the absence of ATP (lanes 
7 and 8, and 11 and 12). Beads were washed as in A. Input, 1% unless indicated; Elution, 
50%. Migration of proteins is shown on the left and those analyzed are indicated on the 
right.  
 
Figure 3.6: In vitro reconstitution of Mcm2-7 loading 
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E. coli-expressed proteins was able to load onto origins as efficiently as Mcm2-7 purified 
from yeast. However, these authors used yeast-purified ORC in both loading reactions.  
 In order to determine the reason for the difference in Mcm2-7 loading efficiency, 
we next examined the ORC and Mcm2-7 complexes in more detail. It was conceivable 
that there was a difference in the subunit assemblies between yeast- and bacterial-
expressed complexes. However, regardless of the source, the stoichiometry of ORC and 
Mcm2-7 subunits within each complex was approximately 1:1 (Figures 3.8A, B). The 
hydrolysis of ATP by ORC and Cdc6 is required for the stable association of Mcm2-7 
with origins 6, 9, 22-24.  As such, we examined the ATPase activity of the pre-RC 
components on their own or in combination with each other (Figure 3.8C). Preliminary 
results demonstrated that while the ATPase activity of bacterial-expressed ORC was 
approximately two-fold lower than that of ORC purified from G1-arrested yeast extracts 
(yORC), the ATPase activity of ORC and Cdc6 together was augmented, but comparable 
between the two sources of ORC.  Whereas the hydrolysis of ATP by yeast-purified 
Mcm2-7 (yMCM) was slightly lower than that of reconstituted Mcm2-7, there was little 
to no difference in ATPase activity between the two sources of protein when combined 
with other pre-RC components.  
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(A) Western blot analysis of complete pre-RC formation using proteins purified from 
bacterial-expression systems. Reactions contained 25 nM ARS1-coated beads, 5 mM 
ATP, 25 nM ORC, 50 nM Cdc6, 100 nM Mcm2-7 or 100 nM Mcm2-7•Cdt1. Beads were 
washed with low salt buffer (lanes 1 and 2, and 5 and 6) or high salt buffer (lanes 3 and 4, 
and 7 and 8). Beads were treated with DNase I, and then boiled in 1x SDS sample 
loading buffer (SDS). Control reactions in the (B) absence of ORC and Cdc6 (lanes 3-10) 
or (C) absence of ATP (lanes 5-12) are also shown. Beads were washed and treated as in 
A. Input, 10%; DNase I or SDS elution, 50%. Migration of proteins is shown on the left 
and those analyzed are indicated on the right. 
 
 
  
Figure 3.7: In vitro loading reactions using pure proteins 
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(A) Aliquots of each of the protein component were run on an 8% SDS-PAGE gel and 
stained with Coomassie brilliant blue. yMCM and yORC (kindly provided by Mike 
O’Donnell) were purified from G1-arrested yeast extracts; Cdc6 and Cdt1 were purified 
from E. coli. (B) Individual proteins were purified from bacterial-expression systems as 
described in Materials and Methods. An aliquot of each component was run on an 8% 
SDS-PAGE gel and stained with SYPRO Ruby protein gel stain (Life Technologies). 
Cdt1, 500 ng. Protein amounts represent 50% of the input used in the loading reactions 
shown in Figure 3.7. (C) ATP hydrolysis was measured by thin layer chromatography as 
described in Materials and Methods. Reactions contained 200 nM of each component and 
were incubated at 30°C for 30 minutes.  yORC (grey bars), yMCM (checkered grey bars), 
complexes purified from G1-arrested yeast extracts.  
 
 
3.3.6 Cdt1 stabilizes Mcm2-7 
We observed in our initial Mcm2-7 reconstitutions (Figure 3.1) that Cdt1 appeared to 
“rationalize” Mcm2-7. That is, in the presence of Cdt1, stoichiometric amounts of Mcm2-
7 were observed, whereas in the absence of Cdt1, multimers and/or subcomplexes of 
Mcm subunits were more pronounced. Reconstitutions of Mcm2-7•Cdt1 complexes in 
the O’Donnell lab have also shown similar results (L. Langston, pers. comm.). From 
these data, we hypothesized that Cdt1 may play a role in stabilizing Mcm2-7 and took 
several approaches to explore this in greater detail. Using pure proteins, we investigated 
the formation of Mcm2-7 subcomplexes in the presence or absence of Cdt1 (Figure 3.9). 
Similar to that observed for Mcm2-7, in the presence of Cdt1, stoichiometric amounts of 
Mcm2, 4 and 6 (Mcm evens) were observed (compare Figures 3.9A and B). Surprisingly, 
while a subcomplex consisting of Mcm odds formed in the absence of Cdt1 (Figure 
3.9C), a subcomplex consisting of stoichiometric amounts of all four proteins appeared to 
form (Figure 3.9D). We also found that in the absence of Cdt1, Mcm odds eluted from 
gel filtration as both trimers and hexamers (Figure 3.9D, fractions 30-32 and 24-26).  
Figure 3.8: Biochemical analysis of pre-RC components 
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Individual proteins were combined and purified over a Superose 6 gel filtration column 
as described in Materials and Methods. Shown are reconstitutions for (A) Mcm246, (B) 
Mcm246 in the presence of Cdt1, (C) Mcm357 and (D) Mcm357 with Cdt1. (E) Size 
exclusion chromatography of Cdt1 alone under the same conditions. The migration of 
size standards is shown on the left and the proteins stained are shown on the left of each 
panel. The elution of molecular weight standards run separately under the same 
conditions is shown at the top of each panel. 
 
It is of note that Mcm2-7 complexes and subcomplexes reconstituted from 
subunits purified from E. coli were done in the absence of ATP. Serendipitously, we 
discovered that when all six Mcm subunits are expressed in yeast, purification over anti-
FLAG M2 resin (via FLAG-Mcm5) in the absence of ATP only pulls out the Mcm3, 5 
and 7. Conversely, the addition of ATP to the purification recovers all six Mcm subunits 
(Figure 3.10).  
 The Diffley lab recently showed that after a low salt wash, only Mcm3, 5 and 7 
(Mcm odds) are retained on origin DNA in ATPγS upon mixing Mcm2-7 in a pre-RC 
loading reaction lacking Cdt1 9.  As such, we next investigated the recruitment of Mcm 
odds to ORC-Cdc6 in the absence of Mcm evens and Cdt1 using silver staining (Figure 
3.11). We found that the Mcm357 subcomplex was associated (low salt) with origin 
DNA in the absence of both Mcm246 and Cdt1 (Figure 3.11, lanes 1 and 2). In addition, 
this association was enhanced in the presence of the poorly hydrolysable ATP analog, 
ATPγS (Figure 3.11, compare lanes 1 and 2). Consistent with published results 5, 9, and 
regardless of the ATP analog used, none of the pre-RC components bound to origin DNA 
in the absence of ORC and Cdc6 (Figure 3.11, lanes 3 and 4). While we observed binding 
of ORC and Cdc6 in the absence of ATP, the association of the Mcm odds complex was 
dependent on ATP (Figure 3.11, lane 5).  
Figure 3.9: Reconstitution of Mcm2-7 subcomplexes 
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Yeast Mcm2-7 was isolated from G1-arrested yeast extracts and purified by anti-FLAG 
M2 resin via a FLAG tag on Mcm5. (A) Purification in the absence of ATP recovers only 
Mcm3, 5 and 7. Shown is a Coomassie brilliant blue-stained SDS-PAGE gel (8%) of the 
indicated fractions. (B) All six Mcm subunits are recovered when Flag-Mcm2-7 is 
purified in the presence of ATP. Individual fractions were separated on an 8% SDS-
PAGE gel and stained with Coomassie brilliant blue. The migration size of protein 
standards is shown on the left and of the Mcm subunits isolated on the right.  
 
 
 
Figure 3.10: Mcm2-7 dissociates into subcomplexes in the absence of ATP 
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Mcm357 subcomplexes were tested for the association with ARS1 origin DNA in the 
absence of Cdt1. Complete reactions contained 400 nM Mcm357, 100 nM yORC, 200 
nM Cdc6 and 62.5 nM ARS1-coated magnetic beads in the presence of 5 mM ATP (lane 
1) or ATPγS (lane 2). Control reactions in the absence of ORC and Cdc6 (lanes 3 and 4) 
and in the absence of ATP (lane 5) are also shown. Samples were incubated at 30°C for 
30 minutes, the beads were then washed once with low salt buffer and DNA-bound 
proteins eluted with DNase I.  Samples were separated on an 8% SDS-PAGE gel and 
silver stained. The asterix (*) denotes DNase I in reaction lanes 1-5. Elution (lanes 1-5), 
100%; Input (lanes 6-8), 0.2 pmol each protein component.  
 
 
 
  
Figure 3.11: Mcm357 associates with origins in the absence of Cdt1 
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3.4 Discussion 
We have shown here, using yeast proteins purified from bacterial-expression systems, 
that Cdt1 can form a stable complex with Mcm2-7. It is noteworthy that this interaction 
did not require any other replication factors or post-translational modification. This is 
consistent with a recent report demonstrating that Mcm2-7•Cdt1 complexes could be 
reconstituted from pure proteins 9. We also demonstrated that Cdt1 inhibits the ATPase 
activity of Mcm2-7, either when reconstituted with Mcm2-7 (Mcm2-7•Cdt1) or when 
added separately to Mcm2-7. There was an approximate two-fold reduction in ATPase 
activity compared to Mcm2-7 alone.  Fernández-Cid and colleagues 6 recently observed 
that in the presence of ARS1 origin DNA, the binding of Cdt1 to Mcm2-7 caused a 35% 
reduction in the rate of ATPase activity. In addition, we discovered a two-fold reduction 
in DNA unwinding by Mcm2-7•Cdt1 relative to Mcm2-7. We also observed that Mcm2-
7 and Mcm2-7•Cdt1 complexes bound DNA with equal affinity. Since the hydrolysis of 
ATP by Mcm2-7 is neither augmented by nor dependent on DNA and the fact that ATP 
hydrolysis by Mcm2-7 is required for the complex to translocate along and unwind DNA 
20, our results suggest that the defect in helicase activity by Mcm2-7•Cdt1 is not due to a 
reduced ability to bind DNA, but rather the result of the inhibitory effect on Mcm2-7 
ATPase activity conferred by Cdt1 binding.  
 Consistent with published results, we further demonstrated that recombinant Cdt1 
is both required and competent to load Mcm2-7 complexes onto replication origins in a 
high salt-stable manner.  The loading efficiency was greater in the presence of Mcm2-7 
and ORC purified from G1-arrested yeast extracts than pure proteins. We found little to 
no difference in the stoichiometry of the two ORC complexes or the hydrolysis of ATP 
by ORC-Cdc6 that would account for this difference.  ORC is a target for CDK to 
prevent re-replication during S phase (reviewed in 25) and it has been shown that 
phosphorylated ORC reduces the association of Mcm2-7•Cdt1 with ORC-Cdc6 and 
inhibits Mcm2-7 loading 26. In addition, a complex consisting of ORC-Cdc6-Mcm2-7 
(OCM) that is essential for Mcm2-7 double hexamer formation at origins was severely 
reduced by CDK-phosphorylated ORC 6.  These findings rule out post-translational 
modification as a determining factor. Attempts to determine the DNA binding efficiency 
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of bacterial-expressed ORC failed and as such we cannot preclude that subtle structural 
differences between yeast- and bacterial-expressed ORC confer upon the former a more 
stable interaction with DNA and/or other pre-RC components.  
 Furthermore, we observed that the stability of Mcm2-7 is enhanced in the 
presence of Cdt1. Interestingly, we found that when ATP was present during the 
purification of Mcm proteins from G1-arrested yeast extracts, all six Mcm subunits 
formed hexamers with equal stoichiometry. Conversely, Mcm2-7 dissociated into a stable 
Mcm357 complex when ATP was absent during purification.  Previous results from our 
lab suggest that the binding of ATP by Mcm467 stabilizes the formation of hexamers. 
Moreover, the Mcm odds appeared to migrate as a hexamer in the absence of Cdt1, 
indicating intermolecular contacts. This is not without precedence as several Mcm 
subunits can form homodimers 27. Consistent with data from the Diffley lab 9, a 
subcomplex consisting of Mcm357 can associate with origin DNA in the absence of 
Mcm2, 4, and 6 and Cdt1. This association was greater in the presence of ATPγS. 
Furthermore, the association of Mcm357 with ORC-Cdc6 at origins, via Mcm3 9, was 
severely reduced in the presence of ATP. Consistent with published results 9, this 
suggests that ATP hydrolysis can cause the release of Mcm subunits when attempts to 
load an incomplete Mcm2-7•Cdt1 complex are made.  
 We do not yet know how Cdt1 inhibits the ATPase activity of Mcm2-7, but it is 
likely mediated through Mcm6. Several reports have shown that Cdt1 interacts with the 
C-terminus of Mcm6 to load Mcm2-7 onto origins 7, 8, 15, 16, 18.  Since ATPase active sites 
are located at the interface between Mcm subunits 12, 20, 28, it is also possible that Cdt1 
binds to and disrupts the ATPase sites formed between Mcm6 and its neighboring 
subunits, namely Mcm2 and Mcm4.  The Mcm6/2 active site represents one of the three 
major sites of ATP hydrolysis within Mcm2-7 12.  Binding of Cdt1 to Mcm2-7 may also 
induce subtle structural changes in the Mcm2-7 complex that disrupt one or more of the 
three major ATPase active sites. Indeed, the ATPase rate of AAA+ ATPases is altered 
upon subtle structural changes, such as due to interaction with another protein 29. 
Furthermore, structural changes in Mcm2-7 have been suggested, such as due to the 
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binding of Cdc45 and GINS which causes a 300-fold increase in ATPase activity by 
Mcm2-7 30, 31.   
As further evidence to support the essential role of Cdt1, the Speck lab 6 recently 
showed that in the absence of Cdt1, recruitment of Mcm2-7 to origins by ORC-Cdc6 is 
abrogated. On the other hand, the binding of Cdt1 to Mcm2-7 alleviates an autoinhibitory 
property within the C-terminal tail of Mcm6 to promote helicase loading. The hydrolysis 
of ATP by Orc1 and Cdc6 causes the release of Cdt1 and formation of a complex 
consisting of ORC, Cdc6 and Mcm2-7 (OCM) which functions in Mcm2-7 double 
hexamer assembly 6. Of note, the inhibitory effect conferred upon Mcm2-7 by Cdt1 was 
independent of origin DNA and other pre-RC factors. It is also intriguing that we and 
others 6 have observed a partial, rather than a complete, inhibition of Mcm2-7 activity in 
the presence of Cdt1. Any amount of untimely helicase activity by Mcm2-7 would be 
detrimental to the fidelity of DNA replication. As such, it is possible that another 
mechanism exists to fully downregulate Mcm2-7 function during G1 phase. Taken 
together, our results further support the essential role Cdt1 plays in modulating Mcm2-7 
activity. Moreover, the interaction of Cdt1 with Mcm2-7 may represent a quality control 
mechanism during G1 phase to prevent wanton DNA unwinding until all pre-RC 
components are recruited and post-translational modification states are met.  
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Chapter 4  
4 Investigating the role of phosphorylation on Mcm2-7 
activity 
4.1 Introduction 
Faithful duplication of the genome is essential to the maintenance of the genetic integrity 
of all organisms. Errors during this process can lead to diseases arising from genomic 
instability, such as cancer 1. Eukaryotes have developed highly conserved and tightly 
controlled mechanisms to ensure this occurs once and only once per cell division cycle. 
Primary to this control is the strict temporal separation of helicase loading during late M 
and G1 phase and helicase activation during S phase of the cell cycle 2-4. Mcm2-7 is 
loaded into the pre-RC in an inactive state.  During S phase, a series of events are thought 
to occur in order to activate Mcm2-7 to unwind DNA. The prevailing view suggests that 
one of these events involves DDK-dependent hyperphosphorylation of the N-terminal 
domains of Mcm4 and Mcm6 within Mcm2-7 5-8. There exist conflicting results 
surrounding the activation of Mcm2-7 to unwind DNA. While some studies demonstrated 
that DDK-dependent hyperphosphorylation of Mcm4 and Mcm6 was required for Mcm2-
7 activation 5-8, another study showed no effect on Mcm2-7 activity after phosphatase 
treatment 9. A recent report 8 demonstrated that the N-terminus of Mcm4 contains an 
inhibitory activity that is alleviated by DDK. Indeed, mutations in N-terminal domains of 
Mcm subunits that can be phosphorylated are able to bypass the requirement for DDK in 
vivo 8, 10. Recently, the Stillman lab identified a phosphomimetic (PM) form of Mcm4 
deleted for the inhibitory domain (Figure 4.1A) that when incorporated into Mcm2-7 is 
able to bypass the requirement for DDK 8. In contrast, the Schwacha lab demonstrated 
that the activity of yeast Mcm2-7 purified from baculovirus-expression systems was 
unaltered after phosphatase treatment 9. In an effort to clarify the ambiguity between 
Mcm2-7 phosphorylation and activation, I incorporated the phosphomimetic Mcm4 
mutant into Mcm2-7 complexes. Here I show that wildtype and phosphomimetic Mcm2-7 
complexes reconstituted from individual subunits purified from bacterial-expression 
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systems exhibit activity. I also show that the activity of phosphomimetic Mcm2-7 is 
comparable to that of wildtype. 
4.2 Materials and Methods 
4.2.1 Cloning of Mcm2-7 genes 
For bacterial expression of Mcm proteins, each of the MCM genes was amplified from 
Saccharomyces cerevisiae genomic DNA and cloned into pET plasmids as described in 
Davey et al. 11. A PKA recognition motif was fused to MCM3 as described in Stead et al. 
12. For mcm4pm, a mutant version of the MCM4 gene containing glutamic acid 
substitutions at the previously characterized DDK targets sites 5 was generated by gene 
synthesis. To do so, a portion of the MCM4 coding sequence was synthesized with 
substitutions of the codons coding for threonine 163 and serines 164 to 167, 171 and 174 
to codons coding for glutamic acids generating a fragment spanning nucleotides 302 and 
923 of the MCM4 coding sequence (Bio Basic Inc). A silent HpaI cut site was introduced 
to facilitate cloning by making the following base substitutions: G474T and T477C. The 
fragment was then digested with XbaI and StuI and inserted into the same sites of a Leu-
selectable CEN/ARS plasmid containing MCM4 (pMD379), generating YCplac111-
mcm4pm (pMD390).  pMD390 was then used to PCR amplify the mcm4pm deletion 
fragment (residues 146-933) with primer MD456, 5’-d(CGATTACATATGCCAAGAA-
GAATTGTGGATTTTG)-3’, which inserts a NdeI site at the mcm4pm start codon, and  
primer MD274, 5’-d(TGATTGTAGAGATCTTCAGACACGGTTATTCAG)-3’, which 
inserts a BglII site immediately downstream of the mcm4pm stop codon. The resultant 
PCR product was digested with NdeI and BglII and cloned into the same sites of pET24a 
(Novagen) to generate pMD418 and the construct confirmed by sequencing.  
 For yeast expression of mcm4pm, pMD390 was used to PCR amplify the 
mcm4pm deletion fragment (amino acids 146-933) with primer MD456, 5’-
d(CGATTACATATGCCAAGAAGAATTGTGGATTTTG)-3’, which inserts a NdeI site 
at the mcm4pm start codon, and  primer MD420, 5’-d(ATCGACGCTCAGCGAATGAA-
TGTAGTAGACAGC)-3’, which inserts a BlpI site immediately downstream of the 
mcm4pm stop codon. This PCR fragment was digested with NdeI and BlpI and cloned 
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into the same sites of NdeI-BlpI of YCplac111 containing the MCM4 5’ UTR in-frame 
with the ATG start site to generate pMD421 and the construct confirmed by sequencing. 
 
4.2.2 mcm4pm yeast strain 
For yeast expression of mcm4pm, pMD421 was transformed into a heterozygous diploid 
yeast strain (MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 lys2Δ0/LYS2 MET15/met15Δ0 
ura3Δ0/ura3Δ0 MCM4/mcm4::KanMX DBF4/dbf4::NatMX).  Transformants were 
grown on synthetic complete (SC) media lacking leucine and containing G418 (200 
µg/ml) and clonNAT (100 µg/ml). The diploid strain was sporulated, the tetrads dissected 
and Leu+, G418R and clonNATR haploid spore colonies selected. A single spore colony 
was isolated and the strain (YMD230) was confirmed by sequencing of pMD421 and the 
NatMX and KanMX cassettes, at the DBF4 and MCM4 loci, respectively.    
4.2.3 Purification of Mcm subunits 
Mcm subunits were purified as previously described 11, with the following modifications. 
Mcm2 and Mcm3pk were purified as described in Stead et al. 12. Cell lysis was 
performed using an Avestin Emulsiflex C3 homogenizer.  
Mcm4wt-containing cells were lysed in 800 ml Tris/sucrose (50 mM Tris-HCl, 
pH 7.5; 10% (w/v) sucrose) containing 0.5 M NaCl and 2 mM DTT.  Insoluble material 
was removed by centrifugation at 27, 000 x g for 30 minutes at 4°C. The resulting 
supernatant was treated with 0.3 g/ml ammonium sulfate and then centrifuged again. The 
pellet was resuspended in 200 ml Buffer H (20 mM HEPES-NaOH, pH 7.5; 10% (v/v) 
glycerol; 1 mM EDTA; 2 mM DTT) and dialyzed against Buffer H overnight. The 
protein was diluted to a conductivity equal to 60 mM NaCl in Buffer H and then applied 
to a 200 ml SP Sepharose column equilibrated in Buffer H containing 100 mM NaCl. The 
column was washed with 1 L Buffer H before eluting the protein with a 1400 ml, 100-
350 mM NaCl gradient in Buffer H. Fractions containing Mcm4wt, as determined by 
Coomassie-stained gels, were pooled (280 ml, 0.2 mg/ml) and dialyzed against Buffer H 
for 2 h at 4°C. The protein was then applied to a 40 ml heparin agarose column 
equilibrated in Buffer H containing 100 mM NaCl. The column was washed with 200 ml 
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Buffer H containing 100 mM NaCl and the protein eluted with a 400 ml, 100-500 mM 
NaCl gradient in Buffer H. Fractions containing Mcm4wt were pooled (90 ml, 0.2 
mg/ml) and dialyzed against Buffer H overnight at 4°C. The protein was applied to a 20 
ml ssDNA-Sepharose column equilibrated in Buffer H. The column was washed with 200 
ml Buffer H and the protein eluted with a 200 ml, 0-500 mM NaCl gradient in Buffer H. 
Fractions containing Mcm4wt were pooled (17 ml, 1 mg/ml) and dialyzed against Buffer 
H containing 100 mM NaCl for 2 h at 4°C. The protein was then applied to a 1 ml 
MonoS 5/50 column equilibrated in Buffer H containing 100 mM NaCl. The column was 
washed with 10 ml Buffer H containing 100 mM NaCl before eluting the protein with a 
20 ml, 100-500 mM NaCl gradient in Buffer H. Fractions containing Mcm4wt were 
pooled and then stored at -80°C.     
Cells containing Mcm4PM were lysed in 400 ml Tris/sucrose containing 0.5 M 
NaCl and the insoluble material was removed by centrifugation at 27, 000 x g for 30 
minutes at 4°C. The lysate was treated with 0.2 g/ml ammonium sulfate and re-pelleted. 
The resulting supernatant was removed and the pellet resuspended in Buffer A (20 mM 
Tris-HCl, pH 7.5; 10% (v/v) glycerol; 1 mM EDTA; 2 mM DTT) containing 0.15 g/ml 
ammonium sulfate and re-pelleted. The supernatant was removed and the pellet 
resuspended in Buffer A containing 0.1 g/ml ammonium sulfate and re-pelleted. The 
pellet was resuspended in 50 ml Buffer A and dialyzed against Buffer A for 3 h. The 
protein was diluted to a conductivity equal to 60 mM NaCl in Buffer A before being 
applied to a 70 ml Fast Flow Q Sepharose column equilibrated in Buffer A containing 
100 ml NaCl. The column was washed with 700 ml Buffer A containing 100 mM NaCl 
and the protein eluted with a 700 ml, 100-500 mM NaCl gradient in Buffer A. Fractions 
containing Mcm4PM were pooled (44 ml, 1.1 mg/ml) and dialyzed against Buffer A 
containing 50 mM NaCl overnight. The supernatant was centrifuged at 27, 000 x g for 10 
minutes at 4°C and then applied to an 8 ml MonoQ 10/100 column equilibrated in Buffer 
A containing 100 mM NaCl. The column was washed with 80 ml Buffer A containing 
100 mM NaCl before eluting the protein with an 80 ml, 100-500 ml NaCl gradient in 
Buffer A. Fractions containing Mcm4PM were pooled and then stored at -80°C. 
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4.2.4 Reconstitution of Mcm2-7 complexes 
Mcm2-7 complexes were reconstituted as described in Davey et al. 11 with the following 
exceptions. An equimolar amount (2 nmol) of each MCM subunit (Mcm4PM was 
substituted for Mcm4wt in the case of Mcm2-74PM) was mixed and concentrated using an 
Amicon Ultra 50 kDa cutoff device (Millipore) at 4°C to a final volume of 0.2 ml. High 
molecular weight fractions containing all six MCM proteins from the MonoQ column 
were pooled and concentrated using an Amicon Ultra 50 kDa cutoff device at 4°C to a 
final volume of 0.2 ml. The protein was then applied to a Superose 6 10/300 gel filtration 
column (GE Healthcare) equilibrated in Buffer H containing 100 mM NaCl. After the 
first 5.9 ml, fractions of 250 µl were collected at 4°C. Peak fractions were analyzed by 
SDS-PAGE (6%) and confirmation of equal stoichiometry determined by densitometry 
using ImageQuant 5.2 software (Molecular Dynamics). Peak fractions were also 
examined for ATPase and DNA unwinding activity as described below.  
4.2.5 ATP hydrolysis 
ATP hydrolysis was measured by thin layer chromatography (TLC). Each 12 µl reaction 
contained 1 mM [γ-32P]ATP (10 Ci/mmol; PerkinElmer Life Sciences), 20 mM Tris 
acetate, pH 7.5, 10 mM magnesium acetate, and 2 mM DTT as well as 0.5 µM of each 
MCM protein or 200 nM Mcm2-7, unless otherwise indicated. For end point assays, 
reactions were incubated for 60 minutes at 30°C and then quenched with 12 µl of ATPase 
stop solution (50 mM EDTA, pH 8; 1% SDS). For time course experiments, 2 µl of each 
reaction was removed at 0, 15, 30, 45 and 60 minute intervals and quenched with 2 µl of 
ATPase stop solution. A portion (1 µl) of each reaction was spotted onto a 
polyethyleneimine cellulose TLC sheet (EM Science) and then developed in 0.6 M 
potassium phosphate, pH 3.4 for 15 minutes. The dried TLC sheets were exposed to a 
PhosphorStorage screen (GE Healthcare) and then scanned on a Storm 860 scanner (HE 
Healthcare). Densitometry analysis using ImageQuant 5.2 (Molecular Dynamics) was 
used to determine the volume of the spots corresponding to Pi and ATP. The amount of Pi 
produced (in pmol) was determined by: [(volume Pi)/(volume Pi+volume ATP)] x 500 
µM.  
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4.2.6 DNA unwinding 
DNA unwinding assays were performed using a DNA substrate containing 30 base pairs 
of duplex with 60 nucleotides of single stranded DNA on one strand and a 5’ biotin on 
the other as previously described 13. Primer 2T, 5’-d(ATGTCCTAGCAAGCCAGAAT-
TCGGCAGCGTC-(T)60)-3’ was labelled with 32P at the 5’ end and annealed to 1B, 5’-
biotin-d(GACGCTGCCGAATTCTGGCTTGCTAGGACAT)-3’ by boiling 2 minutes in 
10 mM Tris-HCl, pH 8.5, 30 mM sodium citrate and 300 mM NaCl, and then cooled 
slowly to room temperature. Each 6 µl reaction contained 20 mM Tris-acetate, pH 7.5, 10 
mM magnesium acetate, 100 µM EDTA, 5 mM DTT, 5 mM ATP, 67 nM streptavidin, 
5% PEG 3350, 100 mM sodium glutamate, 5 mM creatine phosphate, 20 µg/ml creatine 
kinase, 1 nM DNA substrate (concentration of labelled strand) and the indicated 
concentrations of Mcm2-7. DNA unwinding assays involving PEG titrations lacked 
sodium glutamate. If necessary, proteins were diluted in 20 mM Tris-acetate, pH 7.5, 100 
µM EDTA, 2 mM DTT, 10% glycerol, 40 µg/ml BSA. Reactions were incubated at 37°C 
for 10 minutes and then quenched by adding 0.7 µl of unlabelled 2T (1 µM) and 1.5 µl of 
Proteinase K (10 mg/ml) and incubated at 37°C for an additional 2 minutes. Samples 
were then treated with 2 µl of 5% SDS, 100 mM EDTA, 25% (v/v) glycerol, 0.1% 
bromophenol blue and 0.1% xylene cyanol FF. DNA products were resolved on 8% 
native polyacrylamide gels using 1x TBE (100 mM Tris, 90 mM borate, 1 mM EDTA) at 
150 V for 40 minutes at room temperature. The gels were dried, exposed to 
PhosphorStorage screens and scanned on a Storm 860 scanner (GE Healthcare). The 
volume of bands corresponding to ssDNA and dsDNA as well as a background volume 
were determined by densitometry using ImageQuant 5.2 (Molecular Dynamics). The 
percentage of ssDNA product in an unreacted sample (no protein) was ≤ 5%. To 
normalize for the variability in these values, the percentage of unwinding was calculated 
by: % unwinding = (% ssDNAS-% ssDNAU)/(1-% ssDNAU), where % ssDNAS 
represents the percentage of ssDNA in the sample lane and % ssDNAU represents the 
percentage of ssDNA in the unreacted sample lane.  
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4.2.7 DNA binding 
DNA binding was measured by electrophoretic mobility shift assay (EMSA) using a 5’- 
end 32P-labelled poly dT60 DNA substrate. Each 6µl reaction contained 20 mM Tris-
acetate, pH 7.5, 10 mM magnesium acetate, 100 µM EDTA, 5 mM DTT, 5 mM ATP, 5 
mM creatine phosphate, 20 µg/ml creatine kinase and 1 nM DNA substrate and the 
indicated concentrations of Mcm2-7 complexes. Reactions were incubated for 10 minutes 
at 37°C and glycerol added to a final concentration of 5% (v/v).  Samples were resolved 
on a 5% native (Tris-borate-EDTA) polyacrylamide gel (19:1 acrylamide:Bis-
acrylamide) containing 5% glycerol, 0.1% NP-40 and 10 mM magnesium acetate at 30 
mA for 3 hours. The gel was dried and exposed to a PhosphorStorage screen and imaged 
on a Storm 860 scanner (GE Healthcare).  
4.3 Results 
4.3.1 Creation of phosphomimetic Mcm4 
To explore the role of phosphorylation on Mcm2-7 activity, we first cloned the 
phosphomimetic mutant of Mcm4 8 (Figure 4.1A) into a centromere-based (CEN) 
plasmid with a single replication origin as described in Materials and Methods. In order 
to confirm that this mutant supported viability in the absence of DDK, the mcm4pm- 
containing plasmid (CEN-mcm4pm) was initially transformed into a heterozygous diploid 
yeast strain deleted for MCM4 and DBF4. The use of a heterozygous diploid was 
required since MCM4 and DBF4 are essential genes. Upon sporulation, tetrads were 
dissected and screened for Leu+ (CEN-mcm4pm), G418 (mcm4Δ) and clonNAT (dbf4Δ) 
resistances. Figure 4.1B shows growth of the isolated mcm4pm-containing haploid spore 
that fulfilled the function of Mcm4 and bypassed the requirement for DDK efficiently.  
Of note, yeast cells bearing the Mcm4 phosphomimetic mutation exhibit robust cell cycle 
progression in the absence of DDK similar to wildtype cells 8.  
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(A) Shown are schematic diagrams for the N-terminal regions of wildtype Mcm4 and 
phosphomimetic Mcm4 (Mcm4PM). mcm4pm was created by deleting the first 435 
nucleotides of MCM4, corresponding to residues 1-145, and mutating one proximal 
threonine (T163) and six serine residues (S164-167, S171, S174) (underlined) to glutamic 
acid (E, bold and underlined). Adapted from 8. (B) DDK bypass by the mcm4pm allele 
(CEN-mcm4pm) was confirmed in a haploid yeast strain deleted for MCM4 and DBF4 
(indicated by a circle). Haploid spores were grown on synthetic complete (SC) media 
lacking leucine and containing G418 (200 µg/ml) and clonNAT (100 µg/ml). Columns 
denoted by letters represent tetrads. Rows denoted by numbers represent haploid spores 
dissected from the same tetrad.  
Figure 4.1: Phosphomimetic Mcm4 
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4.3.2 Characterization of the Mcm4PM subunit 
After confirming that the mcm4pm mutant allele was able to bypass the requirement for 
DDK, we thought to characterize the mutant subunit using in vitro biochemical analyses. 
To this end, yeast Mcm subunits, including the Mcm4PM mutant, were purified 
separately from bacterial-expression systems. Figure 4.2 depicts an SDS-PAGE gel of 
each of the Mcm subunits after the final purification step. Consistent with the deletion of 
145 N-terminal residues, or approximately 15 kDa, the Mcm4PM subunit migrated faster 
than Mcm4wt (105 kDa) on SDS-PAGE with an apparent size of approximately 90 kDa.   
 
The Mcm2-7 complex contains six unique ATPase sites located at subunit 
interfaces that play important roles for function of the complex 14.  Within Mcm2-7, 
Mcm4 forms dimer interfaces with Mcm7 and Mcm6. Mcm3/7, Mcm7/4 and Mcm6/2 
(Figure 1.2D) have been shown to be functionally important to the ATPase activity of the 
complex and cell viability 11, 15. In order to investigate the role of phosphorylation on 
Mcm2-7 ATPase activity, I set out to examine the hydrolysis of ATP by Mcm4PM 
pairwise combinations. For this, Mcm4 was mixed separately with each of its 
neighboring subunits, Mcm6 or Mcm7, and incubated at 30°C.  As shown in Figure 4.3A, 
the rate of ATP hydrolysis for the Mcm7/4 dimer was two-fold lower for the 
phosphomimetic protein relative to wildtype Mcm4. On the other hand, the Mcm4/6 
dimer showed little to no difference in the rate of ATP hydrolysis between the 
phosphomimetic and the wildtype Mcm4 (Figure 4.3B).  Consistent with Mcm7/4 being 
one of the functional ATPase active sites, this pairwise combination showed considerably 
higher ATPase activity relative to Mcm4/6, regardless of the form of Mcm4 used 
(compare Figures 4.3A and B).  
Next, the ATPase activity of multimers of Mcm subunits with and without 
phosphomimetic Mcm4 was investigated. To this end, various derivations of Mcm 
subunits with Mcm4wt or Mcm4PM were incubated with radiolabelled ATP. In general, 
and consistent with the time course experiment above, there was a two-fold reduction in 
ATPase activity of Mcm7/4PM compared to Mcm7/4wt (Figure 4.3C).  Interestingly, the 
addition of Mcm6 or Mcm3 to Mcm7/4 stimulated ATPase activity for both wildtype and 
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phosphomimetic Mcm4. On the other hand, the addition of Mcm2 and/or Mcm5 to 
Mcm7/4-containing multimers reduced ATPase activity relative to a Mcm7/4 dimer. 
When the phosphomimetic Mcm4 subunit was included with combinations of the other 
five subunits, a slightly lower ATPase activity was observed relative to that when 
wildtype was included.  
 
 
 
 
 
 
 
 
Individual Mcm subunits were expressed and purified separately from E. coli as 
described in Materials and Methods. Aliquots of each of the purified Mcm subunits were 
run on an 8% SDS-PAGE gel and stained with Coomassie brilliant blue. The migration of 
size standards is depicted on the left. 
  
Figure 4.2: Purification of Mcm2-7 subunits 
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ATP hydrolysis was determined by combining Mcm subunits and incubating at 30°C in 
the presence of radiolabelled ATP. (A) Mcm7/4wt and Mcm7/4PM and (B) Mcm4wt/6 
and Mcm4PM/6 as determined in a time course experiment. Shown are the time course 
(left) and the rate of hydrolysis from part B (right). (C) ATPase activity of Mcm 
multimers with or without phosphomimetic Mcm4. ATPase activity of individual Mcm 
subunits is also shown. Protein combinations were incubated at 30°C for one hour in the 
presence of radiolabelled ATP. Reactions were performed in triplicate with the mean and 
standard error plotted where indicated.  
 
4.3.3 Reconstitution of Mcm2-7 complexes 
Mcm2-7 complexes were assembled from individual subunits as described in Materials 
and Methods. Peak fractions of wildtype and phosphomimetic Mcm2-7 from size 
exclusion chromatography are shown in Figures 4.4A and C, respectively. Both Mcm2-
7wt and Mcm2-74PM displayed a peak of elution corresponding to a size of ~670 kDa. 
This elution profile is consistent with the predicted molecular weight of the ~600 kDa 
toroidal Mcm2-7 complex 15.  Densitometry analysis of fractions 20-24 demonstrated that 
both wildtype and phosphomimetic Mcm2-7 formed hexameric complexes assembled 
from six Mcm subunits in equal stoichiometry (ie. 1:1 ratio).  
4.3.4 Biochemical activities of Mcm2-7 complexes 
Following reconstitution of wildtype and phosphomimetic Mcm2-7 (Figure 4.4A, C), I 
set out to confirm that the complexes exhibited activity. To this end, Mcm2-7wt and 
Mcm2-74PM were assayed for ATPase and DNA unwinding activity as described in 
Materials and Methods. In contrast to MtMCM, SsoMCM and other DNA helicases, the 
ATPase activity of eukaryotic Mcm2-7 is not stimulated by DNA 16, 17. First, to test 
ATPase activity, peak fractions from size exclusion chromatography were mixed with 
Figure 4.3: ATPase activity of Mcm4PM 
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32P-radiolabelled ATP, incubated at 30°C for 60 minutes, and the products from 
hydrolysis were separated by thin layer chromatography (TLC). The peak in ATPase 
activity co-eluted with peak protein from size exclusion chromatography for both the 
wildtype and the phosphomimetic Mcm2-7 complexes (Figure 4.4). These results 
confirmed that both complexes were competent to hydrolyze ATP. 
To test the ability of Mcm2-7 to unwind DNA, an established helicase assay was 
employed utilizing a radiolabelled synthetic fork substrate 13. The DNA substrate 
contains a duplex region of 31 base pairs, one strand with a biotin-streptavidin moiety 
and one single-stranded extension or tail composed of 60 deoxythymidylates (dT60) 13.  
The Schwacha lab observed that the in vitro helicase activity of baculovirus-expressed 
yeast Mcm2-7 was inhibited by chloride ions, yet stimulated by acetate or glutamate 9. In 
contrast to this, the addition of ≤ 200 mM acetate or glutamate to the assay had no 
discernible effect on helicase activity.  
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Mcm2-7 complexes were reconstituted from individual subunits shown in Figure 4.2 and 
as described in Materials and Methods. (A) Size exclusion chromatography and (B) 
ATPase activity of Mcm2-7wt complexes. (C) Size exclusion chromatography and (D) 
ATPase activity of Mcm2-74PM complexes.  (A, C) For size exclusion chromatography, 
shown are representative 6% SDS-PAGE gels of peak fractions stained with Coomassie 
brilliant blue.  The migration of size standards and individual Mcm subunits is depicted 
on the left and right of each panel, respectively.  The elution of molecular size standards 
run separately under the same conditions is indicated above the respective panels. (B, D) 
ATP hydrolysis was measured across the peak fractions of Mcm2-7 complexes. Mcm2-7 
fractions were incubated with radiolabelled ATP for 60 minutes and processed as 
described in Materials and Methods. Shown are representative assays of the amount of Pi 
produced as determined by densitometry using ImageQuant 5.2 (Molecular Dynamics). 
 
 
 
 
 
 
 
  
Figure 4.4: Reconstitution of Mcm2-7 complexes 
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After observing no anion-dependent stimulation of Mcm2-7 activity, I tested volume 
excluders. In contrast to Bochman and Schwacha 9, the addition of polyethylene glycol 
(PEG) to the assay greatly enhanced helicase activity of Mcm2-7wt (Figure 4.5). This 
stimulation was concentration-dependent with maximum DNA unwinding activity 
achieved with 5% PEG. Sodium glutamate and PEG were added to the standard helicase 
buffer in subsequent assays.  
  To assay for DNA unwinding activity of wildtype (Figure 4.6A) and 
phosphomimetic Mcm2-7 (Figure 4.6B), peak fractions from gel filtration 
chromatography were incubated with radiolabelled synthetic fork substrate and processed 
as described in Materials and Methods. Consistent with ATPase activity (Figure 4.4), 
there was a good correlation between peak DNA unwinding activity (Figure 4.6) and 
elution profile (Figure 4.4) of both Mcm2-7 complexes. Together with the ATPase 
activity, these data demonstrated that both Mcm2-7wt and Mcm2-74PM formed active 
hexameric complexes.   
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Mcm2-7wt was first incubated with or without the indicated amounts of PEG 3350 for 15 
minutes on ice.  Reactions contained standard helicase buffer and included ssDNA (lane 
1), no Mcm (lane 2), 200 nM Mcm467 (lane 3) or 200 nM Mcm2-7wt (lanes 4-10) and 
were supplemented with the indicated amounts of PEG 3350. Reactions were separated 
on an 8% native polyacrylamide gel, exposed to a phosphorstorage screen and scanned on 
a Storm Phosphorimager (GE Healthcare Life Sciences). The relative amount of DNA 
unwinding (% unwinding) was determined by subtracting the amount of ssDNA in the 
No Protein control. 
 
 
    
 
 
 
 
 
 
 
 
Figure 4.5: PEG stimulates Mcm2-7 helicase activity 
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DNA unwinding activity of (A) wildtype and (B) phosphomimetic Mcm2-7 complexes. 
Peak fractions from size exclusion chromatography of Mcm2-7 complexes were 
incubated with 1 nM 32P-radiolabelled synthetic fork substrate in the presence of ATP. 
Reactions were separated on an 8% native polyacrylamide gel, exposed to a 
phosphorstorage screen and analyzed by a Storm Phosphorimager (GE Healthcare Life 
Sciences). Densitometry analysis of the gel image was done using ImageQuant 5.2 
(Molecular Dynamics) and is shown on the right.  
 
 
 
 
 
Figure 4.6: Mcm2-7 complexes exhibit DNA unwinding activity 
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4.3.5 Comparison of Mcm2-7wt and Mcm2-74PM Activity 
While we observed lower ATPase activity in majority of the Mcm multimers containing 
Mcm4PM compared to Mcm4wt (Figure 4.3), we thought it best to evaluate the activities 
of wildtype and phosphomimetic Mcm2-7 complexes in a side-by-side comparison.  
First, the ability of phosphomimetic Mcm2-7 to hydrolyze ATP relative to Mcm2-7 
wildtype was examined. As shown in Figure 4.7A, the ATPase activity of 
phosphomimetic Mcm2-7 was comparable to that of wildtype, and remained linear over 
several protein concentrations. Next, using the radiolabelled synthetic fork substrate 
described above, the helicase activity of Mcm2-74PM relative to Mcm2-7wt was 
investigated. Consistent with ATPase activity, phosphomimetic Mcm2-7 displayed 
wildtype DNA unwinding activity at all concentrations tested (Figure 4.7B). We also 
sought to investigate any subtle differences between these complexes in ssDNA binding. 
Preliminary data showed that the ability of phosphomimetic Mcm2-7 to bind ssDNA was 
comparable to that of wildtype (Figure 4.7C). Taken together, the data presented here 
suggest that phosphomimetic Mcm4 has little to no effect on the activity of the Mcm2-7 
complex.   
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Figure 4.7: Phosphomimetic Mcm2-7 exhibits wildtype activity 
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(A) ATPase activity of wildtype and phosphomimetic Mcm2-7 complexes. Shown is a 
representative assay. Increasing amounts of Mcm2-7 were incubated with radiolabelled 
ATP and processed as described in Materials and Methods. (B) DNA unwinding activity 
of wildtype and phosphomimetic Mcm2-7. Shown is a gel image of a representative assay 
(left panel) and the amount of DNA unwinding activity less background determined by 
densitometry analysis (right panel).  (C) The effect on ssDNA binding by 
phosphomimetic Mcm2-7 was determined in an EMSA. Shown on the left is a gel image 
and on the right is the relative amount of DNA binding less background determined by 
densitometry.  
 
4.4 Discussion 
Mcm2-7 is the replicative DNA helicase in eukaryotes. In this study, we have shown that 
both wildtype and phosphomimetic Mcm2-7 complexes can be reconstituted from 
individual subunits purified from bacterial expression systems. Gel filtration 
chromatography demonstrated that both complexes eluted as hexamers consisting of 
Mcm subunits in equal stoichiometry. In addition, these complexes were competent to 
hydrolyze ATP and unwind DNA. Of note, the amount of DNA unwinding observed was  
comparable to that seen with yeast Mcm2-7 purified from baculovirus 9. Unlike 
baculovirus-expressed Mcm2-7 9, however, the addition of glutamate or acetate did not 
stimulate DNA unwinding activity by Mcm2-7 in this study. Surprisingly, helicase 
activity of Mcm2-7 was stimulated by the addition of PEG in a concentration-dependent 
manner. Notably, the results presented in this report demonstrate that Mcm2-7 can 
unwind DNA in the absence of DDK-dependent phosphorylation and that this activity 
occurs in the absence of other factors.   
DDK-dependent phosphorylation of Mcm2-7 is thought to be required to activate 
Mcm2-7 to unwind DNA 5-8. In yeast, DDK is proposed to be essential to relieve an 
inhibitory activity in the NSD of Mcm4 8. The combined deletion of the inhibitory 
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domain in the initial 145 amino acids of the N-terminus and the mutation of 7 proximal 
serine or threonine residues to aspartic acid 8 or glutamic acid (this study) in the NSD 
allows growth of yeast cells in the absence of DDK.  In the present study, since Mcm2-7 
was reconstituted from individual subunits expressed in bacteria, the wildtype complex 
represents an unmodified state. Comparison of the biochemical activities of wildtype and 
phosphomimetic Mcm2-7 suggest that phosphorylation is not required for in vitro 
helicase activity, a finding consistent with published results 9.  The results presented here 
do not exclude the possibility that DDK-dependent phosphorylation of Mcm2-7 and/or 
association with other factors (discussed below) is essential to regulate Mcm2-7 under the 
more stringent conditions of a cycling cell.    
Unlike in cells, the DNA substrate used in this study contains DNA ends which 
facilitate helicase loading. Under the experimental conditions presented here, the Mcm2-
7 complex can load onto ssDNA regardless of an open or closed conformation. The large 
biotin-streptavidin moiety would further assist in DNA unwinding by steric exclusion as 
Mcm2-7 translocates along DNA in a 3’ to 5’ direction.  In vivo, since there are no DNA 
ends, Mcm2-7 must first load onto dsDNA and somehow switch to a ssDNA binding 
mode in order to unwind DNA. Indeed, Mcm2-7 is first loaded onto origins as a double 
hexamer 18. Conceivably, phosphorylation of Mcm2-7 by DDK may facilitate a 
conformational change to permit this switch in binding modes and/or stabilize the 
association of Mcm2-7 with DNA. Studies of Methanothermobacter thermautotrophicus 
MCM suggest that a single point mutation analogous to the bob1 mutation in yeast Mcm5 
that can bypass the requirement for DDK causes a structural change in the complex 19.  
DDK-dependent phosphorylation of Mcm2-7 is also thought to be required for the 
stable formation of a large helicase complex consisting of Cdc45/Mcm2-7/GINS (CMG 
complex) 20.  Additionally, reconstitution of Drosophila Mcm2-7 and CMG complexes  
purified from baculovirus showed that Cdc45 and GINS stimulated the ATPase, helicase 
and DNA binding activity of Mcm2-7 in vitro 21. As well, Costa et al. 22 used single-
particle electron microscopy to show that while Mcm2-7 alone exists as an open ring, 
CMG adopts a closed conformation with two distinct small pores. These authors propose 
a model in which the CMG complex induces melting of the DNA duplex and then 
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separates the single strands between the two pores. Interestingly, unlike Mcm2-7, CMG 
cannot bind dsDNA 18, 21, 23.  As well, Ilves et al. 21 found that the N-termini of Mcm2 and 
Mcm4 were not hyperphosphorylated in the CMG complex and that the modified 
residues mapped were the same in the free pool of MCMs and in CMG.  
The data presented here do not completely address the role phosphorylation plays 
in activating Mcm2-7 to unwind DNA. Confounding the link between DDK 
phosphorylation and Mcm2-7 activation is the fact that under certain conditions, Mcm2 
within Mcm2-7 is the primary target for DDK phosphorylation. For instance, studies with 
yeast and human proteins have shown that DDK can phosphorylate Mcm2 in vitro 24, 25. 
Furthermore, previous studies from our lab showed that, in yeast, phosphorylation of 
Mcm2 regulates Mcm2-7 activity and affects the cell’s response to DNA damage 26 and 
replicative stress 27. The reconstitution of large macromolecular complexes from 
individual components is a powerful tool in which to easily manipulate, such as by order 
of addition or phosphorylation, and examine complexes as a whole and the contribution 
made by each protein involved.  
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Chapter 5  
5 Discussion 
5.1 Why study the regulation of Mcm2-7? 
The regulation of DNA replication in eukaryotes is a fundamental process that ensures 
the faithful duplication of genetic material from one cell division cycle to the next 
(reviewed in 1). The study of the regulation DNA replication is crucial for understanding 
how perturbations during this process can lead to disease states caused by an unregulated 
cell cycle, such as cancer. Replicative DNA helicases are tasked with unwinding the 
double helix ahead of the replication fork in order to facilitate DNA synthesis by DNA 
polymerases 1-4. These complexes can exist in various oligomeric states, ranging from 
monomers to dodecamers. Archaeal MCMs, for example, form a hexameric complex 
comprised of six identical subunits that are proposed to be functionally equal. In contrast, 
the eukaryotic Mcm2-7 complex is a heterohexamer formed from six paralogous 
subunits. This assembly is unique among hexameric helicases and creates six distinct 
ATPase active sites at subunit interfaces that vary in their ability to hydrolyze ATP 5-7. 
Intriguingly, Mcm2-7 is loaded onto origins of replication as a head-to-head double 
hexamer, yet unwinds DNA as a single hexamer 8-10. Additionally, outside of their 
helicase function, the Mcm subunits can exist as trimers, dimers and monomers 6, 11, 12. 
Studies of the Mcm2-7 complex as a whole or the parts of which are essential to 
understanding the mechanism of DNA unwinding by this helicase.  
 Of further interest are the processes involved during Mcm2-7 helicase loading and 
helicase activation that ensure origins are fired once per cell cycle. In this context, 
Mcm2-7 is assembled into the pre-RC during G1 phase of the cell cycle. This process 
requires the collective effort of ORC, Cdc6 and Cdt1 to load the double hexamer around 
dsDNA 1. While replication origins are licensed for DNA replication, no DNA unwinding 
occurs until the Mcm2-7 helicase is activated throughout S phase to unwind DNA by 
mechanisms that have yet to be fully elucidated. What is known is that the conversion 
from an inactive to an active helicase is dependent on the combined action of CDK and 
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DDK. These activities lead to an association between Mcm2-7 and two other replication 
factors, Cdc45 and GINS 13-15. While several studies have explored this interaction, little 
is known about how Cdc45 and GINS stimulate Mcm2-7 to unwind DNA. Furthermore, 
Mcm2-7 is also phosphorylated by additional kinases, the consequences of which are not 
fully understood.  
 The importance of studying the regulation of Mcm2-7 is further exemplified by 
the plethora of studies demonstrating the potential for using the factors involved as 
biomarkers and/or targets for pharmacological inhibition in anti-cancer therapeutics. For 
example, a study evaluating the ability of proteins to be used as biomarkers to detect 
cancer cells in a wide variety of tissue samples found that the Mcm proteins were 
consistently better biomarkers for cell proliferation compared to traditional biomarkers 
such as Ki-67 and proliferating cell nuclear antigen (PCNA). Moreover, in cervical 
carcinoma samples, antibodies raised against human Cdc6 were found to detect a greater 
percentage of abnormal cells compared to anti-Ki-67 or anti-PCNA (reviewed in 16). 
Anti-cancer agents that target the degradation of Cdt1 may also be of value since Cdt1 is 
overexpressed in colon and non-small-cell lung carcinomas 17-19. In addition, a synergistic 
effect between human Cdt1 and mutant p53 or human Cdc6 and mutant p53 
overexpression resulted in augmented tumor growth and chromosomal instability in non-
small-cell lung carcinomas 17. Furthermore, many cancers with proliferative mutations 
typically have aberrant checkpoint responses which allow tumor cells to survive. In this 
regard, Cdc7, which is involved in the checkpoint response, has shown promise as a 
pharmacological target to inhibit in pre-clinical anti-cancer trials and indeed, small 
molecule inhibitors have been developed and are being optimized for this purpose 20, 21. 
Additionally, Cdc7 overexpression was found in 91% of oral squamous cell carcinoma 
patient samples. The authors of this study further suggest that, since Cdc7 inhibits 
genotoxin-induced apoptosis, which in turn increases cancer cell survival during the 
DNA damage response, upregulation of Cdc7 increases the resistance to chemotherapy 22. 
Cdc7 also phosphorylates TDP-43, a protein implicated in a number of neurodegenerative 
diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer’s. A recent study 
suggests repurposing a small molecule inhibitor of Cdc7 (PHA767491), originally 
144 
 
developed as an anti-cancer agent, for use in preventing neurodegeneration caused by 
TDP-43 phosphorylation 23.   
5.2 Summary of results 
5.2.1 The C-terminal residues of Saccharomyces cerevisiae Mec1 
are required for its localization, stability and function 
To determine if the FATC domain has a general role in the stability of PIKK family 
members, we altered the C-terminus of S. cerevisiae Mec1 and integrated these into the 
yeast genome. Haploid yeast cells harboring a mec1 W2368A mutation, either untagged 
or epitope tagged, showed slower growth at the elevated temperature of 37°C compared 
to the physiological temperature of 30°C (Figure 2.1B). This change in the terminal 
tryptophan to alanine also caused sensitivity to hydroxyurea, an inhibitor of 
ribonucleotide reductase (Figure 2.1B).  
 Continuing from this, we explored the expression levels of C-terminal mutant Mec1 
proteins in diploid yeast strains (Figure 2.2B). Western blotting using anti-Flag 
antibodies showed that all Flag-tagged mec1 mutant alleles (Δ1, Δ2, Δ 3 and 2369G) were 
expressed when yeast cells were grown at 30°C. While Flag-Mec1-W2368A and Flag-
Mec1-2369G were expressed at near wild-type levels, the deletion proteins showed 
reduced expression, which was exacerbated by the extent of the deletion. As an 
interaction between Lcd1 and Mec1 is required for the checkpoint functions of Mec1, we 
investigated whether the mutant Mec1 proteins interacted with Lcd1 (Figure 2.2C). Co-
immunoprecipitations of Flag-Mec1-W2368A, -Δ1 and -2369G revealed that each of 
these derivatives interacted with Lcd1 as efficiently as wild-type Mec1.   
 After discovering that the phenotypes of the Mec1 mutants were not due to their 
lack of expression or impaired interaction with Lcd1 we explored the kinase activity of 
the Mec1 derivatives (Figure 2.3B). Flag-tagged Mec1wt and derivatives were 
immunoprecipitated from diploid yeast cells and incubated with the substrate 4E-BP1. 
While phosphorylation of 4E-BP1 was considerably higher than background with the 
wildtype protein, the phosphorylation by Flag-Mec1-W2368A was 10-fold less than that 
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observed for Flag-Mec1wt. This result suggests that only low levels of kinase activity are 
required for cell viability since strains harboring the Mec1-W2368A mutation are viable 
at both 30°C and 37°C (Figure 2.1B).  The lack of kinase activity demonstrated by the 
Mec1-2369G protein (Figure 2.2B) was most likely the cause of inviability of yeast 
strains carrying this mutation. Finally, the kinase activity was not above background for 
the Mec1 deletion mutants (Figure 2.2B). We cannot however, preclude the fact that the 
abrogation in kinase activity was a consequence of the lower protein levels of these 
mutants relative to Mec1wt (Figures 2.2B and 2.3A).    
 To investigate the lack of kinase activity demonstrated by the Mec1 mutants, we 
explored protein stability by various methods. First, examination of protein extracts 
revealed that the Mec1 mutants were susceptible to proteolysis in the absence of protease 
inhibitors after incubating at 30°C for 10 minutes compared to Mec1wt which remained 
stable up to two hours (Figure 2.4). Size exclusion chromatography of Flag-tagged Mec1 
yeast extracts showed that each of the Mec1 mutants eluted in significantly higher 
molecular weight fractions relative to wildtype Mec1 (Figure 2.5). We suggest that the 
aberrant elution profiles by the Mec1 mutants may be due to improper folding of the 
proteins or extended interaction with chaperone complexes that are required for assembly 
of functional PIKK family members 24, 25.   In addition, we investigated the localization of 
Mec1 derivatives by confocal microscopy.  Whereas eGFP-Mec1wt was predominantly 
localized to the nucleus, each of Mec1-W2368A, Mec1-2369G, Mec1-Δ1 and Mec1-Δ2 
were found dispersed between the nucleus and cytoplasm (Figure 3.6).  
Taken together, the above results indicated that the C-terminus of Mec1 was 
critical for proper folding and/or stability of the protein. Consequently, we predicted that 
it should be possible to discover second site suppressor mutations that restored protein 
levels and permitted growth of the mec1-W2368A strain at 37°C. We identified four 
unique mutations in three genes: Rfx1, Sml1 and Rpn3. We chose to investigate the rpn3-
L140P mutation in more detail for two reasons. First, loss of function of Sml1 and Rfx1 
are known to suppress nonfunctional alleles of mec1 26-28. Second, Rpn3 encodes a 
component of the 19S proteasomal regulatory particle 29, thus possibly linking it to the 
stability of Mec1.  Growth of a yeast strain carrying the mec1-W2368A rpn3-L140P 
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mutations was comparable to that of a wildtype strain at 37°C. In addition, the suppressor 
mutation was partially dominant (Figure 2.7B). Of note, the rpn3-L140P allele did not 
suppress the inviability of mec1-Δ1, mec1-Δ2 or mec1-2369G. Moreover, we observed 
that this mutation caused a further reduction in growth on HU-containing plates (Figure 
2.7C).  We then confirmed the suppression of mec1-W2368A was due to rpn3-L140P by 
two independent methods. First, we compared the partially dominant effect of the rpn3-
L140P/RPN3 heterozygous diploid strain to the phenotype of a mec1-W2368A strain in 
which rpn3-L140P was genomically integrated (Figure 2.7D). Similar to the 
heterozygous diploid, integration of rpn3-L140P partially reversed the slow growth 
defect at 37C due to mec1-W2368A.  Second, we screened the RPN3 allele, via PCR and 
sequencing analysis, of independent spore colonies from a cross between rpn3-L140P 
mec1-W2368A and RPN3 mec1-W2368A.  For 14 alleles (7 fast growing strains and 7 
slow growing strains), the fast growth predicted the presence of the rpn3-L140P allele.   
We next looked at the rpn3-L140P mutation alone in more detail since Rpn3 is an 
essential protein and L140 is located in a hydrophobic region conserved in fungal species 
(Figure 2.8A) and more broadly in eukaryotes Figure 2.8B). The protein levels of myc-
Rpn3-L140P were comparable to that of myc-Rpn3 (Figure 2.8C).  In addition, the 
growth of a rpn3-L140P strain was comparable to that of a wildtype strain at 30°C in rich 
media (Figure 2.8D).  A very minimal reduction in growth was shown for cells grown at 
37°C and in media containing the arginine analog canavanine.  
  To investigate whether rpn3-L140P would suppress a mutation similar to mec1-
W2368A in a related PIKK family member, we introduced rpn3-L140P into a tra1-
F3744A strain. We found that the rpn3-L140P mutation did not suppress the slow growth 
at 37°C or in media containing 6% ethanol (Figure 2.8E).   
As Mec1-W2368A showed reduced protein stability (Figure 2.4), we explored the 
protein levels in the context of the rpn3-L140P mutation. For this, protein extracts were 
prepared in the absence of protease inhibitors from a Flag5-mec1-W2368A/MEC1 rpn3-
L140P/rpn3-L140P yeast strain grown at either 30°C or 37°C. Western blot analysis 
revealed that the level of Mec1-W2368A in cells grown at 30°C was lower than that of 
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wildtype Mec1 (Figure 2.9A).  The rpn3-L140P mutation augmented the level of Mec1-
2368A relative to that from a RPN3 mec1-W2368A strain. While the level of Mec1-
W2368A from extracts prepared from cells grown at 37C was considerably reduced 
relative to the wildtype, the rpn3-L140P mutation caused a striking increase in the level 
of Mec1-W2368A. From these results we suggest that rpn3-L140P helps to stabilize 
Mec1-W2368A, thereby permitting growth at elevated temperature. We also discovered 
that the rpn3-L140P mutation acts more broadly as it dramatically increased the level of 
Mec1-2369G in cells grown at 37C (Figure 2.9B).   
We were intrigued by the suppression of mec1-W2368A by rpn3-L140P and thus 
explored Mec1 turnover mediated by proteasomal degradation. To this end, cells 
expressing Flag-tagged Mec1 or Mec1-W2368A were grown at 37°C and treated with 
MG-132, a proteasome inhibitor.  Whereas wildtype Mec1 was unaltered by MG-132 
treatment, there was an approximate two-fold increase in Mec1-W2368A levels 
following treatment (Figure 2.9D). These results suggest that the proteasome plays some 
part in Mec1 turnover. We did not observe evidence of ubiquitylation in either the 
wildtype or Mec1-W2368A proteins.    
5.2.2 Modulation of Mcm2-7 activity by Cdt1 
In budding yeast, Cdt1 is required for nuclear import and loading of Mcm2-7 onto 
chromatin in early G1 phase of the cell cycle. To investigate the interaction between 
Mcm2-7 and Cdt1 in isolation, individual components purified separately from bacterial-
expression systems were combined and the complexes purified by size exclusion 
chromatography (Figure 3.1). Cdt1 co-eluted with each of the six Mcm subunits with the 
peak of elution equivalent to ~670 kDa and with equal stoichiometry (Figure 3.1A).  
We next addressed whether the Mcm2-7•Cdt1 complex behaved differently from 
Mcm2-7 alone. Initially, the ability of the two complexes to hydrolyze ATP was 
compared. During both the titration of protein (Figure 3.2A) and time course experiments 
(Figure 3.2B), we consistently observed a lower ATPase activity with the Mcm2-7•Cdt1 
complex compared to the Mcm2-7 complex. Overall, there was a two-fold reduction in 
the hydrolysis of ATP by Mcm2-7•Cdt1 relative to that of Mcm2-7 alone. 
148 
 
The two-fold reduction, rather than a complete inhibition, in ATPase activity by 
Mcm2-7•Cdt1 suggested that this reconstitution comprised a mixture of Mcm2-7 
complexes with and without Cdt1. To this end, we asked whether the hydrolysis of ATP 
by the Mcm2-7•Cdt1 complex would be further inhibited if recombinant Cdt1 were 
added in solution (Figure 3.2C). While the rate of ATP hydrolysis by Mcm2-7 and 
Mcm2-7•Cdt1 was comparable after adding two-fold excess Cdt1, a maximum reduction 
in Mcm2-7•Cdt1 ATPase activity was reached with an equimolar amount of Cdt1 added. 
These data indicated that most, if not all, of the Cdt1 was associated with Mcm2-7 in the 
Mcm2-7•Cdt1 reconstitution.  
We further compared the activity of Mcm2-7 and Mcm2-7•Cdt1 complexes in an 
established helicase assay 30. In this regard, complexes were incubated with radiolabelled 
synthetic dsDNA fork substrate containing a biotin-streptavidin moiety and the ssDNA 
generated by unwinding were separated from duplex DNA by native polyacrylamide gel 
electrophoresis. Similar to ATPase activity, the DNA unwinding activity by Mcm2-
7•Cdt1 was approximately two-fold lower than by Mcm2-7 alone (Figure 3.3). 
Unfortunately, the presence of nuclease contamination in the Cdt1 preparation nullified 
our ability to assess the effect on DNA unwinding by adding Cdt1 in solution to the 
Mcm2-7•Cdt1 complex.   
 We next addressed whether the DNA binding activity of Mcm2-7•Cdt1 was 
different from that of Mcm2-7. For this, radiolabelled Mcm2-7 or Mcm2-7•Cdt1 was 
incubated with either single-stranded M13 DNA (Figure 3.4) or double-stranded plasmid 
DNA (Figure 3.5). Whereas ssDNA binding increased in a DNA-dependent fashion, little 
to no difference in the ability of the two complexes to bind ssDNA was found.  For 
dsDNA binding, Mcm2-7•Cdt1 demonstrated slightly lower binding relative to Mcm2-7 
at all except the lowest concentration of dsDNA tested. Consistent with the poor ability 
of Mcm2-7 to bind dsDNA 31, 32, the overall amount of binding to dsDNA by either 
complex was much lower than that to ssDNA. Taken together, these results indicate that 
Cdt1 has little to no effect on the DNA binding activity of Mcm2-7. In addition and 
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consequently, the ability for Cdt1 to inhibit the DNA unwinding activity of Mcm2-7 was 
not due to a defect in DNA binding by this helicase complex.  
 To further investigate the individual roles of Mcm2-7 and Cdt1, we set out to 
assemble the pre-RC on replication origins from pure proteins and proteins purified from 
G1-arrested yeast extracts. To this end, Mcm2-7 was added to biotinylated ARS1 origin 
DNA coupled to streptavidin-coated magnetic beads in the presence of ORC, Cdc6 and 
ATP. Beads were washed with either low salt or high salt buffer to differentiate between 
Mcm2-7 complexes that were associated with versus loaded onto origin DNA, 
respectively.  Consistent with published results 8, 10, 33, 34, we found that origin loading of 
Mcm2-7 was dependent on ORC, Cdc6 and Cdt1 (Figures 3.6 and 3.7). We also observed 
a greater extent of loading using Mcm2-7 and ORC purified from G1-arrested yeast 
extracts compared to pure proteins. To determine the cause for this discrepancy, we 
examined these complexes in more detail. Analysis of complexes run on SDS-PAGE gels 
(Figures 3.8A and B) revealed that there was approximately equal stoichiometry of 
subunits in the respective complexes. Since the hydrolysis of ATP by ORC and Cdc6 is 
required for the stable association of Mcm2-7 with replication origins, we determined the 
ATPase activity of the pre-RC factors in isolation or in combination with each other 
(Figure 3.8C). While low, the hydrolysis of ATP by bacterial-expressed ORC was two-
fold lower than that of ORC purified from G1-arrested yeast extracts. In contrast, and 
regardless of the source of ORC, the ATPase activity of ORC and Cdc6 combined was 
similar.     
 Intriguingly, we found that in the presence of Cdt1, the Mcm2-7 complex was 
comprised of subunits at or near equal stoichiometry. In contrast, in the absence of Cdt1, 
subcomplexes of Mcm subunits were more pronounced (Figure 3.1; M. O’Donnell and L. 
Langston, unpublished). In light of this, we predicted that Cdt1 plays a role in stabilizing 
Mcm2-7.  To this end, we evaluated by gel filtration the formation of Mcm2-7 
subcomplexes in the presence or absence of Cdt1 using purified proteins (Figure 3.9). 
Similar to that observed for Mcm2-7, a subcomplex containing Mcm2, 4 and 6 neared 
stoichiometry in the presence as opposed to the absence of Cdt1 (Figures 3.9A and B). 
Whereas the addition of Cdt1 had no discernible effect on the stoichiometry of a Mcm357 
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(Mcm odds) complex, the formation of both trimers and hexamers of Mcm357 was 
observed in the absence of Cdt1 (Figures 3.9C and D). Furthermore, we observed that 
when all six Mcm subunits were expressed in yeast, and when ATP was omitted from 
affinity chromatography purification, only the Mcm odds were recovered (Figure 3.10).     
Encouraged by the above results and the recent finding that, in the presence of the 
poorly hydrolysable ATP analog ATPγS, only Mcm3, 5 and 7 were associated with origin 
DNA upon mixing Mcm2-7 in a pre-RC loading reaction lacking Cdt1 33, we performed a 
loading assay in the absence of Mcm2, 4, 6 and Cdt1 (Figure 3.11).  Consequently, after 
treating loading reactions with low salt buffer, we observed that the Mcm357 subcomplex 
could associate with ARS1 in the absence of Mcm2, 4, 6 and Cdt1. While the association 
of the Mcm odds complex was dependent on nucleotide, there was a greater amount of 
origin recruitment in the presence of ATPγS relative to ATP.  Additionally and consistent 
with published data 10, 33, none of the pre-RC factors bound to origin DNA in the absence 
of ORC and Cdc6. Finally, we also observed non-specific binding of ORC and Cdc6 in 
the absence of ATP.  
5.2.3 Investigating the role of phosphorylation on Mcm2-7 activity 
To determine what role DDK-dependent phosphorylation of Mcm2-7 plays in modulating 
helicase activity, we utilized a phosphomimetic mutant of Mcm4 (Mcm4PM) deleted for 
the first 145 N-terminal residues and containing glutamic acid substitutions for seven 
proximal serine or threonine DDK target sites (Figure 4.1A) 35. To confirm this mutant 
was able to bypass the requirement for DDK, we first cloned the mcm4pm allele into a 
CEN plasmid and transformed the construct into a dbf4Δ/DBF4 mcm4Δ/MCM4 
heterozygous diploid yeast strain. After sporulation and screening of tetrads, I isolated a 
haploid spore harboring the mcm4pm allele and that was viable upon the simultaneous 
loss of MCM4 and DBF4 (Figure 4.1B). 
 After confirming that the mcm4pm allele was able to bypass the requirement for 
DDK in vivo, we set out to analyze the Mcm4PM protein in vitro. For this, we utilized a 
bacterial-expression system to separately purify yeast Mcm subunits including the 
Mcm4PM mutant (Figure 4.2). As ATPase active sites are located at dimer interfaces 
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within the Mcm2-7 hexamer, I next investigated the effect of the Mcm4 phosphomimetic 
mutation on the hydrolysis of ATP over time by Mcm pairwise combinations (Figure 
4.3). The rate of ATPase activity for the Mcm7/4 dimer was two-fold lower when 
Mcm4PM was used instead of the wildtype protein (Figure 4.3A). Although not 
statistically significant, combining the phosphomimetic Mcm4 mutant with Mcm6 
resulted in a marginally higher rate of ATPase activity compared to when wildtype 
Mcm4 was used (Figure 4.3B). Overall and regardless of the version of Mcm4 used, the 
Mcm7/4 pairwise combination demonstrated a much higher level of ATPase activity 
relative to Mcm4/6.         
 We next evaluated the effect of the phosphomimetic Mcm4 mutant on ATPase 
activity by multimers of Mcm subunits in an end-point assay (Figure 4.3C). As with the 
time course experiment, there was an approximately two-fold reduction in ATPase 
activity by Mcm7/4PM relative to Mcm7/4wt. Regardless of the derivative of Mcm4 
used, combining Mcm6 or Mcm3pk with Mcm7 and Mcm4 stimulated ATPase activity. 
In contrast, the addition of Mcm2 and/or Mcm5 to Mcm7/4-containing multimers 
reduced the hydrolysis of ATP relative to Mcm7/4 dimers. When Mcm4PM was 
combined with the other five Mcm subunits, a somewhat reduced ATPase activity was 
shown compared to that when wildtype Mcm4 was used. 
 To further investigate the role of phosphorylation by DDK on Mcm2-7 activity, 
we reconstituted Mcm2-7 complexes with wildtype (Figure 4.4A) or phosphomimetic 
Mcm4 (Figure 4.4C) from individual proteins purified from bacterial-expression systems. 
Since these complexes were assembled from pure proteins, the wildtype Mcm2-7 
complex represents a non-phosphorylated state, whereas the phosphomimetic Mcm2-7 
complex corresponds to a DDK-phosphorylated (on Mcm4) state. Individual subunits 
were mixed, concentrated and complexes purified by size exclusion chromatography. 
Consistent with the predicted molecular weight of a ~600 kDa toroidal complex, both 
Mcm2-7wt and Mcm2-74PM demonstrated a peak of elution of ~670 kDa. In addition, 
each of these hexamers was comprised of six Mcm subunits in equal stoichiometry.  
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Following the reconstitution of these complexes, we investigated their respective 
activities via in vitro biochemical methods. First, the ATPase activity across the peak 
fractions from size exclusion chromatography was assessed (Figures 4.4B and D). For 
this, protein complexes were mixed with 32P-radiolabelled ATP, incubated at 30°C and 
samples spotted onto TLC sheets to separate ATP and Pi. The peak in ATPase activity 
co-eluted with peak protein for both the wildtype and the phosphomimetic Mcm2-7 
complexes.  Since the essential function of Mcm2-7 is to unwind duplex DNA, we 
performed a helicase assay using a radiolabelled synthetic fork substrate (Figure 4.5) 30.  
Experimental conditions to achieve efficient DNA unwinding activity were initially 
performed with wildtype Mcm2-7. As a previous report found that the in vitro helicase 
activity of yeast Mcm2-7 purified from baculovirus was stimulated by anions, acetate or 
glutamate was added to the standard helicase conditions. Interestingly, while there was 
little to no anion-dependent effect on Mcm2-7 DNA unwinding activity, the addition of 
5% PEG augmented helicase activity nearly six-fold.  After determining the appropriate 
buffer conditions to achieve helicase activity, peak gel filtration fractions of wildtype and 
phosphomimetic Mcm2-7 were assayed for their ability to unwind DNA (Figure 4.6). As 
with ATPase activity, the peak in DNA unwinding activity co-eluted with peak protein 
for both complexes. Together, these data indicated that both wildtype and 
phosphomimetic Mcm2-7 formed active hexameric complexes.  
 As lower ATPase activity was demonstrated in majority of the Mcm multimers 
containing the Mcm4PM mutant subunit (Figure 4.3C), we next performed in vitro 
biochemical analyses to compare activities of the wildtype and the phosphomimetic 
Mcm2-7 complexes. Surprisingly, the ATPase (Figure 4.7A) and DNA unwinding 
(Figure 4.7B) activities of phosphomimetic Mcm2-7 were comparable to those of the 
wildtype complex. In addition, we investigated the DNA binding activity of these 
complexes using a radiolabelled poly dT60 substrate. Similarly to the ATPase and 
helicase activities, preliminary data demonstrated that the ability of phosphomimetic 
Mcm2-7 to bind ssDNA was comparable to that of wildtype Mcm2-7 (Figure 4.7C).  
Whereas the Mcm4PM subunit showed lower ATPase activity in subunit combinations, 
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the above comparative results suggest that the phosphomimetic Mcm4 subunit has little 
to no effect on the activity of the Mcm2-7 helicase.   
5.3 Phosphoregulation of Mcm2-7 to unwind DNA 
It is interesting that in eukaryotes Mcm2-7 is loaded onto replication origins in early G1 
phase of the cell cycle in an inactive state. Throughout S phase, the events that trigger 
Mcm2-7 to unwind DNA are poorly understood. Several reports have shown that the 
amino termini of Mcm2, Mcm4 and Mcm6 are the major substrates for DDK 36, 37. In 
particular, studies in budding yeast indicate that hyperphosphorylation of Mcm4 within 
Mcm2-7 is the essential function of DDK 35.  As the wildtype Mcm2-7 complex was 
reconstituted from pure proteins, my results suggest that in vitro helicase activity can 
occur in the absence of post-translational modification. In support of this, biochemical 
analyses of a phosphomimetic Mcm2-7 complex did not show augmented activity. While 
phosphomimetic Mcm4 can bypass the requirement for DDK in vivo (35 and this study), it 
is possible that this mutant, when reconstituted into the Mcm2-7 hexamer, was not 
sufficient to observe enhanced activity. My results, however, are consistent with data 
from the Schwacha lab showing that yeast Mcm2-7 purified from baculovirus-expression 
systems exhibits robust in vitro helicase activity 38. Their study also found that DNA 
unwinding is unaffected by phosphatase treatment of Mcm2-7. 
 Upon origin loading, Mcm2-7 double hexamers switch from a dsDNA binding 
mode to a ssDNA binding mode. The mechanisms involved in this process have yet to be 
elucidated. It is possible that throughout S phase, phosphorylation of Mcm2-7 is required 
to induce a conformational change to permit a switch in binding modes to facilitate DNA 
unwinding.   Structural changes have been proposed based on studies of an archaeal 
MCM complex harboring a mutation analogous to the bob1 mutation in budding yeast 39. 
In fact, Bochman and Schwacha 38 proposed that circularization of Mcm2-7 is required 
for DNA unwinding. This theory is further supported by studies of the bovine 
papillomavirus E1 helicase 40. Interestingly, Mcm2-7 does not unwind DNA as a double 
hexamer, but rather as single hexamers to facilitate bidirectional replication fork 
progression. It is possible that DDK-dependent phosphorylation of Mcm2-7 may disrupt 
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the double hexamer and stabilize the association of single Mcm2-7 hexamers with 
ssDNA.   	  
Phosphorylation of Mcm2-7 may create binding sites for the accessory factors 
Cdc45 and GINS. In budding yeast, Cdc45 is recruited to early origins during G1 phase, 
yet the stable interaction between Mcm2-7 and Cdc45 during S phase is dependent on the 
activities of CDK and DDK 41-43. Furthermore, RNAi knock-down of GINS and Cdc45 
revealed that these proteins are essential for S phase progression in Drosophila cells 44. 
Mcm2-7 is thought to be the core of a larger CMG complex assembled at replication 
origins. To date, CMG complexes that associate with replicating DNA have been shown 
in Xenopus egg extracts 45, Drosophila embryos 44, budding yeast 46 and human cells 
(reviewed in 47).  In fact, Drosophila Mcm2-7 CMG exhibited enhanced activity relative 
to Mcm2-7 alone 48. These included an increase in the rate of ATP hydrolysis, robust 
helicase activity and augmented affinity for DNA. However, the role of Mcm2-7 
phosphorylation is still unknown as the amino termini of Mcm2 and Mcm4 were not 
hyperphosphorylated in the CMG and the modified residues mapped were the same in the 
CMG and in Mcm2-7.  Additionally, the disparity in in vitro helicase activity between 
budding yeast Mcm2-7 and Drosophila Mcm2-7 is not known. It may be due to 
differences in the modulation of Mcm2-7 activity between these organisms. Perhaps 
combining the phosphomimetic Mcm2-7 complex with Cdc45 and GINS would augment 
helicase activity beyond the level reported in this study. Future reconstitution studies of 
budding yeast CMG using pure proteins will help to address the role of phosphorylation 
in activating Mcm2-7 to unwind DNA.  
 While Mcm4 is the essential DDK target in vivo, phosphorylation of other Mcm 
subunits may also be necessary for Mcm2-7 activation. It was recently reported that Cdc7 
associated with Mcm4 and Mcm5 in yeast two-hybrid and co-immunoprecipitation 
analyses 49. The binding of Cdc7 to Mcm5 is intriguing as Mcm5 is the only Mcm 
subunit not phosphorylated by DDK in budding yeast or any other species 47. 
Furthermore, DDK phosphorylation of Mcm4 and Mcm6 is highly influenced by pre-RC 
formation 50.  In an extensive study using in vitro assembled pre-RCs as a DDK substrate 
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and mass spectrometry, the Bell lab identified DDK phosphorylation sites on budding 
yeast Mcm4 and Mcm6 36. That study also found that phosphorylation of either subunit 
was sufficient for yeast cell proliferation. As such, it would be interesting to investigate 
the effect on in vitro helicase activity by a Mcm2-7 complex containing phosphomimetic 
mutations in either or both of Mcm4 and Mcm6.  
 DDK phosphorylation of Mcm2-7 is also stimulated by prior phosphorylation by 
one or more kinases.  In fact, it was previously observed that DDK could not bind Mcm2-
7 or phosphorylate Mcm4 or Mcm6 without prior phosphorylation 50. Using in vitro 
assembled pre-RCs as a DDK substrate, the Bell lab demonstrated that DDK 
phosphorylation of Mcm4 and Mcm6 required prior phosphorylation of these subunits at 
either S/T-P or S/T-Q sites 36. That same report strongly suggested that Mec1 directly 
targets the S/T-Q sites and that DNA replication is positively modulated by these 
modifications. The authors further propose that priming phosphorylation by Mec1 and 
other kinases enhances DDK phosphorylation of Mcm4 and Mcm6 in two ways. First, 
phosphorylation at S-S/T-P and S-S/T-Q sites generates an acidic 
phosphoserine/threonine that directs DDK to an adjacent serine residue upstream. In this 
regard, the number of possible DDK targets sites in Mcm4 and Mcm6 is increased by 
approximately two-fold. Second, it is possible that the processive phosphorylation of the 
N-terminal tail of Mcm4 by DDK 42 is due to phosphorylation of S/T stretches that 
precede several of these phosphogenerated DDK target sites 36.   
 The role of Mec1 has been most characterized for its function in checkpoint 
signaling. Data from the Bell lab has now extended that role to include requisite priming 
phosphorylation of Mcm2-7 for subsequent DDK targeting. From the current study, it 
appears that the terminal tryptophan of Mec1 is required for its function. As our results 
suggest that only low levels of kinase activity are essential for viability, it would be 
intriguing to determine the effect of Mec1wt and the Mec1-W2368A mutant on Mcm2-7 
phosphorylation in vitro. It is possible that any effect on Mcm2-7 by Mec1 
phosphorylation will only be evident in the context of the pre-RC. As such, it would also 
be beneficial to carry out in vitro studies, such as pre-RC loading experiments, to 
determine the effect of Mec1 and DDK phosphorylation on Mcm2-7 helicase activity 
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within the pre-RC. However, the involvement of priming Mcm2-7 by the metazoan Mec1 
homolog ATR may not hold true in these organisms as S-S/T-Q sites are not found in the 
N-termini of metazoan Mcm2-7 36. As such, future studies examining the 
phosphorylation of and downstream effect on Mcm2-7 activity in metazoans is necessary.     
5.4 Cdt1 acts as a negative regulator of Mcm2-7 activity 
Cdt1 is an important eukaryotic replication licensing factor that is tasked with the nuclear 
import and origin loading of the Mcm2-7 replicative helicase during early G1 phase 51, 52. 
Mcm2-7 remains inactive within the pre-RC until it is activated during S phase by 
mechanisms yet to be fully elucidated. Here, I propose a model in which Cdt1 acts to 
negatively regulate the helicase activity of Mcm2-7 (Figure 5.1) prior to the onset of S 
phase. In this model, Cdt1 induces a structural change in Mcm2-7 which alters its 
ATPase activity and ultimately the helicase function of Mcm2-7. It has been reported that 
AAA+ ATPases, such as Mcm2-7, exhibit altered ATPase rates upon subtle structural 
changes, such as caused by an interaction with another protein 53. In the absence of Cdt1, 
Mcm2-7 exhibits fully functional ATPase activity. This ATPase activity is sufficient to 
facilitate DNA unwinding by Mcm2-7. In contrast, the association of Cdt1 with Mcm2-7 
via the C-terminal region of Mcm6 54-56 induces a conformational change such that it 
disrupts the ATPase sites within Mcm2-7. A recent report suggested that in addition to 
the C-terminus of Mcm6, there is at least one more binding site in a different region of 
Mcm2-7 34. In support of this model, the ATPase assays presented in the current study 
involving Mcm2-7•Cdt1 complexes or when Cdt1 is added in solution to Mcm2-7 
showed that the hydrolysis of ATP is reduced by approximately two-fold relative to 
Mcm2-7 alone. To further corroborate this, a recent report demonstrated that the binding 
of Cdt1 to Mcm2-7 resulted in a 35% reduction in the ATPase rate 34.  The abrogation in 
ATPase activity, in turn, prevents DNA unwinding. The DNA unwinding assays 
presented in Chapter 3 revealed a two-fold reduction in helicase activity by Mcm2-
7•Cdt1 complexes compared to Mcm2-7 alone. As the energy produced from ATP 
hydrolysis is required for helicase activity, the reduced DNA unwinding activity is due to 
the inhibition in ATPase activity by Mcm2-7. Mcm2-7 demonstrates an ATP-dependent 
DNA binding activity, with approximately 100-fold higher affinity for ssDNA (35 nM)  
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than dsDNA (25µM) 31. As we observed little to no difference in ssDNA binding between 
Mcm2-7 alone and Mcm2-7•Cdt1 complexes, the reduction in ATPase activity is not 
likely due to a defect in ATP binding by Mcm2-7.  
 
In the absence of Cdt1, Mcm2-7 is capable of ATP hydrolysis (Functional ATPase). This 
activity allows Mcm2-7 to unwind duplex DNA. Conversely, an interaction between 
Cdt1 and the C-terminus of Mcm6 induces a structural change that disrupts ATPase 
activity by Mcm2-7 (Inhibited ATPase). In addition to a Cdt1-Mcm6 interaction, Cdt1 
may bind to other sites within Mcm2-7.    
 
 
 
 
 
 
Figure 5.1: Model of inhibition of Mcm2-7 helicase activity by Cdt1 
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5.5 Cdt1 acts to stabilize Mcm2-7 
In vivo, Cdt1 is required for the assembly of Mcm2-7 in both the cytoplasm and 
nucleoplasm prior to pre-RC formation 55.  In vitro reconstitution of the pre-RC using 
purified components from either S. cerevisiae or Xenopus egg extracts has demonstrated 
that Cdt1 is required to load Mcm2-7 onto origins of replication in a high salt-stable 
manner 8-10. Consistent with this, using yeast pre-RC proteins purified from E. coli, we 
demonstrated that Cdt1 is required for origin loading of Mcm2-7. Recently, it was 
demonstrated that while Mcm3, 5 and 7, which are neighbours in the Mcm2-7 hexamer, 
associated (low salt) with origins independently of Cdt1 in the presence of the poorly 
hydrolysable analog of ATP, ATPγS, substoichiometric levels of Mcm2, 4 and 6 were 
present.  In the presence of ATPγS and Cdt1, however, all six Mcm subunits associated 
with origin DNA with equimolar ratio33.  Of note, Cdt1-independent association of 
Mcm2-7 was abolished in the presence of ATP 33.  The authors of that study propose a 
model in which Cdt1 plays a role in stabilizing Mcm2-7 during initial origin recruitment. 
We believe our data fit this model.  In the presence of Cdt1, stoichiometric levels of 
Mcm2-7 subunits were observed, whereas in the absence of Cdt1, multimers and/or 
subcomplexes of Mcm subunits were more pronounced. Furthermore, indicative of Mcm 
release via ATP hydrolysis by ORC-Cdc6 when criteria for appropriate origin licensing 
are not met 33, we observed a reduction in origin association of a subcomplex of Mcm357 
in the presence of ATP relative to ATPγS. Surprisingly, we observed that when ATP was 
added during the purification of Mcm2-7 proteins from G1-arrested yeast extracts, 
hexamers were formed from Mcm subunits in equimolar ratio. Conversely, only Mcm3, 5 
and 7 were isolated in the absence of ATP. Significantly, reconstitutions of Mcm2-7 
complexes from bacterial-expressed proteins were performed in the absence of ATP.  The 
basis for the requirement for ATP during purification of Mcm2-7 complexes from yeast 
extracts is currently unknown. The ATP binding status at ATPase active sites within 
Mcm2-7 is thought to be communicated between subunits and cause conformational 
changes 6.  Predicated on this, we suggest that ATP substitutes for the lack of Cdt1 to 
stabilize the Mcm2-7 hexamer when purified from yeast extracts.  By the same token, 
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conformational changes in Mcm2-7 from Cdt1 binding help to stabilize the Mcm2-7 
hexamer.  
5.6 Conclusions 
Although much work has focused on the Mcm2-7 eukaryotic replicative DNA helicase, 
very little is known about how its activity is regulated during the early stages of the 
initiation of DNA replication. Taken together, the work presented in this thesis will aid in 
decoding the regulatory processes and protein factors involved in modulating Mcm2-7 
activity. I have demonstrated that the C-terminus of budding yeast Mec1 plays a role in 
folding and stability of this kinase; a feature likely common to PIKK family members. 
My results also indicate that Mec1 turnover may be regulated by the proteasome. 
Moreover, I have demonstrated that Cdt1 negatively regulates Mcm2-7 activity. This 
provides a mechanism to prevent untimely DNA unwinding by Mcm2-7. My studies also 
demonstrate that a phosphomimetic mutant of Mcm4 does not augment enzymatic 
activity of Mcm2-7. This suggests that phosphorylation of Mcm4 by DDK alone is not 
sufficient to stimulate the activity of Mcm2-7 and which may involve prior 
phosphorylation by other kinases, such as Mec1.   
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